Advance Program - Society of Thoracic Surgeons

The Society of Thoracic Surgeons

49th A n n u a l Meeting & Exhibition Adva nce Program Los Angeles, California Exhibit dates: january 27 – 29, 2013 meeting dates: january 26 – 30, 2013

Table of Contents Education Disclosure Policy

2

Program At-A-Glance

3

Program Grid

4

Subspecialty Sessions of Interest

6

STS/AATS Tech-Con 2013

8

Saturday, January 26, 2013

10

Sunday, January 27, 2013

11

Monday, January 28, 2013

15

Tuesday, January 29, 2013

21

Wednesday, January 30, 2013

28

Scientific Posters

31

Registration Instructions

36

Travel and Housing Information

37

Pricing 38 Spouse and Guest Activities

39

Sponsors and Exhibitors

40

Annual Meeting Task Forces and Abstract Reviewers

41

THE SOCIETY OF THORACIC SURGEONS

www.sts.org

PRESIDENT’S MESSAGE As President of The Society of Thoracic Surgeons, I invite you to join me for the STS 49th Annual Meeting in Los Angeles. It will be an unparalleled experience that will leave you informed and inspired. The Workforce on Annual Meeting has been hard at work to provide you with an outstanding educational program. One of our exciting new offerings will be co-sponsored by the American Je ff rey B. R ich, MD

College of Chest Physicians and will cover the theory and

practice of endobronchial ultrasound and interventional bronchoscopy as it relates to the practicing cardiothoracic surgeon. We’re also thrilled to welcome Mark B. McClellan, MD, former leader of the FDA and CMS

Future M eetings STS 50th Annual Meeting January 25–29, 2014 Orlando, Florida STS 51st Annual Meeting January 24–28, 2015 San Diego, California STS 52nd Annual Meeting January 23–27, 2016 Phoenix, Arizona

and current Director of the Engelberg Center for Health Care Reform at The Brookings Institution, as the speaker for the Thomas B. Ferguson Lecture. His talk will surely provide an enlightening look at US health care policy. Additionally, we’re honored that Carolyn M. Clancy, MD, Director of the Agency for Healthcare Research and Quality, has agreed to present the C. Walton Lillehei Lecture. I’m also looking forward to our combined STS/American College of Cardiology session, which will include a discussion on the National Coverage Determination for transcatheter aortic valve replacement and the lessons learned from the pilot program that reduced the time between FDA approval and the Medicare coverage decision. One of the things I enjoy most about the Annual Meeting is the chance to connect with colleagues and experts in our specialty, and the upcoming meeting will provide plenty of opportunity for networking. We’ll also be welcoming more than 100 exhibitors to our Exhibit Hall, giving you the chance to stay up-to-date on what’s new in the field. Take a moment now to read through this Advance Program, discover the many choices available, and set your schedule. You’ll see just how much innovation and creativity has gone into planning the STS 49th Annual Meeting. I hope to see you in Los Angeles! Jeffrey B. Rich, MD President, The Society of Thoracic Surgeons

Please note: The information in this program is subject to change. 49th ANNUAL MEETING

Advance Program 1

T he S ociety o f T horacic Surgeons Education D isclosure Policy

As a sponsor of continuing medical education

of influence (e.g., as officer, director, trustee

approved or (b) an off-label use of an approved

accredited by the Accreditation Council for

or public spokesperson). EXCLUDED from this

device, product, or drug must also be disclosed.

Continuing Medical Education (ACCME), The

disclosure requirement are blind trusts or other

This requirement has been adopted in response

Society of Thoracic Surgeons requires that any

passive investments such as mutual funds. In the

to FDA policy and case law involving medical

individual who is in a position to control the

case of a financial or other relationship disclosure,

societies, and is not intended to prohibit or inhibit

content of an educational activity must disclose all

the company, product/service, and specific nature

independent presentation or discussion regarding

relationships with commercial interests (including

of the relationship must be noted. Disclosure is

the uses of devices, products, and drugs as

known relationships of his or her immediate

mandatory for any person involved in the planning,

described in (a) or (b) above.

family, department, and partners). The ACCME

management, presentation, and/or evaluation of

defines a commercial interest as “any entity

STS educational activities.

producing, marketing, reselling, or distributing

For live presentations, all disclosures must be stated orally and on a slide at the beginning

health care goods or services consumed by, or

Failure to disclose all relationships with

of the presentation and will be noted in

used on, patients. The ACCME does not consider

commercial interests disqualifies the individual

published material related to the activity. Slides,

providers of clinical service directly to patients

from being a planning committee member, a

handouts, and other materials utilized as part

to be commercial interests.” The question of

teacher, or an author of educational materials,

of an educational activity cannot contain any

whether a disclosed conflict situation could

and this individual cannot have any responsibility

advertising, trade names or a product group

represent undue influence on the educational

for the development, management, presentation,

message. Speakers are required to disclose that

activity by a commercial interest or whether the

or evaluation of STS educational activities. This

they have nothing to disclose if this is the case.

disclosed information is sufficient to consider

requirement is intended neither to imply any

an abstract, presentation, or other educational

impropriety of such relationships nor to prejudice

Amended by the STS Executive Committee:

enduring material to represent potentially

any individual planner, presenter or author. It

April 11, 2012

biased information must be resolved prior to

is merely to identify such relationships through

an individual’s involvement in STS educational

full disclosure, and to allow STS to assess and

programming.

resolve potential influences on the educational activity prior to the planning and implementation

Required disclosures include (1) a financial interest

of an educational activity. If no relationships with

of any amount (e.g., through ownership of stock,

commercial interests exist, the individual must

stock options, or bonds) (2) the receipt of any

indicate this on the disclosure form.

amount of cash, goods or services within the current 12-month period (e.g., through research

Additionally, the fact that the presentation, paper,

grants, employment, consulting fees, royalties,

or other educational product describes (a) the

travel, or gifts) or (3) a nonremunerative position

use of a device, product, or drug that is not FDA

A c c r e d i tat i o n S tat e m e n t

S T S / S C A : I n t r a o p e r at i v e E c h o a n d D e c i s i o n Ma k i n g i n Ca r d i o vas c u l a r S u r g e ry

The Society of Thoracic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Board of Cardiovascular Perfusion designates this activity for 4.2 Category I CEUs.

STS 49th Annual Meeting The Society of Thoracic Surgeons designates this live activity for a maximum of 28.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Board of Cardiovascular Perfusion designates this activity for 32.9 Category I CEUs.

2


The Society of Thoracic Surgeons designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

S T S / A CCP : P r i m e r o n A d va n c e d a n d T h e r a p e u t i c B r o n c h o s c o p y : T h e o ry a n d Ha n d s - O n S e ss i o n The Society of Thoracic Surgeons designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Board of Cardiovascular Perfusion designates this activity for 4.8 Category I CEUs.

www.sts.org

P ROGR AM AT-A- GLA NCE

Friday, January 25, 2013

Monday, January 28, 2013

3:00 PM – 6:00 PM Registration: STS/AATS Tech-Con 2013 and STS 49th Annual Meeting

6:30 AM – 5:00 PM Registration: STS 49th Annual Meeting

Saturday, January 26, 2013 7:00 AM – 6:00 PM Registration: STS/AATS Tech-Con 2013 and STS 49th Annual Meeting ONE 8:00 AM – 12:00 PM ADMIT STS/SCA: Intraoperative Echo and Decision Making in Cardiovascular Surgery ONE 8:00 AM – 12:15 PM ADMIT NEW! STS/ACCP: Primer on Advanced and Therapeutic Bronchoscopy: Theory and Hands-On Session

7:15 AM – 10:45 AM General Session I

8:15 AM – 11:45 AM General Session II

7:15 AM – 7:35 AM Opening Remarks

8:15 AM – 9:15 AM J. Maxwell Chamberlain Memorial Paper Presentations

7:35 AM – 7:45 AM Introduction of New Members 7:45 AM – 8:30 AM Richard E. Clark Paper Presentations 8:30 AM – 9:30 AM Thomas B. Ferguson Lecture 9:00 AM – 4:30 PM Scientific Posters Open

12:00 PM – 6:30 PM STS/AATS Tech-Con 2013 Exhibits

9:00 AM – 4:30 PM STS Exhibit Hall Open

1:00 PM – 2:30 PM STS Cardiopulmonary Bypass Simulation Course

9:45 AM – 10:45 AM Jeffrey B. Rich Presidential Address

1:00 PM – 5:00 PM STS/AATS Tech-Con 2013

11:30 AM – 12:30 PM (7 parallel sessions)

5:00 PM – 6:30 PM STS/AATS Tech-Con 2013 Reception

Adult Cardiac Session: Arrhythmia Adult Cardiac Session: Heart Failure Congenital Session: Adult Congenital General Thoracic Session: New Techniques and Bioassays Basic Science Research Critical Care Affordable Care Act

Sunday, January 27, 2013 7:00 AM – 6:30 PM Registration: STS/AATS Tech-Con 2013 and STS 49th Annual Meeting 7:00 AM – 8:00 AM STS/AATS Tech-Con 2013 Continental Breakfast 7:00 AM – 3:00 PM STS/AATS Tech-Con 2013 Exhibits ONE 7:50 AM – 12:00 PM ADMIT STS Practice Management Summit

1:15 PM – 5:15 PM Joint Council on Thoracic Surgery Education: Cardiothoracic Surgical Education 1:30 PM – 3:30 PM (6 parallel sessions)

8:00 AM – 11:35 AM STS/AATS Tech-Con 2013

Adult Cardiac Session: Aortic Adult Cardiac Session: Ischemic Congenital Session: Pediatric Congenital I General Thoracic Session: Lung Cancer I General Thoracic Session: Lung Transplantation ACC @ STS

1:00 PM – 4:00 PM Residents Symposium: Transitioning from Training to Practice

4:15 PM – 5:15 PM Surgical Motion Pictures Matinees: Adult Cardiac, Congenital, and General Thoracic

ONE 8:00 AM – 4:30 PM ADMIT STS/AATS Cardiothoracic Critical Care Symposium

ONE 1:15 PM – 4:30 PM ADMIT Parallel Surgical Symposia: Congenital and General Thoracic Surgery

1:15 PM – 4:30 PM STS/AATS Tech-Con 2013 2:30 PM – 4:30 PM Associate Membership Symposium: Interprofessional Leadership in the Operating Room and Lung Cancer Treatment

4:15 PM – 5:15 PM Late-Breaking Sessions 4:15 PM – 5:15 PM General Thoracic Session: Mediastinal/Pulmonary I 5:00 PM – 6:30 PM Scientific Posters and Wine 5:30 PM – 6:30 PM Business Meeting (STS Members Only)

4:30 PM – 6:30 PM Scientific Posters Open


4:30 PM – 6:30 PM Opening Reception in STS Exhibit Hall

6:30 AM – 4:30 PM Registration: STS 49th Annual Meeting

ONE 4:30 PM – 6:30 PM ADMIT International Reception and Symposium: Choosing Repair or Replacement in Rheumatic Mitral Valve Disease

ADMIT ONE

ONE 7:00 AM – 8:00 AM ADMIT Early Riser Health Policy Forum: Transitioning from the Sustainable Growth Rate Formula—Solutions for Medicare Physician Payment Reform

ONE 7:00 AM – 8:00 AM ADMIT Early Riser Sessions

9:00 AM – 4:30 PM Scientific Posters Open 9:00 AM – 4:30 PM STS Exhibit Hall Open 9:15 AM – 9:45 AM The Society of Thoracic Surgeons: Moving Cardiothoracic Surgery Forward 10:30 AM – 10:45 AM Award Presentations: President’s Award TSDA Benson R. Wilcox Award TSRA Socrates Award Earl Bakken Scientific Achievement Award 10:45 AM – 11:45 AM C. Walton Lillehei Lecture ONE 11:45 AM – 12:45 PM ADMIT Ethics Debate: Patients Declared Dead for Organ Donation Are Not Really Dead: Should the Dead Donor Rule Be Abandoned?

11:45 AM – 12:45 PM Residents Luncheon 12:45 PM – 2:45 PM (7 parallel sessions) Adult Cardiac Session: Mitral Valve Adult Cardiac Session: TAVR Congenital Session: Pediatric Congenital II General Thoracic Session: Esophageal General Thoracic Session: Lung Cancer II Patient Safety Symposium: The Nexus of Data, Outcomes, and Public Awareness NEW! SCA @ STS 3:30 PM – 5:30 PM (7 parallel sessions) Adult Cardiac Session: General Adult Cardiac Session: Aortic Valve Congenital Session: Pediatric Congenital III General Thoracic Session: Mediastinal/Pulmonary II NEW! Cardiothoracic Surgical Education NEW! Clinical Trials: Reflections on Old and Plans for New NEW! What CT Surgeons Need to Know About Vascular Surgery in 2013 ONE 6:30 PM – 9:00 PM ADMIT STS Social Event

Wednesday, JANUARY 30, 2013 6:30 AM – 9:30 AM Registration: STS 49th Annual Meeting ONE 7:00 AM – 10:00 AM ADMIT STS University Courses

Indicates that a ticket is required to attend. *Invited 49th ANNUAL MEETING

Advance Program 3

p rogr am grid

Registration

7:00 AM

7:30 AM

8:00 AM

General

8:30 AM

Adult Cardiac

9:00 AM

9:30 AM

Congenital

10:00 AM

10:30 AM

General Thoracic

11:00 AM

11:30 AM

12:00 PM

Friday

6:30 AM

STS/AATS Tech-Con

Registration

Saturday

STS/SCA: Intraoperative Echo and Decision Making in Cardiovascular Surgery STS/ACCP: Primer on Advanced and Therapeutic Bronchoscopy: Theory and Hands-On Session

Registration STS/AATS Tech-Con 2013 Exhibits STS Practice Management Summit STS/AATS Cardiothoracic Critical Care Symposium

sunday

STS/AATS Tech-Con 2013

Registration Scientific Posters Open Exhibits Open General Session I

monday

Adult Cardiac Session Adult Cardiac Session Congenital Session General Thoracic Session Basic Science Research Critical Care Affordable Care Act

Registration Early Riser Sessions

Scientific Posters Open

Health Policy Forum

Exhibits Open General Session II Ethics Debate

wednesday

tuesday

Residents Luncheon

4

Registration STS University Courses


www.sts.org

p rogr am grid

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

5:00 PM

5:30 PM

6:00 PM

Registration

STS/AATS Tech-Con 2013 Exhibits STS/AATS Tech-Con 2013 STS Cardiopulmonary Bypass Simulation Course

STS/AATS Tech-Con 2013 Reception

STS/AATS Tech-Con 2013 Residents Symposium: Transitioning from Training to Practice Congenital Parallel Surgical Symposium General Thoracic Parallel Surgical Symposium Associate Membership Symposium Scientific Posters Open Opening Reception in Exhibit Hall International Reception & Symposium

Joint Council on Thoracic Surgery Education: Cardiothoracic Surgical Education Adult Cardiac Session Adult Cardiac Session

Surgical Motion Pictures

Congenital Session

Late-Breaking Sessions

General Thoracic Session



Scientific Posters and Wine

ACC @ STS

Business Meeting

Adult Cardiac Session




Congenital Session

Congenital Session




Cardiothoracic Surgical Education

SCA @ STS

Clinical Trials: Reflections on Old and Plans for New

Patient Safety Symposium

What CT Surgeons Need to Know About Vascular Surgery

49th ANNUAL MEETING

Advance Program 5

S u b s p eci a lty S essions o f I nterest

The following is a list of sessions with particular

A D U LT C A R D I AC SU RG ERY



7:00 AM – 8:00 AM Early Riser Session #1: STS National Database: Adult Cardiac Surgery

focus in three subspecialty areas: adult cardiac, general thoracic, and congenital heart surgery. The poster sessions listed on pages 31–34 are also divided by subspecialty.

1:00 PM – 2:45 PM STS/AATS Tech-Con 2013: Joint Session – Cardiac and General Thoracic 3:15 PM – 5:00 PM STS/AATS Tech-Con 2013: Cardiac Track I – Coronary

Sunday, January 27, 2013 8:00 AM – 9:35 AM STS/AATS Tech-Con 2013: Cardiac Track II – The Changing Landscape of Aortic Valve Therapies

Early Riser Session #6: How to Start a TAVR Program Early Riser Session #7: Mechanical Circulatory Support and LVAD Early Riser Session #8: Simulation in Cardiothoracic Surgery 8:55 AM – 9:15 AM J. Maxwell Chamberlain Memorial Paper for Adult Cardiac Surgery: Composite Analysis of 189,793 Medicare Patients with Multi-vessel Coronary Disease Demonstrates a Long-Term Advantage for CABG Compared to Stent Placement

10:20 AM – 11:35 AM STS/AATS Tech-Con 2013: Cardiac Track III – Next Generation TAVR Devices

12:45 PM – 2:45 PM Adult Cardiac Session: Mitral Valve

1:15 PM – 2:50 PM STS/AATS Tech-Con 2013: Cardiac Track IV – Leaking Valves and Failing Pumps

3:30 PM – 5:30 PM Adult Cardiac Session: Aortic Valve

3:20 PM – 4:30 PM STS/AATS Tech-Con 2013: Cardiac Track V – Thoracic Vascular


4:30 PM – 6:30 PM International Reception and Symposium: Choosing Repair or Replacement in Rheumatic Mitral Valve Disease

Adult Cardiac Session: TAVR

Adult Cardiac Session: General

Wednesday, January 30, 2013 7:00 AM – 10:00 AM STS University Course #1: Mitral Valve Repair STS University Course #2: Valve-Sparing Root Replacement and Aortic Arch Repair

Monday, January 28, 2013 7:45 AM – 8:00 AM Richard E. Clark Paper for Adult Cardiac Surgery: Preoperative Beta-Blocker Use Should Not Be Used as a Quality Metric for Coronary Artery Bypass Grafting: A Statewide, Multi-institutional STS Adult Cardiac Surgery Database Analysis 11:30 AM – 12:30 PM Adult Cardiac Session: Arrhythmia

STS University Course #3: Hybrid Revascularization STS University Course #4: TAVR/TEVAR STS University Course #5: Short- and Long-Term Mechanical Support

Congenital Heart Surgery

Adult Cardiac Session: Heart Failure Basic Science Research


1:30 PM – 3:30 PM Adult Cardiac Session: Aortic

1:15 PM – 4:30 PM Parallel Surgical Symposium: Congenital

Adult Cardiac Session: Ischemic ACC @ STS 4:15 PM – 5:15 PM Surgical Motion Pictures Matinee: Adult Cardiac 5:00 PM – 6:30 PM Scientific Posters and Wine: Adult Cardiac

Monday, January 28, 2013 8:15 AM – 8:30 AM Richard E. Clark Paper for Congenital Heart Surgery: Multi-institutional Experience with Surgery for Ebstein’s Malformation: An Analysis of the STS Congenital Heart Surgery Database 11:30 AM – 12:30 PM Congenital Session: Adult Congenital Basic Science Research 1:30 PM – 3:30 PM Congenital Session: Pediatric Congenital I

6


www.sts.org

S u b s p eci a lty S essions o f I nterest

4:15 PM – 5:15 PM Surgical Motion Pictures Matinee: Congenital 5:00 PM – 6:30 PM Scientific Posters and Wine: Congenital


Monday, January 28, 2013 8:00 AM – 8:15 AM Richard E. Clark Paper for General Thoracic Surgery: Evaluation of the Reliability of Clinical Staging of T2N0 Esophageal Cancer: A Review of the STS General Thoracic Surgery Database

7:00 AM – 8:00 AM Early Riser Session #3: STS National Database: Congenital Heart Surgery

11:30 AM – 12:30 PM General Thoracic Session: New Techniques and Bioassays

Early Riser Session #12: Controversies in Aortic Valve Repair in Congenital Patients

1:30 PM – 3:30 PM General Thoracic Session: Lung Cancer I

8:35 AM – 8:55 AM J. Maxwell Chamberlain Memorial Paper for Congenital Heart Surgery: Effect of Conduit Type and Size on Right Ventricle-Pulmonary Artery Conduit Durability in Infants Less Than 2 Years of Age: A Congenital Heart Surgeons’ Society Study

General Thoracic Session: Lung Transplantation

12:45 PM – 2:45 PM Congenital Session: Pediatric Congenital II 3:30 PM – 5:30 PM Congenital Session: Pediatric Congenital III

Wednesday, January 30, 2013 7:00 AM – 10:00 AM STS University Course #12: Traditional and Modified Konno Procedures

General Thoracic Surgery

Saturday, January 26, 2013 1:00 PM – 2:45 PM STS/AATS Tech-Con 2013: Joint Session – Cardiac and General Thoracic 3:15 PM – 5:00 PM STS/AATS Tech-Con 2013: General Thoracic Track I – Current Technology Update

4:15 PM – 5:15 PM Surgical Motion Pictures Matinee: General Thoracic General Thoracic Session: Mediastinal/Pulmonary I 5:00 PM – 6:30 PM Scientific Posters and Wine: General Thoracic

Tuesday, January 29, 2013 7:00 AM – 8:00 AM Early Riser Session #2: STS National Database: General Thoracic Surgery Early Riser Session #9: Starting a Stereotactic Body Radiation Therapy Program: Thoracic Surgery Involvement in the Next Frontier Early Riser Session #10: Starting a Lung Cancer Screening Program 8:15 AM – 8:35 AM J. Maxwell Chamberlain Memorial Paper for General Thoracic Surgery: National Cooperative Group Trials of “High-Risk” Patients with Lung Cancer: Are They Truly High-Risk? 12:45 PM – 2:45 PM General Thoracic Session: Lung Cancer II General Thoracic Session: Esophageal 3:30 PM – 5:30 PM General Thoracic Session: Mediastinal/Pulmonary II


Wednesday, January 30, 2013

8:00 AM – 9:35 AM STS/AATS Tech-Con 2013: General Thoracic Track II – A Look into the Future of Thoracic Surgery

7:00 AM – 10:00 AM STS University Course #6: VATS and Robotic Lobectomy

10:20 AM – 11:35 AM STS/AATS Tech-Con 2013: General Thoracic Track III – Endoluminal, Minimally Invasive, and Ex-Vivo

STS University Course #7: Ultrasound- and Navigation-Guided Bronchoscopy

1:15 PM – 4:30 PM Parallel Surgical Symposium: General Thoracic

STS University Course #8: Novel Techniques in Esophageal and Tracheal Surgery STS University Course #9: Chest Wall Resection and Reconstruction/Thoracic Outlet Syndrome

49th ANNUAL MEETING

Advance Program 7

STS /AATS Tech-Con 2013

Registration: STS/AATS Tech-Con 2013 and STS 49th Annual Meeting

Interactive presentations on the most novel therapies in adult cardiac and general thoracic surgery will enhance the superior educational experience at STS/AATS Tech-Con 2013.

3:00 PM – 6:00 PM

The program will open with a joint cardiac and general thoracic surgery session that will look to the future and discuss how cardiac and general thoracic surgeons can innovate. Separate cardiac and general thoracic surgery sessions will follow with discussions on coronary revascularization strategies, how to improve coronary artery bypass grafting (CABG) results, and extracorporeal membrane oxygenation (ECMO). General thoracic and cardiac surgery will have parallel tracks on Sunday. Among the topics featured in the general thoracic surgery sessions are peroral endoscopic myotomy, minimally invasive foregut techniques, and tracheal replacement. The adult cardiac surgery track will focus on the changing landscape of aortic valve therapies, next generation transcatheter aortic valve replacement (TAVR) devices, congestive heart failure, and much more.

Friday, January 25, 2013 7:00 AM – 6:00 PM

Saturday, January 26, 2013 7:00 AM – 6:30 PM


Don’t miss these exciting, cutting-edge presentations! Make plans now and register for Tech-Con 2013. SATURDAY, JANUARY 26, 2013

3:15 PM

Is All Arterial Grafting the Standard of Care? Joseph F. Sabik III, Cleveland, OH

4:21 PM Could Better OPCAB Technology Further Improve Outcomes? Husam H. Balkhy, West Allis, WI

3:25 PM

Hybrid Approach Allows for A Optimal Therapy for Long-Term Benefit: Percutaneous Coronary Intervention Plus CABG and Post-CABG Catheterization John G. Byrne, Nashville, TN

4:29 PM Debate: Totally Endoscopic Coronary Artery Bypass (TECAB) Is Now and Will Remain an Investigational Procedure Pro: Ralph J. Damiano Jr., St. Louis, MO Con: Johannes Bonatti, Baltimore, MD

1:00 PM – 2:45 PM

Joint Session – Cardiac and General Thoracic Moderators: Gregory P. Fontana, New York, NY, and Keith S. Naunheim, St. Louis, MO 1:00 PM

elcome and Introductory Remarks W Gregory P. Fontana, New York, NY

1:05 PM Cardiac Surgeon: The Year 2020 Michael J. Mack, Plano, TX 1:25 PM

eneral Thoracic Surgeon: The Year 2020 G G. Alexander Patterson, St. Louis, MO

4:49 PM Debate: The Ongoing Off-Pump 3:35 PM CABG (OPCAB) Conundrum: OPCAB is Superior to ONCAB John D. Puskas, Atlanta, GA

1:45 PM The Cardiac Surgical Innovator: Opportunities Abound! Jacques R. Seguin, Creteil, France* 2:05 PM The General Thoracic Surgical Innovator: Opportunities Abound! Thomas A. D’Amico, Durham, NC 2:25 PM “Thinking Way Outside the Box” William E. Cohn, Houston, TX*

3:55 PM

BREAK – Visit STS/AATS Tech-Con 2013 Exhibits

Moderator: Marc de Perrot, Toronto, ON, Canada

CABG Crossfire

3:20 PM ECMO, ECMO Alternatives, and Mobile Products Matthew G. Hartwig, Durham, NC

Session II: Can CABG Results Significantly Improve? Is Facilitating Technology Required?

4:05 PM eMesh I Study Michele F. Genoni, Kilchberg, Switzerland

3:15 PM – 5:00 PM

Cardiac Track I – Coronary Session I: Coronary Revascularization: Strategies

3:15 PM – 5:00 PM

General Thoracic Track I – Current Technology Update

ebate: The Issue Is Settled: CABG D Should Be Performed On-Pump Unless Contraindicated O. Wayne Isom, New York, NY*

Moderators: Robert S. Poston, Tucson, AZ, and William E. Cohn, Houston, TX

2:45 PM – 3:15 PM

CABG Advances Crossfire

4:13 PM Anastomotic Devices: It Is About the Anastomosis! Nirav C. Patel, New York, NY

Moderators: Robert W. Emery, Minneapolis, MN, and Robert A. Guyton, Atlanta, GA

3:15 PM Introductory Remarks Marc de Perrot, Toronto, ON, Canada

3:45 PM Localization of Lung Nodules Min P. Kim, Houston, TX 4:10 PM Internet Presence/Website Development William R. Mayfield, Marietta, GA* 4:35 PM Video-Assisted Thoracic Surgery (VATS) Enabling Tools and Intraoperative Event Management Todd L. Demmy, Buffalo, NY 5:00 PM – 6:30 PM

STS/AATS Tech-Con 2013 Reception

A c c r e d i tat i o n S tat e m e n t The Society of Thoracic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

S T S / A AT S T e c h - c o n 2 0 13 The Society of Thoracic Surgeons designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Board of Cardiovascular Perfusion designates this activity for 10.9 Category I CEUs. 8


www.sts.org

STS /AATS Tech-Con 2013


10:27 AM The Valves – CoreValve Zeus Michael J. Reardon, Houston, TX

1:47 PM Left Atrial Appendage Closure A. Marc Gillinov, Cleveland, OH

Cardiac Track II – The Changing Landscape of Aortic Valve Therapies

10:34 AM The Valves – Portico Gregory P. Fontana, New York, NY

Session II: Congestive Heart Failure

Moderators: Gregory P. Fontana, New York, NY, and Joseph E. Bavaria, Philadelphia, PA

10:41 AM The Valves – Sadra TBD

8:00 AM The Surgeon in the Cath Lab: Training, Skills, and Politics Mathew R. Williams, New York, NY

10:48 AM The Valves – Direct Flow Steven F. Bolling, Ann Arbor, MI

8:00 AM – 9:35 AM

The Rapidly Evolving Landscape in the 8:10 AM Treatment of Aortic Stenosis Sapien Valve: Todd M. Dewey, Dallas, TX CoreValve: Michael J. Reardon, Houston, TX Debate: Alternative Access: Is Femoral 8:30 AM First Strategy Baseless? Pro: Vinod H. Thourani, Atlanta, GA Con: Raj Makkar, Los Angeles, CA

10:55 AM Facilitating Technology: Closure, Expandable Sheaths, Distal Protection Raj Makkar, Los Angeles, CA 11:05 AM Surgical AVR in One Hour Skin to Skin? (Ministernotomy and Rapid Deployment Devices) Michael A. Borger, Leipzig, Germany

10:20 AM – 11:35 AM

Impact of TAVR Commercialization on the 9:05 AM Surgical Treatment of Aortic Stenosis Thomas Walther, Leipzig, Germany

Moderator: Joseph B. Shrager, Stanford, CT

Changing Landscape of Aortic Valve 9:25 AM Therapies Crossfire

11:35 AM – 11:50 AM

8:00 AM Peroral Endoscopic Myotomy (POEM) Haruhiro Inoue, Yokohama, Japan*

11:50 AM – 1:00 PM

8:25 AM Thoracic Imaging and Localization (Hybrid Room) Kazuhiro Yasufuku, Toronto, ON, Canada

1:00 PM – 1:15 PM

Networking Lunch BREAK – Visit STS/AATS Tech-Con 2013 Exhibits

8:50 AM Tracheal Replacement Philippe G. Dartevelle, Le Plessis Robinson, France*

1:15 PM – 2:50 PM

9:15 AM Discussion

Session I: Mitral Valve Disease

9:35 AM – 10:20 AM

Moderators: Michael Argenziano, New York, NY, and Nirav C. Patel, New York, NY

10:20 AM – 11:35 AM

1:15 PM The Next Wave of Percutaneous Therapy Repair: Francesco Maisano, Milan, Italy Replacement: Joseph E. Bavaria, Philadelphia, PA

10:20 AM The Valves – Sapien III and Centera Anson Cheung, Vancouver, BC, Canada

Medical Therapy Will Remain the Treatment for the Vast Majority of CHF Patients for the Foreseeable Future Jignesh K. Patel, Los Angeles, CA*

BREAK

3:20 PM – 4:30 PM 10:45 AM New Minimally Invasive Foregut Techniques Katie S. Nason, Pittsburgh, PA

Moderator: M. Blair Marshall, Washington, DC

Moderators: Arvind K. Agnihotri, Boston, MA, and Robert C. Hagberg, Hartford, CT

Ventricular Assist: Is It Reasonable? TBD

2:50 PM – 3:20 PM

10:20 AM Endoluminal Esophagus Wayne L. Hofstetter, Houston, TX


Cardiac Track III – Next Generation TAVR Devices

2:20 PM Debate: For Class II and III Congestive Heart Failure, What Is the Best Therapeutic Option?

2:40 PM CHF Crossfire

11:10 AM Ex-Vivo Lung Salvage for Transplant Shaf Keshavjee, Toronto, ON, Canada


2:10 PM Mini–Ventricular Assist Devices Will Revolutionize the Treatment for CHF Anson Cheung, Vancouver, BC, Canada

General Thoracic Track III – Endoluminal, Minimally Invasive, and Ex-Vivo

8:00 AM – 9:35 AM

General Thoracic Track II – A Look into the Future of Thoracic Surgery

1:55 PM Cell Therapy for the Failing Heart Eduardo Marbán, Los Angeles, CA

11:15 AM TAVR Crossfire

Alternative Access: What They Afford to 8:55 AM TAVR and Beyond Anson Cheung, Vancouver, BC, Canada

Moderate Risk AVR: How Good Does 9:15 AM TAVR Need to Be? Friedrich W. Mohr, Leipzig, Germany

Moderators: John V. Conte, Baltimore, MD, and Nicholas G. Smedira, Cleveland, OH*

Cardiac Track IV – Leaking Valves and Failing Pumps

Cardiac Track V – Thoracic Vascular Moderators: Ali Khoynezhad, Los Angeles, CA, and Joseph S. Coselli, Houston, TX 3:20 PM Debate: Endovascular Therapies for Thoracic Aortic Disease Should Be Reserved for Inoperable and High-Risk Surgical Patients Pro: Leonard N. Girardi, New York, NY Con: Eric E. Roselli, Cleveland, OH Primary Stenting for Acute Type B Aortic 3:36 PM Dissection Wilson Y. Szeto, Philadelphia, PA Innovative Endovascular Solutions 3:46 PM Descending Thoracic and Thoracoabdominal G. Chad Hughes, Durham, NC 3:56 PM Advances in Stent Technology: Leaning Toward All Endovascular Solutions for Thoracic Aortic Disease Ali Khoynezhad, Los Angeles, CA 4:06 PM Thoracic Vascular Crossfire

1:31 PM Will Robotic Mitral Valve Repair Make it to Mainstream? Yes: Tomislav Mihaljevic, Cleveland, OH No: Friedrich W. Mohr, Leipzig, Germany

4:16 PM “This is How I See It” Crossfire Irving L. Kron, Charlottesville, VA versus William E. Cohn, Houston, TX Facilitator: Gregory P. Fontana, New York, NY

*Invited 49th ANNUAL MEETING

Advance Program 9


7:00 AM – 6:00 PM

Registration: STS/AATS Tech-Con 2013 and STS 49th Annual Meeting 8:00 AM – 12:00 PM

ADMIT ONE

STS/SCA: Intraoperative Echo and Decision Making in Cardiovascular Surgery Course Description: Intraoperative echo is an integral component of successful cardiac surgery. This course will include instruction on standard intraoperative transesophageal echocardiogram (TEE) imaging techniques and their interpretation. The utility of TEE in the intraoperative decision making process will be demonstrated by interactive case presentations of patients undergoing surgery of the mitral valve, aortic valve, and thoracic aorta. Learning Objectives: Upon completion of this program, participants should be able to:  Identify the routine imaging planes for TEE diagnosis and identification of cardiac structures;  Correlate TEE imaging planes to cardiac anatomy;  Verbalize how a 3D image may augment surgical decision making;  Recognize normal and abnormal ventricular function;  Discuss the role of echocardiography for the assessment of hemodynamic instability;  Discuss the role of intraoperative echo in the decision making process for patients undergoing mitral valve surgery; and  Discuss the role of intraoperative echo in the decision making process in aortic valve and thoracic aorta surgery. Course Directors: John V. Conte, Baltimore, MD, and Katherine P. Grichnik, Durham, NC

Session I: Basics of Intraoperative Echocardiography 8:00 AM Introduction on the Need for Echocardiography Knowledge Among CT Surgeons John V. Conte, Baltimore, MD 8:10 AM Cardiac Anatomy and Image Planes Katherine P. Grichnik, Durham, NC 8:25 AM 3D Echocardiography – Orientation and Use in the OR Stan K. Shernan, Boston, MA 8:45 AM Ventricular Function (RV/LV): Normal and Abnormal Solomon Aronson, Durham, NC 9:05 AM You Are the Expert: Use of Echo for Hemodynamic Instability Katherine P. Grichnik, Durham, NC, Stan K. Shernan, Boston, MA, Solomon Aronson, Durham, NC, and Aman Mahajan, Los Angeles, CA

8:00 AM – 12:15 PM

ADMIT ONE

STS/ACCP: Primer on Advanced and Therapeutic Bronchoscopy: Theory and Hands-On Session Course Description: This course will introduce participants to the theory and practice of endobronchial ultrasound and interventional bronchoscopy as relevant to the practicing thoracic surgeon. The target is the practicing surgeon who wishes to expand his/her scope of practice and become familiar with the increasing array of technological solutions to lung cancer staging and management of airway obstruction. A combination of lectures, case presentations, and simulation will be used to teach the basics of endobronchial ultrasound (EBUS), endobronchial ultrasound guided biopsy, and the management of airway obstruction by stenting and several modalities of tumor ablation. Several hands-on workstations will be available for participants to gain exposure to and familiarity with EBUS endoscopes, cryoablative technology, rigid bronchoscopes, and airway stent deployment. Learning Objectives: Upon completion of this program, participants should be able to:  Identify indications, yield, and complications of EBUS;  Recognize benefits and limitations of airway ablative modalities; and  Outline benefits and limitations of various airway stents. Course Directors: Momen M. Wahidi, Durham, NC, and Richard I. Whyte, Boston, MA 8:00 AM Welcome and Course Overview Momen M. Wahidi, Durham, NC, and Richard I. Whyte, Boston, MA 8:05 AM Endobronchial Ultrasound: Guidance of Transbronchial Needle Aspiration (TBNA) Momen M. Wahidi, Durham, NC 8:30 AM Airway Stents: Silicone, Metallic, and Hybrid Michael S. Mulligan, Seattle, WA 8:55 AM Ablative Modalities in the Airways: Laser, Electrocautery, Argon Plasma Coagulation (APC), and Cryotherapy Stephen R. Hazelrigg, Springfield, IL 9:20 AM

Q&A

Hands-On Breakout Sessions 9:30 AM – 12:15 PM Station Rotations

9:30 AM Break

Station 1: Interactive Case Discussions Stations 2 & 3: EBUS-TBNA on Airway Models Station 4: Electrocautery, APC, and Cryotherapy Station 5: Airway Stents

Session II: Decision Making in Cardiovascular Surgery

1:00 PM – 2:30 PM

9:15 AM Discussion

10:00 AM

TEE Assessment in Mitral Valve Surgery Stan K. Shernan, Boston, MA

10:25 AM

Decision Making in Mitral Valve Surgery Prem S. Shekar, Boston, MA, and John V. Conte, Baltimore, MD

10:50 AM

Discussion

11:00 AM

TEE Assessment in Surgery of the Aortic Valve and Thoracic Aorta Aman Mahajan, Los Angeles, CA

11:25 AM

Decision Making in Aortic Valve and Thoracic Aortic Surgery Richard J. Shemin, Los Angeles, CA*

11:50 AM Discussion 10


www.sts.org

STS Cardiopulmonary Bypass Simulation Course Course Director: Thomas E. MacGillivray, Boston, MA

S und ay, J anuary 27, 2013

7:00 AM – 6:30 PM

Registration: STS/AATS Tech-Con 2013 and STS 49th Annual Meeting 7:50 AM – 12:00 PM

ADMIT ONE

Practice Management Summit Course Description: Concerns over changes in health care have impacted providers and hospitals alike. Quality based initiatives, data reporting, and reimbursements under the Affordable Care Act have become more closely linked than ever before. Concerns about the status quo and incentives of health care alignment have resulted in health systems increasingly engaging cardiothoracic surgeons to aid in program development and quality improvement. This summit has been designed to guide participants in how to interpret trends in health care that may directly impact cardiothoracic surgical practice. Learning Objectives: Upon completion of this program, participants should be able to:  Summarize the philosophical and regulatory changes behind value-based health care reform and its impact on cardiothoracic surgery;  Describe and evaluate current quality initiatives;  Interpret knowledge from bundled payments for acute episodic care;  Identify new procedural terminology codes and upcoming changes to the Medicare fee schedule; and  Appreciate the governance and management implications behind the alignment of cardiovascular services and its impact on cardiothoracic surgery.

Session I: Health Care Delivery in Cardiothoracic Surgery Moderators: Vinay Badhwar, Pittsburgh, PA, and Frank L. Fazzalari, Ann Arbor, MI 7:50 AM Introductory Remarks Vinay Badhwar, Pittsburgh, PA, and Jeffrey B. Rich, Norfolk, VA 8:00 AM The Impact of the Affordable Care Act on CT Surgery: Value-Based and Outcome-Directed Health Care Delivery Jeffrey B. Rich, Norfolk, VA

11:00 AM Economic Realities of Community TAVR Programs in the United States: Revisiting Fiscal and Strategic Drivers in the Post-Market Approval Era Drew Rector, Rockledge, FL 11:20 AM Reimbursement in Cardiothoracic Surgery 2013–2014 Peter K. Smith, Durham, NC 11:40 AM

Open Panel Discussion Forum

8:00 AM – 4:30 PM

ADMIT ONE

STS/AATS Cardiothoracic Critical Care Symposium Course Description: This symposium is dedicated to advancing knowledge and expertise in the complex field of cardiothoracic critical care. The American Board of Thoracic Surgery recognizes critical care as a core component of thoracic surgery. As cardiothoracic critical care rapidly evolves, this symposium is designed to update cardiothoracic surgeons and members of their critical care teams on the unique physiology, operations, procedures, and potential complications of cardiothoracic patients. Learning Objectives: Upon completion of this course, participants should be able to:  Apply principles of goal-directed hemodynamic management;  Integrate into practice protocols for blood management in the CT ICU;  Practice pathways to early extubation;  Integrate state-of-the-art renal replacement therapy into the practice of CT critical care;  Discuss the application of principles of crew resource management to CT critical care;  Apply principles to prevent and manage hospital acquired infections;  Discuss the management of chronic thromboembolic pulmonary hypertension;  Describe the latest ventricular assist device (VAD) technology and the management of the associated complications;  Recognize the challenges of the CT critical care of obese patients; and  Apply the latest protocols for postoperative atrial fibrillation. Moderators: Nevin M. Katz, Baltimore, MD, and Michael S. Mulligan, Seattle, WA

8:20 AM The Economic Impact of Quality in Cardiothoracic Surgery John E. Mayer Jr., Boston, MA*

8:00 AM

W elcome and Opening Remarks Michael S. Mulligan, Seattle, WA

8:40 AM The Future of National Public Reporting of STS Data, Beginning with the New AVR Composite Jeffrey P. Jacobs, St. Petersburg, FL

8:10 AM

oal-Directed Hemodynamic Management G Nevin M. Katz, Baltimore, MD

9:00 AM The Acute Care Episode (ACE) Demonstration Project in Cardiovascular Care: Lessons Learned Mark A. Ammons, Denver, CO* 9:20 AM

Open Panel Discussion Forum

9:50 AM Break

Session II: Defining Health System Value

8:40 AM Management of Postoperative Atrial Fibrillation Ralph J. Damiano Jr., St. Louis, MO 9:10 AM VAD Technology and Management of Complications in the ICU John V. Conte, Baltimore, MD 9:40 AM

Case Scenarios Nahush A. Mokadam, Seattle, WA

10:00 AM

Break

10:30 AM

Management of Neurologic Complications in CT Surgical Patients Aaron M. Cheng, Seattle, WA

Moderators: V. Seenu Reddy, Nashville, TN, and Todd A. Carl, St. Petersburg, FL 10:00 AM Tabulating Health System Value in General Thoracic Surgery Program Development Thomas A. D`Amico, Durham, NC 10:20 AM Tabulating Health System Value in Cardiac Surgery Program Development Joseph E. Bavaria, Philadelphia, PA 10:40 AM How a Health System Views Surgeon Value Beyond the Operating Room TBD

ADMIT ONE

Indicates that a ticket is required to attend. *Invited

11:00 AM Blood Management in the CT ICU Glenn J. R. Whitman, Baltimore, MD 11:30 AM Case Scenarios Michael S. Mulligan, Seattle, WA 12:00 PM

Break

12:15 PM Luncheon Symposium: Crew Resource Management for the CT ICU Charles C. Hill, Stanford, CA 1:15 PM Break 49th ANNUAL MEETING

Advance Program 11


1:30 PM Hospital Acquired Infections in the Critical Care Unit John B. Lynch, Seattle, WA 2:00 PM Latest Management of Acute Postoperative Renal Failure Derek M. Fine, Baltimore, MD 2:30 PM Management of Chronic Thromboembolic Pulmonary Hypertension Michael S. Mulligan, Seattle, WA 3:00 PM

Break

3:30 PM Obesity Risk and Challenges in the CT ICU Juan N. Pulido, Rochester, MN 4:00 PM Pathways to Early Extubation Richard E. Fagley, St. Louis, MO 1:00 PM – 4:00 PM

Residents Symposium: Transitioning from Training to Practice Course Description: This symposium will provide residents with practical career information. Topics will include fundamentals of the job search, contract negotiations for the academic and private practice sectors, billing for professional services, training the cardiothoracic surgery team, and preparation for the American Board of Thoracic Surgery exams. Experienced surgeons will lead the discussion to educate residents on how to carve a successful career path. Learning Objectives: Upon completion of this program, participants should be able to:  Define the elements of a successful job search;  Appraise the private and academic sector hiring process;  Recognize legal issues regarding documentation and coding; and  Discuss the importance of successful training of the cardiothoracic surgery team. Moderator: Ara A. Vaporciyan, Houston, TX

1:10 PM Identifying and Securing a Position and Contract Negotiations Academic: Aditya K. Kaza, Salt Lake City, UT Private Practice: Kevin D. Accola, Orlando, FL

1:40 PM The Importance of Effective Time Management Ara A. Vaporciyan, Houston, TX Q&A

2:10 PM

Break

Learning Objectives: Upon completion of this program, participants should be able to:  Summarize the advantages and disadvantages of three different surgical approaches to patients with transposition of the great arteries with ventricular septal defect (VSD) and pulmonary stenosis;  Compare and contrast differing strategies for management of newborns with tetralogy of Fallot;  Describe current approaches to the highly sensitized pediatric heart transplant candidate;  Discuss factors that must be considered for the decision to transplant a failing Fontan patient;  Recognize which patients and conditions are best served by the Berlin heart; and  Compare and contrast three differing surgical approaches to the teenager with severe aortic valve insufficiency. Moderators: Erle H. Austin III, Louisville, KY, Mark S. Bleiweis, Gainesville, FL, and Ralph S. Mosca, New York, NY 1:15 PM Introductory Remarks Erle H. Austin III, Louisville, KY

Session I: Technical Variations: Surgical Approaches to Transposition/ Double Outlet Right Ventricle with VSD and Pulmonary Stenosis 1:20 PM Rastelli Procedure Joseph A. Dearani, Rochester, MN 1:32 PM Nikaidoh Procedure Victor O. Morell, Pittsburgh, PA

1:56 PM Discussion

Session II: Technical Variations: Approaches to the Newborn with Tetralogy of Fallot with Pulmonary Stenosis

2:22 PM Individualized Surgical Management Charles D. Fraser, Houston, TX

2:46 PM Discussion 3:00 PM Break

Session III: Issues in Transplantation

Q&A

3:00 PM Managing, Handling, and Dealing with Risk Joseph C. Cleveland, Denver, CO 3:20 PM

Course Description: This course will present a review of pertinent and controversial topics in congenital heart disease, pediatric heart surgery, postoperative management, and decision making.

2:34 PM Primary Repair without a Transannular Patch Giovanni Stellin, Padova, Italy

2:30 PM Physician Payment: The Art & Science of Surgical Billing for Professional Services Peter K. Smith, Durham, NC 2:50 PM

Parallel Surgical Symposium: Congenital

2:10 PM Routine Early Primary Repair Vadiyala M. Reddy, Stanford, CA

Q&A

2:00 PM

ADMIT ONE

1:44 PM Ross-Konno-Switch Procedure Pedro J. del Nido, Boston, MA

1:00 PM Introductory Remarks Ara A. Vaporciyan, Houston, TX

1:30 PM

1:15 PM – 4:30 PM

3:15 PM Management of Highly Sensitized Patients Adrianna Zeevi, Pittsburgh, PA 3:27 PM If and When to Transplant the Failing Fontan Jonathan M. Chen, New York, NY

Q&A

3:30 PM ABTS Oral Exam Preparation William A. Baumgartner, Baltimore, MD

3:39 PM Berlin Heart Update David L. Morales, Cincinnati, OH

3:50 PM

3:51 PM Aortic Valve Insufficiency in the Teenage Patient: Repair Michel N. Ilbawi, Oak Lawn, IL

Q&A

4:01 PM Aortic Valve Insufficiency in the Teenage Patient: Ross John W. Brown, Indianapolis, IN 12


www.sts.org


4:11 PM Aortic Valve Insufficiency in the Teenage Patient: Prosthesis Scott M. Bradley, Charleston, SC 4:21 PM Discussion 1:15 PM – 4:30 PM

ADMIT ONE

Parallel Surgical Symposium: General Thoracic Course Description: This symposium will address commonly encountered issues in general thoracic surgery. Each symposium session is dedicated to a specific area in the diagnosis or management of lung or esophageal cancer where there have been recent developments or controversy and that are both germane to practicing surgeons and which may represent gaps in knowledge. The competencies addressed in this symposium include patient care, medical knowledge, systems-based practice, and practice-based learning and improvement. These general competencies will be addressed through a series of individual lectures, panel discussions, and audience interaction. Learning Objectives: Upon completion of this program, participants should be able to:  Describe the indications and limitations of new techniques in the preoperative localization of pulmonary nodules including hook wire localization, videoassisted thoracic surgery (VATS) ultrasound, navigational bronchoscopy, and radionuclide tracers;  Discuss the advantages and disadvantages of different conduit choices for esophageal replacement, as well as the optimal methods of conduit preparation;  Identify the technical details of anastomoses as related to esophageal reconstruction and how postoperative anastomotic complications can be minimized;  Recognize the controversy surrounding the need for gastric drainage following esophagectomy and the options available to the surgeon; and  Summarize how current concepts surrounding the molecular and cellular biology of lung cancer relate to the practicing thoracic surgeon. Moderators: Frank C. Detterbeck, New Haven, CT, Moishe A. Liberman, Montreal, QC, Canada, and Richard I. Whyte, Boston, MA

Session I: Solitary Pulmonary Nodule Localization Techniques 1:15 PM Hook Wire Localization/Microcoils/Dye Injection Richard J. Finley, Vancouver, BC, Canada 1:25 PM VATS Ultrasound Moishe A. Liberman, Montreal, QC, Canada 1:35 PM Navigational Bronchoscopy Richard I. Whyte, Boston, MA 1:45 PM Radionuclide Tracers K. Robert Shen, Rochester, MN 1:55 PM Discussion

Session III: Biology of Lung Cancer on a Practical Level 3:25 PM Molecular Diagnostics in Lung Cancer Charles A. Powell, New York, NY 3:45 PM Clinical Implications of Cancer Stem Cells for Thoracic Surgeons Robert J. Downey, New York, NY 4:05 PM Discussion 2:30 PM – 4:30 PM

Associate Membership Symposium: Interprofessional Leadership in the Operating Room and Lung Cancer Treatment Course Description: The second annual Associate Membership symposium will cover two hot topics: utilizing interprofessional leadership to improve patient safety in cardiac surgery and utilizing diverse expertise in caring for lung cancer patients. Session I will cover the Flawless Operative Cardiovascular Unified Systems (FOCUS) initiative. The goal of FOCUS is to significantly decrease the number of human errors in the operating room through scientific analysis and an overall culture change. To achieve this culture change, all members of an interprofessional team must work together. Session I will discuss the methods, outcomes, and experiences of interprofessional care team members working to establish a social-field based model of collaborative care. Session II will focus on the interprofessional approach to treating lung cancer patients. As advances in diagnosis, staging techniques, surgical procedures, radiation therapy, and chemotherapeutic options become available, the care of patients with lung cancer becomes increasingly complex. Therefore, an interprofessional approach to lung cancer care that employs the services of multiple specialists with diverse expertise is fundamental in ensuring expedient, quality care. Session II will also provide an overview of the process from screening to the postoperative phase of care, including discussion of risks and outcome adjustments based on the STS National Database. Learning Objectives: Upon completion of the program, participants should be able to:  Use the literature regarding the importance of teamwork and communication to improve patient safety in the cardiac operating room;  Describe the mission and history of the FOCUS Patient Safety Initiative and discuss how the FOCUS tools can improve teamwork and communication in the cardiac operating room;  E xplain how to become involved in FOCUS;  Discuss the concept of social fields and how these are related to high reliability health care teamwork;  Summarize the methods, outcomes, and experiences of interprofessional care team members working to establish a social-field based model of collaborative care in their cardiac surgery program at a community hospital;  Recognize the benefits of a comprehensive, interprofessional lung cancer clinic to patients with lung cancer; and  Describe and analyze the process from diagnosis of lung cancer to postoperative care.

Session II: Esophagectomy – Technical Details

Session I: Interprofessional Leadership of Quality and Safety Initiatives in Cardiothoracic Surgery

2:15 PM Choice of Conduit and Tips for Conduit Creation Tony E. Lerut, Leuven, Belgium

Moderators: Kelly C. Gustafson, Morgantown, WV, and Richard L. Prager, Ann Arbor, MI

2:25 PM Anastomotic Selection and Pearls Stephen G. Swisher, Houston, TX 2:35 PM Pyloric Drainage: Yes/No, Why, and How Michael S. Kent, Boston, MA 2:45 PM Discussion 3:05 PM Break

ADMIT ONE


2:30 PM Introduction Kelly C. Gustafson, Morgantown, WV 2:33 PM The FOCUS Initiative: Interprofessional Teamwork to Improve Cardiac Operating Room Safety Bruce Spiess, Richmond, VA 2:54 PM Understanding and Implementing Interprofessional Collaborative Care in Cardiac Surgery: Methods and Outcomes Paul N. Uhlig, Wichita, KS, Matt Steadham, Wichita, KS, John Irving, Wichita, KS, and Carolyn Kitchens, Wichita, KS 3:15 PM

Open Discussion 49th ANNUAL MEETING

Advance Program 13


Session II: Team Approach to Lung Cancer Moderator: Stephanie Cain, Peoria, IL 3:20 PM Screening for Lung Cancer and Utilizing Thoracic Database Information Harmik J. Soukiasian, Los Angeles, CA 3:35 PM Development of the Lung Cancer Center and the Clinic Process Jodi Stoner, Peoria, IL, and Patrick E. Whitten, Peoria, IL 3:50 PM Process, Preop, Intraop, and Postop Phase of Care Shannon R. Foiles, Peoria, IL, and Richard C. Anderson, Peoria, IL 4:05 PM Predictors of Risks and Outcomes Following Resections for Lung Cancer Mitchell J. Magee, Dallas, TX 4:20 PM

Learning Objectives: Upon completion of this program, participants should be able to:  Distinguish whether to repair a rheumatic mitral valve or replace it based on the state of valve damage;  Summarize the impact of the timing of the procedure on patient outcomes; and  Compare and appraise new treatment options that may be appropriate for particular patients with rheumatic mitral valve disease. Moderator: A. Pieter Kappetein, Rotterdam, The Netherlands 4:30 PM Reception 5:00 PM Welcome and Opening Remarks A. Pieter Kappetein, Rotterdam, The Netherlands 5:05 PM Choosing Which Kind of Prosthesis Taweesak Chotivatanapong, Nonthaburi, Thailand, and Arkalud Sampath Kumar, Delhi, India

Open Discussion

4:30 PM – 6:30 PM

Scientific Posters Open

5:25 PM What Techniques Should Be Used for Rheumatic Mitral Valve Repair? Nguyen van Phan, Ho Chi Minh, Vietnam

4:30 PM – 6:30 PM

Opening Reception in STS Exhibit Hall 4:30 PM – 6:30 PM

5:35 PM Anticoagulation A. Pieter Kappetein, Rotterdam, The Netherlands

ADMIT ONE

International Reception and Symposium: Choosing Repair or Replacement in Rheumatic Mitral Valve Disease

5:50 PM Reoperation on the Mitral Valve Adnan Cobanoglu, Cleveland, OH

Course Description: This symposium will focus on choosing how to treat rheumatic mitral valve disease, a problem that is more common in Africa and Asia than in the Western world. Emphasis will be placed on providing insight into valve repair, the optimal timing of the operation, and when to replace instead of repair a valve. The symposium will also offer a review of new treatment options for the care of patients with this condition.

6:05 PM When to Repair, When Not to Repair Zohair Y. Al-halees, Riyadh, Saudi Arabia

14


www.sts.org

6:20 PM

Q&A

M ond ay, J anuary 28, 2013

6:30 AM – 5:00 PM

Registration: STS 49th Annual Meeting 9:00 AM – 4:30 PM

Scientific Posters Open 9:00 AM – 4:30 PM

STS Exhibit Hall Open 7:15 AM – 10:45 AM

General Session I

11:45 AM The Impact of Previous Catheter-Based Ablation on the Efficacy of the Cox-Maze IV Procedure S. Okada, R. J. Damiano, M. R. Moon, H. Maniar Washington University in St. Louis, Richmond Heights, MO 12:00 PM Predictors for Failure of the Cox-Maze Procedure at 12 Months in a Large Prospective Cohort Study: Does Surgeon Experience Matter? N. Ad1, S. D. Holmes2, L.Henry 2, L. S. Halpin2, S. Hunt2 1 CVTSA, Falls Church, VA; 2Inova Heart and Vascular Institute, Falls Church, VA 12:15 PM Current Electrophysiology Perspectives on Ablation David S. Schwartzman, Pittsburgh, PA

Moderators: Jeffrey B. Rich, Norfolk, VA, and David A. Fullerton, Aurora, CO 11:30 AM – 12:30 PM 7:15 AM

Opening Remarks

7:35 AM

Introduction of New Members

7:45 AM Richard E. Clark Paper for Adult Cardiac Surgery: Preoperative BetaBlocker Use Should Not Be Used as a Quality Metric for Coronary Artery Bypass Grafting: A Statewide, Multi-institutional STS Adult Cardiac Surgery Database Analysis D. J. LaPar1, I. K. Crosby1, I. L. Kron1, J. A. Kern1, E. Fonner4, J. B. Rich3, A. M. Speir 2, G. Ailawadi1 1 University of Virginia, Charlottesville; 2Inova Heart and Vascular Institute, Falls Church, VA; 3Mid-Atlantic Cardiothoracic Surgeons, Norfolk, VA; 4Virginia Cardiac Surgery Quality Initiative, Charlottesville Discussant: Frederick L. Grover, Aurora, CO 8:00 AM Richard E. Clark Paper for General Thoracic Surgery: Evaluation of the Reliability of Clinical Staging of T2N0 Esophageal Cancer: A Review of the STS General Thoracic Surgery Database T. D. Crabtree1, A. S. Kosinski2, V. Puri1, W. Burfeind3, A. Bharat1, G. A. Patterson1, W. L. Hofstetter4, B. F. Meyers1 1 Washington University School of Medicine, St. Louis, MO; 2Duke University, Durham, NC; 3St. Luke’s Health Network, Bethlehem, PA; 4 The University of Texas, MD Anderson Cancer Center, Houston Discussant: Cameron D. Wright, Boston, MA 8:15 AM Richard E. Clark Paper for Congenital Heart Surgery: Multi-institutional Experience with Surgery for Ebstein’s Malformation: An Analysis of the STS Congenital Heart Surgery Database R. R. Davies1, M. L. Jacobs3, S. K. Pasquali4, J. P. Jacobs2, C. Pizarro1 1 Nemours/A.I. duPont Hospital for Children, Wilmington, DE; 2All Children’s Hospital and The Congenital Heart Institute of Florida (CHIF), Tampa; 3Cleveland Clinic Foundation, OH; 4Duke University School of Medicine and Duke Clinical Research Institute, Durham, NC Discussant: Jan Modest Quaegebeur, New York, NY 8:30 AM Thomas B. Ferguson Lecture Mark B. McClellan, Washington, DC

Adult Cardiac Session: Heart Failure Moderators: Vivek Rao, Toronto, ON, Canada, and Nicholas G. Smedira, Cleveland, OH 11:30 AM Preoperative Atrial Fibrillation Increases Risk of Thromboembolic Events after Left Ventricular Assist Device Implantation: Should Current Anticoagulation Approaches Be Revisited? J. M. Stulak1, S. V. Deo1, S. J. Park1, R.C. Daly1, L. D. Joyce1, K. D. Aaronson2, J. A. Cowger 2, F. D. Pagani2 1 Mayo Clinic, Rochester, MN; 2University of Michigan Health System, Ann Arbor 11:45 AM ECMO as a Bridge to Decision: Recovery, LVAD Implantation, or Heart Transplantation—an 8-Year Experience N. Rousse, F. Juthier, C. Pinçon, C. Banfi, A. Prat, E. Robin, A. Vincentelli Centre Hospitalier Universitaire de Lille, France 12:00 PM Donor-Related Characteristics in Patients with Mechanical Circulatory Support Undergoing Heart Transplantation: Factors That Really Influence Survival N. P. Jaik, I. Feurer, M. A. Wigger, S. Maltais Vanderbilt University, Nashville, TN 12:15 PM Futility Versus Heroism: Where to Draw the Line for Temporary VADs Support Daniel J. Goldstein, Bronx, NY 11:30 AM – 12:30 PM

Affordable Care Act Moderators: John E. Mayer Jr., Boston, MA*, and T. Bruce Ferguson, Greenville, NC 11:30 AM

CMS Perspective Louis B. Jacques, Baltimore, MD*

12:00 PM

ffordable Care Act and Its Impact on Providers: A Massachusetts A Perspective David F. Torchiana, Boston, MA*

9:30 AM Break

11:30 AM – 12:30 PM

9:45 AM Presidential Address Jeffrey B. Rich, Norfolk, VA

Moderators: Stephen D. Cassivi, Rochester, MN, and Todd K. Rosengart, Stony Brook, NY

10:45 AM – 11:30 AM

Break—Visit Exhibits and Scientific Posters 11:30 AM – 12:30 PM

Adult Cardiac Session: Arrhythmia Moderators: Richard Lee, St. Louis, MO, and Vinay Badhwar, Pittsburgh, PA 11:30 AM Minimally Invasive Standalone Cox-Maze Procedure for Patients with Non-Paroxysmal Atrial Fibrillation N. Ad1, L. Henry 2, S. Hunt2, S. D. Holmes2 1 Cardiac Vascular and Thoracic Surgery Associates, Falls Church, VA; 2 Inova Heart and Vascular Institute, Falls Church, VA ADMIT ONE

Basic Science Research

11:30 AM Cardiac MRI Evaluation of a Novel Active Epicardial Assist Device in a Porcine Heart Failure Model J. McGarvey, N. Kondo, W. R. Witschey, T. Shimaoka, M. Takebe, S. Takebayashi, G. A. Zsido, M. Levack, J. H. Gorman, J. Pilla, R. C. Gorman University of Pennsylvania Health System, Philadelphia 11:45 AM Intramyocardial Delivery of Small Intestinal SubmucosaExtracellular Matrix (SIS-ECM) Enhances Cardiac Function and Vasculomyogenesis after Acute Myocardial Infarction H.Toeg, R. Tiwari-Pandey, R. Seymour, A. Ahmadi, S. Crowe, B. Vulesevic, E. J. Suuronen, M. Ruel University of Ottawa Heart Institute, ON, Canada


Advance Program 15


12:00 PM Cardiac Surgical Delivery of the Sarcoplasmic Reticulum Calcium ATPase (SERCA2A) Gene Rescues Myocytes in Ischemic Heart Failure A. S. Fargnoli1, M. G. Katz1, K. Richardville1, R. A. Hillesheim1, E. Kohlbrenner 2, R. J. Hajjar 2, C. R. Bridges1 1 Carolinas Healthcare System, Charlotte, NC; 2Mount Sinai School of Medicine, New York, NY 12:15 PM Effects of Scaffold Material Used in Congenital Heart Surgery on Human Mesenchymal and Cardiac Stem Cells R. Witt1, G. W. Raff1, S. Kaushal2, M. Si1 1 University of California, Davis Medical Center, Sacramento; 2 University of Maryland Medical Center, Baltimore 11:30 AM – 12:30 PM

Congenital Session: Adult Congenital Moderators: Emmett McKenzie, Houston, TX, and Brian E. Kogon, Atlanta, GA 11:30 AM The Fate of the Remaining Neo-Aortic Root Following Autograft Valve Replacement with a Stented Prosthesis for the Failing Ross Procedure B. Alsoufi1, D. Ahmed1, C. Manlhiot2, Z. Y. Al-halees1, B. McCrindle2, B. M. Fadel1 1 King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 2Hospital for Sick Children, Toronto, ON, Canada 11:45 AM Valve-Sparing Root Replacement after Arterial Switch Procedure for Transposition V. Raju, J. A. Dearani Mayo School of Graduate Medical Education, Rochester, MN 12:00 PM Outcomes after Surgery for Bicuspid Aortic Valve Disease in the Pediatric Population J. Siddiqui1, C. P. Brizard1, I.Konstantinov1, G. Wheaton2, M. Cheung1, S. Horton1, Y. D’udekem1 1 Royal Children’s Hospital, Melbourne, VIC, Australia; 2Women’s and Children’s Hospital, Adelaide, SA, Australia 12:15 PM Outcomes of Myectomy for Mid-ventricular Obstruction in Hypertrophic Cardiomyopathy M. Kunkala, H.V. Schaff, R. Nishimura, M. Abel, P. Sorajja, J. A. Dearani, S. Ommen Mayo Clinic, Rochester, MN 11:30 AM – 12:30 PM

Critical Care

Moderators: David A. Fullerton, Aurora, CO, and Kevin W. Lobdell, Charlotte, NC 11:30 AM Very Prolonged Stay in the Intensive Care Unit after Cardiac Operations: Early Results and Late Survival S. Silberman, D. Bitran, D. Fink, R. Tauber, I. Dzigivker, I. Rosenfeld, O. Merin Shaare Zedek Medical Center, Jerusalem, Israel 11:45 AM Transfusion Rate as a Quality Metric: Is Blood Conservation a Learnable Skill? G. Paone1, R. J. Brewer1, P. F. Theurer 2, G. F. Bell2, C. M. Cogan1, R. L. Prager4 1 Henry Ford Hospital, Detroit, MI; 2Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, East Lansing; 3 University of Michigan, Ann Arbor 12:00 PM Debate: Cardiothoracic ICUs Should Only Be Managed by a Board Certified Intensivist Pro: Jay G. Shake, Temple, TX Con: William D. Hoffman, Boston, MA

11:30 AM – 12:30 PM

General Thoracic Session: New Techniques and Bioassays Moderators: M. Blair Marshall, Washington, DC, and Yolonda L. Colson, Boston, MA 11:30 AM Novel Prognostic Assay Identifies High-Risk T1a Node-Negative Lung Tumors J. R. Kratz1, S. K. Van Den Eeden2, J. He3, P. T. Pham1, M. S. Mulvihill1, D. J. Raz1, B. He1, D. M. Jablons1, M. J. Mann1 1 University of California, San Francisco; 2Kaiser Permanente, Oakland, CA; 3The First Affiliated Hospital of Guangzhou Medical College, China 11:45 AM Preoperative Prediction of Lymph Node Involvement Using Serum Biomarkers in Non-Small Cell Lung Cancer D. E. Rinewalt, J. A. Borgia, S. Daly, D. D. Shersher, S. Basu, E. Hong, G. W. Chmielewski, M. J. Liptay Rush University Medical Center, Chicago, IL 12:00 PM Outcomes of Lobectomy in Patients with Severely Reduced Predicted Postoperative Diffusion Capacity (≤40%) S. Paul, W. Andrews, J. Port, P. C. Lee, B. M. Stiles, A. Nasar, N. K. Altorki New York-Presbyterian/Weill Cornell, New York, NY 12:15 PM Successful Tracheal Replacement in Humans Using Autologous Tissues—An 8-Year Experience P. G. Dartevelle, D. Fabre, E. Fadel, S. Mussot, O. Mercier, F. Kolb Marie Lannelongue Hospital, Le Plessis Robinson, France 12:30 PM – 1:15 PM

Break—Visit Exhibits and Scientific Posters 1:15 PM – 5:15 PM

Joint Council on Thoracic Surgery Education: Cardiothoracic Surgical Education Course Description: Cardiothoracic surgical education is changing dramatically with new residency options, work hour limitations for resident education, new sources of educational content, learning management systems to monitor education progress, and an increased emphasis on competency. Changes are not only occurring in resident education, but also in continuing medical education in the context of lifelong learning. In defining competency, exposure to content or information will no longer be acceptable; accountability for learning is essential both in cognitive as well as technical skills. This symposium will emphasize new initiatives and challenges in both resident and continuing surgical education, nationally and internationally. Participants will be exposed to clearer definitions of competency, new educational resources, current initiatives, and future options in improving teaching, learning, and assessment in both resident and lifelong learning. Participants will also gain a better understanding of educational techniques to bring back to their educational environments, whether academic or private practice, as well as learn how to develop their own educational portfolios for lifelong learning. Learning Objectives: Upon completion of this program, participants should be able to:  Apply milestones to educational initiatives in surgical education;  Summarize the difference between time-based surgical education and competency-based surgical education;  Introduce e-learning courses into resident and practice education;  Apply the concept of mind mapping for navigating educational content;  Implement and maintain a surgical simulation protocol;  Create an educational environment to improve feedback and assessment in surgery;  Discuss the challenges of transitions in surgical practice environments;  Provide new options in improving transitions to practice; and  Develop mentorship programs during times of transition in practice environment. Moderator: Edward D. Verrier, Seattle, WA 1:15 PM The Milestone Project: The ACGME Initiative Carolyn E. Reed, Charleston, SC 1:45 PM Competency-Based Surgical Education: The Can Med Initiative Sean C. Grondin, Calgary, AB, Canada 2:15 PM Case-Based Cognitive Opportunities: The JCTSE LMS Initiative Ara A. Vaporciyan, Houston, TX

16


www.sts.org


2:45 PM

Break

3:00 PM Curriculum Development: The Personal Brain Initiative Craig J. Baker, Los Angeles, CA 3:30 PM Technical Skills Training: Simulation Initiative James I. Fann, Stanford, CA 4:00 PM Break 4:15 PM Train the Trainers: The ISCP Initiative Chris Munsch, Leeds, United Kingdom 4:45 PM Transitions to Practice: The ACS Initiative Edward D. Verrier, Seattle, WA 1:30 PM – 3:30 PM

ACC @ STS

Course Description: This course will cover a wide variety of hot topics in cardiovascular medicine and surgery, including the collaborative “heart team” approach to treating cardiovascular disease, controversies in the treatment of coronary artery disease, challenges in the treatment of atrial fibrillation, the role of appropriate use criteria, and other important issues. The overall goal of this program is to update and hone knowledge of the recent developments in the treatment of cardiovascular disease, with an emphasis on areas of growing collaboration between cardiologists and cardiothoracic surgeons. Learning Objectives: Upon completion of this program, participants should be able to:  D iscuss the controversies surrounding the optimal mode of surgical revascularization in multi-vessel disease;  Review and describe the indications and contraindications, pearls and pitfalls, and rationale for transcatheter and surgical atrial fibrillation ablation;  Describe the construction and makeup of the multidisciplinary “heart team” and its influence in improving patient outcomes and fostering communication among specialties; and  Summarize the role of appropriate use criteria in the management of cardiovascular disease. Moderators: John V. Conte, Baltimore, MD, and Neal Kleiman, Houston, TX 1:30 PM TAVR National Coverage Determination: Lessons Learned Panel Discussion 2:00 PM The Role of the Heart Team in 2015 and Beyond Jeffrey Popma, Boston, MA*

2:00 PM Prognostic Factors in Patients with Uncomplicated Acute Type B Aortic Dissection—What Is the Indication for Prophylactic TEVAR? C. Ueki, T. Komiya, G. Sakaguchi, T. Shimamoto Kurashiki Central Hospital, Japan 2:15 PM Acute Type I Aortic Dissection: Traditional Versus Hybrid Repair with Antegrade Stent Delivery to the Descending Thoracic Aorta O. A. Preventza1, R. Cervera1, D. A. Cooley1, F. G. Bakaeen2, L. D. Cornwell2, J. S. Coselli1 1 Texas Heart Institute at St Luke’s Episcopal Hospital, Baylor College of Medicine, Houston; 2Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 2:30 PM Utilization and Outcomes of Valve–Sparing Aortic Root Replacement in Patients with Marfan Syndrome Enrolled in the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) H. Song1, J. E. Bavaria2, S. A. LeMaire3 1 Oregon Health and Science University, Portland; 2University of Pennsylvania Medical Center, Philadelphia; 3Baylor College of Medicine, Houston, TX 2:45 PM Direct Aortic Approach for Self-Expandable Aortic Bioprosthesis Implantation: The European Experience G. Bruschi1, S. Davies2, F. De Marco1, H. Amrane3, A. Van Boven3, B. Marcheix4, N. Dumonteil5, D. Tchetche7, H. Danenberg6, G. Coletti8, H. Bushnaq9, J. Laborde10, S. J. Brecker10, D. Mazzitelli11, R. Lange11, M. Branny12, P. Branny12, J. M. Bosmans13, U. Trivedi14, M. Bhabra15, P. den Heijer16, N. Moat2 1 Niguarda Ca’ Granda Hospital, Milan, Italy; 2The Royal Brompton Hospital, London, United Kingdom; 3Medisch Centrum Leeuwarden, The Netherlands; 4Rangueil Hospital, Toulouse, France; 5University Hospital of Toulouse, France; 6Hebrew University, Jerusalem, Israel; 7Clinique Pasteur, Toulouse, France; 8Civil Hospital, Brescia, Italy; 9Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany; 10St. George Hospital, London, United Kingdom; 11German Heart Center Munich, Germany; 12Podlesi Hospital, Trinec, Czech Republic; 13University Hospital Antwerp, Belgium; 14 Brighton & Sussex University Hospitals Trust, Brighton, United Kingdom; 15 Heart and Lung Centre, New Cross Hospital, Wolverhampton, United Kingdom; 16Amphia Hospital Breda, The Netherlands 3:00 PM Debate: All Asymptomatic 4.5 Centimeter Ascending Aorta Should Be Resected in the Setting of a Normal Valve Pro: Joseph E. Bavaria, Philadelphia, PA Con: Thoralf M. Sundt, Boston, MA 1:30 PM – 3:30 PM

2:15 PM Is Atrial Fibrillation Appropriately Treated by Catheter-Based Ablation? The Role of Surgical Ablation Ralph J. Damiano Jr., St. Louis, MO 2:30 PM Debate: Hybrid Procedures Are the Wave of the Future Pro: David X. Zhao, Nashville, TN Con: TBD 3:00 PM Debate: Appropriate Use Criteria Are Meaningful Pro: TBD Con: Stephen J. Lahey, Farmington, CT 1:30 PM – 3:30 PM

Adult Cardiac Session: Aortic Moderators: Wilson Y. Szeto, Philadelphia, PA, and Michael P. Fischbein, Stanford, CA 1:30 PM Profound Hypothermia Versus Moderate Hypothermia in Acute Type A Aortic Dissection Repair K. D. Algarni, B. Yanagawa, V. Rao, S. J. Brister, T. M. Yau University of Toronto, ON, Canada 1:45 PM Reverse Remodeling and Improved Left Ventricular Function Following the David V in Patients with Significant Aortic Insufficiency B. Leshnower, R. Myung, R. A. Guyton, L. McPherson, E. P. Chen Emory University, Atlanta, GA ADMIT ONE


Adult Cardiac Session: Ischemic Moderators: Alan M. Speir, Falls Church, VA, and Friedrich W. Mohr, Leipzig, Germany 1:30 PM The Effect of Post-Coronary Artery Bypass Surgery Clopidogrel Use on 1-Year Graft Patency: A Sub-Analysis of the ROOBY Trial R. Ebrahimi1, F. G. Bakaeen2, A. Ardehali1, F. L. Grover4, J. H. Baltz4, B. Hattler4, H. Almassi6, T. Wagner5, J. F. Collins3, A. L. W. Shroyer7 1 University of California, Los Angeles; 2Michael E. DeBakey Veterans Affairs Medical Center, Houston; 3Perry Point VA Medical Center, MD; 4VA Eastern Colorado Health Care System, Denver; 5VA Palo Alto Health Care System, CA; 6Zablocki VA Medical Center, Milwaukee, WI; 7Northport VA Medical Center, NY 1:45 PM Revascularization for the Right Coronary Artery Territory in Off-Pump Coronary Artery Bypass: A Propensity Score-Matched Comparison of Gastroepiploic Artery, Saphenous Vein, and Right Internal Thoracic Artery D. Jeong, S. Jeong, W. Kim, P. Park, Y. Lee Samsung Medical Center, Seoul, Republic of Korea 2:00 PM Off-Pump and On-Pump Coronary Revascularization in Patients with Low Ejection Fraction: A Report from the STS National Database W. B. Keeling1, M. L. Williams1, M. S. Slaughter1, Y. Zhao2, J. D. Puskas3 1 University of Louisville, KY; 2Duke University, Durham, NC; 3Emory University, Atlanta, GA 49th ANNUAL MEETING

Advance Program 17


2:15 PM Time-Varying (0 to 15-Year) Survival Benefit of Radial Artery Grafting in CABG: A Multi-institutional Study T. A. Schwann1, R. F. Tranbaugh2, K. R. Dimitrova2, M. Engoren4, D. M. Hoffman2, A. Kabour 3, C. M. Geller 2, W. Ko2, R. H. Habib5 1 University of Toledo Medical Center, OH; 2Beth Israel Medical Center, New York, NY; 3Mercy Saint Vincent Medical Center, Toledo, OH; 4 University of Michigan, Ann Arbor; 5American University of Beirut, Lebanon 2:30 PM Off-Pump Coronary Artery Bypass Grafting is Associated with Worse Long-Term Survival F. G. Bakaeen1, D. Chu1, R. F. Kelly2, G. J. Chen3, N. J. Petersen3, H. B. Ward2, M. E. Jessen4, W. L. Holman5 1 Texas Heart Institute, Baylor College of Medicine, and Michael E. DeBakey VA Medical Center, Houston, TX; 2University of Minnesota and Minneapolis VA Medical Center; 3Houston VA Health Services Research & Development Centers of Excellence, TX; 4The University of Texas Southwestern Medical Center, Dallas; 5University of Alabama at Birmingham and Birmingham VA Medical Center 2:45 PM Impact of Chronic Obstructive Pulmonary Disease on Perioperative and 1-Year Outcomes of Patients Undergoing Coronary Artery Bypass Surgery: Comparison of Off Pump Versus On Pump G. H. Almassi1, A. L. W. Shroyer 2, J. F. Collins3, B. Hattler4, M. Bishawi2, J. H. Baltz4, R. Ebrahimi5, F.L. Grover 6 1 Medical College of Wisconsin, Milwaukee; 2Stony Brook University School of Medicine, NY; 3VA Medical Center, Perry Point, MD; 4 Eastern Colorado Health Care System, Denver, CO; 5Greater Los Angeles VA Medical Center, CA; 6University of Colorado, Aurora 3:00 PM Debate: Off-Pump CABG Will Not Exist in 2020 Pro: Bruce W. Lytle, Cleveland, OH Con: Robert A. Guyton, Atlanta, GA 1:30 PM – 3:30 PM

Congenital Session: Pediatric Congenital I

3:00 PM Aortic Root Size is an Independent Predictor of Left Ventricular Outflow Tract Obstruction after Repair of Interrupted Aortic Arch with Ventricular Septal Defect P. Chen, A. T. Cubberley, D. Zurakowski, T. Geva, C. W. Baird, F. A. Pigula, S. Emani Children’s Hospital Boston, MA 3:15 PM Biventricular Conversion Following Single Ventricle Palliation in Patients with Small Left Heart Structures: A Description of Surgical Technique B. T. Kalish1, P. Banka2, W. Tworetzky 2, P. J. del Nido2, S. Emani2 1 Harvard Medical School, Boston, MA; 2Boston Children’s Hospital, MA 1:30 PM – 3:30 PM

General Thoracic Session: Lung Cancer I Moderators: John D. Mitchell, Aurora, CO, and David R. Jones, Charlottesville, VA 1:30 PM The Features of Nodal Metastasis in Patients with Subcentimeter Lung Cancer A. Hattori, K. Suzuki, Y. Tsushima, K. Takamochi, S. Oh Juntendo University School of Medicine, Tokyo, Japan

1:45 PM Lymph Node Ratio Predicts Survival Following Non-Small Cell Lung Cancer Resection M. D. Taylor, D. J. LaPar, C. J. Thomas, M. Persinger, B. D. Kozower, C. L. Lau, D. R. Jones University of Virginia, Charlottesville 2:00 PM Comparative Analysis of Clinico-Pathologic Features and Treatment Outcomes Between Unexpected and Expected Pathologic N1 NonSmall Cell Lung Cancer S. Shin1, H. Kim1, Y. Choi1, K. Kim2, J. Kim1, Y. Shim1 1 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 2Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea

Moderators: James Jaggers, Aurora, CO, and Michael E. Mitchell, Milwaukee, WI 1:30 PM Technical Improvements in Anatomical Repair for Congenitally Corrected Transposition of Great Arteries, Left Ventricular Outflow Tract Obstruction, and Ventricular Septal Defect T. Hoashi, K. Kagisaki, T. Yagihara, H. Ichikawa National Cerebral and Cardiovascular Center, Suita, Japan 1:45 PM Impact of Age and Duration of Banding on Left Ventricular Preparation Before Anatomic Repair for Congenitally Corrected Transposition of the Great Arteries P. Myers, P. J. del Nido, T. Geva, V. Bautista-Hernandez, P. Chen, J. E. Mayer, S. Emani Children’s Hospital Boston & Harvard Medical School, MA 2:00 PM Hospital Variation in Postoperative Infection and Associated Outcomes Following Congenital Heart Surgery: An STS Congenital Heart Surgery Database Analysis S. K. Pasquali1, X. He1, M. L. Jacobs2, M. Hall3, J. W. Gaynor4, S. S. Shah5, E. D. Peterson1, K. D. Hill1, J. S. Li1, J. P. Jacobs6 1 Duke University Medical Center, Durham, NC; 2Cleveland Clinic, OH; 3Child Health Corporation of America, Shawnee Mission, KS; 4 Children’s Hospital of Philadelphia, PA; 5Cincinnati Children’s Hospital Medical Center, OH; 6All Children’s Hospital, St. Petersburg, FL 2:15 PM Use of Administrative Data for Surgical Site Infection (SSI) Surveillance after Congenital Cardiac Surgery Results in Inaccurate Reporting of SSI Rates K. D. Atchley, A. T. Kennedy, J. M. Pappas, S. E. Coffin, J. S. Gerber, S. M. Fuller, T. L. Spray, K. McCardle, J. W. Gaynor Children’s Hospital of Philadelphia, PA 2:30 PM Pitfalls and Interpretation of Database Literature Karl F. Welke, Seattle, WA

18


www.sts.org

2:15 PM Long-Term Survival after Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery Versus Thoracotomy P. C. Lee, A. Nasar, J. Port, S. Paul, B. M. Stiles, N. K. Altorki Weill Cornell Medical College, New York, NY 2:30 PM Open Lobectomy for Early Stage Lung Carcinoma Achieves a Superior Lymph Node Dissection Compared to Thoracoscopic Lobectomy R. E. Merritt, C. D. Hoang, J. B. Shrager Stanford University, Palo Alto, CA 2:45 PM Nodal Upstaging is Lower after Thoracoscopic Lobectomy Compared with Thoracotomy for Clinical Stage-1 Lung Cancer: A Nationwide Study P. Licht, L. Ladegaard, E. Jakobsen Odense University Hospital, Denmark 3:00 PM Debate: Open Lobectomy Allows for Superior Nodal Sampling/ Dissection Compared with a Thoracoscopic Approach Pro: Douglas J. Mathisen, Boston, MA Con: Daniel L. Miller, Atlanta, GA 1:30 PM – 3:30 PM

General Thoracic Session: Lung Transplantation Moderators: Michael J. Weyant, Aurora, CO, and Robert D. Davis, Durham, NC 1:30 PM Long-Term Survival Analysis of the Canadian Lung Volume Reduction (CLVR) Surgery Study J. D. Miller1, S. D. Kosa1, R. A. Malthaner 2, L. Tan3 1 McMaster University - St Joseph’s Healthcare, Hamilton, ON, Canada; 2University of Western Ontario, London, ON, Canada; 3Health Science Centre, Winnipeg, MB, Canada


1:45 PM Double Lung Transplantation Can Be Safely Performed Using Donors with Heavy Smoking History S. Taghavi, S. N. Jayarajan, E. Komaroff, T. Horai, S. H. Brann, F. Cordova, G. Criner, T. S. Guy, Y. Toyoda Temple University Hospital, Philadelphia, PA 2:00 PM Physician Assistant Model for Lung Procurements: A Paradigm Worth Considering J. Costa, F. D’ovidio, M. D. Bacchetta, J. Javidfar, M. LaVelle, A. Newmark, J. R. Sonett Columbia University Medical Center, New York, NY 2:15 PM Current State of Ex-Vivo Lung Perfusion in the United States Michael J. Weyant, Aurora, CO 2:30 PM Effects of Maintenance Immunosuppressive Triple Therapies on Airway Mucociliary Clearance of Rats M. P. Silva1, S. F. Soto1, F. M. Almeida1, T. T. Limonete1, E. R. Parra2, F. B. Jatene1, P. M. Pêgo-fernandes1, R. Pazetti1 1 Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil; 2Faculdade de Medicina da Universidade de São Paulo, Brazil 2:45 PM Intermittent mTOR Inhibition Prevents Development of Bronchiolitis Obliterans by Preservation of the Airway Epithelium Y. Zhao, J. R. Gillen, J. A. Burns, I. L. Kron, C. L. Lau University of Virginia, Charlottesville 3:00 PM Functional Status Is Highly Predictive of Outcomes Following Redo Lung Transplantation: An Analysis of 390 Cases in the Modern Era A. Kilic, T. J. George, C. A. Beaty, C. A. Merlo, J. V. Conte, A. S. Shah The Johns Hopkins Hospital, Baltimore, MD 3:15 PM Initial Experience with Lobar Lung Transplantation—A Relevant Option in the Era of Lung Allocation Score N. Shigemura, J. K. Bhama, A. Shiose, C. J. Gries, M. M. Crespo, J. Pilewski, C. Bermudez University of Pittsburgh Medical Center, PA 3:30 PM – 4:15 PM


General Thoracic Session: Mediastinal/Pulmonary I Moderators: Kenneth A. Kesler, Indianapolis, IN, and James Huang, New York, NY 4:15 PM Importance of Lymph Node Dissection in Thymic Carcinoma I. Park1, J. Jeon1, H. Kim1, Y. W. Seong1, C. Kang1, Y. Kim1, J. Kim2 1 Seoul National University Hospital, Seoul National University College of Medicine, Republic of Korea; 2Lung Cancer Center, Dongnam Institute of Radiological and Medical Sciences, Busan, Republic of Korea 4:30 PM How Often Is a Thymectomy “Non-Therapeutic”? Review of a National Database M. S. Kent1, T. Wang2, R. I. Whyte1, S. P. Gangadharan1 1 Beth Israel Deaconess Medical Center, Boston, MA; 2Harvard University, Cambridge, MA 4:45 PM The Role of Incomplete Resections after Radical Pleurectomy for Malignant Pleural Mesothelioma S. Bolukbas1, M. Eberlein2, A. Fisseler-Eckhoff1, J. Schirren1 1 Dr. Horst Schmidt Klinik, Wiesbaden, Germany; 2Carver College of Medicine, University of Iowa, Iowa City

4:15 PM – 5:15 PM

Surgical Motion Pictures Matinee: Adult Cardiac Moderators: Thomas E. MacGillivray, Boston, MA, and Andrea J. Carpenter, San Antonio, TX 4:15 PM Mitral Valve Re-Repair for Late Presentations of Systolic Anterior Motion S. Itagaki, R.Varghese, A. C. Anyanwu, F. Milla, J. Castillo, D. H. Adams Mount Sinai Medical Center, New York, NY 4:27 PM Technique of Geometric Ring Annuloplasty for Human Aortic Valve Repair D. Mazzitelli1, C. Noebauer1, J. S. Rankin2, W. E. Cohn3, M. Krane1, R. Lange1 1 German Heart Center Munich; 2Vanderbilt University, Nashville, TN; 3 Texas Heart Institute, Houston

4:39 PM Implantation of a HeartWare VAD to Support the Systemic Circulation in Congenitally Corrected Transposition C. Mignosa, A. Bivona, A. S. Rubino, G. Leonardi, S. Di Stefano, G. Giuliano, S. Nicosia Ferrarotto Hospital, University of Catania, Italy 4:51 PM Novel Beating Heart Repair for Anomalous Origin of Right Coronary Artery from Left Coronary Sinus Y. Inoue, H. Kawajiri, S. Suzuki, T. Tamura Hiratsuka City Hospital, Kanagawa, Japan 5:03 PM Hybrid Repair of Thoraco-Abdominal Aneurysm with Multi-branched Prosthesis D. Pacini, L. Di Marco, R. Di Bartolomeo S. Orsola-Malpighi Hospital, Bologna, Italy 4:15 PM – 5:15 PM

Surgical Motion Pictures Matinee: Congenital Moderators: James Jaggers, Aurora, CO, and Paul M. Kirshbom, Atlanta, GA 4:15 PM Arterial Switch Operation in Complex Transposition with Criss-Cross Heart, Multiple Ventricular Septal Defects, Straddling of Tricuspid Valve, and Pulmonary Stenosis P. Murin, V. Hraska German Pediatric Heart Center, Skt. Augustin, Germany 4:27 PM Minimally Invasive Surgical Correction of Scimitar Syndrome in an Adult B. G. Rajbanshi, J. A. Dearani Mayo Clinic, Rochester, MN 4:39 PM Modified Nikaidoh Procedure with Double Translocation of the Great Arteries, for a 10 kg Boy with Transposition of the Great Arteries, Ventricular Septal Defect and Left Ventricular Outflow Tract Obstruction K. Sakamoto, N. Ota, Y. Ide, Y. Tosaka Mt. Fuji Shizuoka Children’s Hospital, Japan 4:51 PM Technique of Aortic Valve Repair in a 7-Year-Old Boy with Monocuspid Aortic Valve A. K. Haeussler, C. Mueller, R. Pretre Children’s Hospital Zuerich, Switzerland 5:03 PM Robotic Assisted Repair of Partial Atrioventricular Canal Defect V. Raju, H. M. Burkhart, F. Cetta, R. M. Suri Mayo School of Graduate Medical Education, Rochester, MN

5:00 PM Recurrence Patterns after Resection of Soft Tissue Sarcomas of the Chest Wall R. R. McMillan, J. Huang, V. W. Rusch Memorial Sloan Kettering Cancer Center, New York, NY

ADMIT ONE


Advance Program 19


4:15 PM – 5:15 PM

4:15 PM – 5:15 PM

Moderators: Robert J. Cerfolio, Birmingham, AL, and David T. Cooke, Sacramento, CA

5:00 PM – 6:30 PM

Surgical Motion Pictures Matinee: General Thoracic

4:15 PM Cervical Video-Assisted Thoracoscopic Surgery (C-VATS) Using a Flexible Endoscope for Bilateral Thoracoscopy M. Liberman, M. Khereba, E. Goudie, M. Tahiri, A. Duranceau, V. Thiffault, P. Ferraro University of Montreal, QC, Canada 4:27 PM Long Segment Supercharged Pedicled Jejunal Interposition for Esophageal Replacement S. H. Blackmon, M. P. Kim, P. M. Chevray The Methodist Hospital, Houston, TX 4:39 PM Pulmonary Embolectomy Performed for Bilateral Methylmethacrylate Emboli Following Percutaneous Vertebroplasty S. R. Broderick, H. Maniar, G. A. Patterson Washington University in St. Louis, MO 4:51 PM En Bloc Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet and the Spine O. Mercier, E. Fadel, G. Missenard, R. Bellini, S. Mussot, D. Fabre, P. G. Dartevelle Marie Lannelongue Hospital, Le Plessis Robinson, France 5:03 PM VATS Distal Tracheal and Right Upper Lobe Sleeve Resection M. B. Marshall1, B. Sullivan1, N. M. Bauman2 1 Georgetown University Medical Center, Washington, DC; 2Children’s National Medical Center, Washington, DC

20


www.sts.org

Late-Breaking Sessions Scientific Posters and Wine 5:30 PM – 6:30 PM

Business Meeting (STS Members Only)

Tuesday, Jan uary 29, 2013

6:30 AM – 4:30 PM

Registration: STS 49th Annual Meeting 7:00 AM – 8:00 AM

ADMIT ONE

Early Riser Session #1: STS National Database: Adult Cardiac Surgery Richard L. Prager, Ann Arbor, MI

Early Riser Session #2: STS National Database: General Thoracic Surgery Cameron D. Wright, Boston, MA

Early Riser Session #3: STS National Database: Congenital Heart Surgery Jeffrey P. Jacobs, St. Petersburg, FL, and Marshall L. Jacobs, Newtown Square, PA

Early Riser Session #4: Women in Thoracic Surgery: Innovative Opportunities for Alternative Research Funding

Learning Objectives: Upon completion of this program, participants should be able to:  Discuss how the flawed SGR formula directly impacts cardiothoracic surgeons;  Classify various SGR reform proposals; and  Identify opportunities to participate in the SGR reform proposal development process in support of ideas that: Allow physicians to share the savings generated by their quality  improvement efforts; Mandate and incentivize the development and utilization of clinical data  registries; Require CMS and other payers to make administrative (cost) data available  to registries for use in their analyses; Address barriers imposed by federal and state privacy regulations; and  Utilize registries and other resources to generate comparative effectiveness  research and post-market surveillance of drugs and medical devices.

Virginia R. Litle, Rochester, NY

Early Riser Session #5: Thoracic Trauma: Lessons Learned from the Conflicts in Southwest Asia Matthew D. Bacchetta, New York, NY, and Theodore C. Koutlas, Greenville, NC

Early Riser Session #6: How to Start a TAVR Program Michael J. Mack, Plano, TX, and Vinod H. Thourani, Atlanta, GA

Early Riser Session #7: Mechanical Circulatory Support and LVAD

Moderator: T. Bruce Ferguson, Greenville, NC 9:00 AM – 4:30 PM

Scientific Posters Open 9:00 AM – 4:30 PM

STS Exhibit Hall Open

Ranjit John, Minneapolis, MN

Early Riser Session #8: Simulation in Cardiothoracic Surgery Richard H. Fein, Chapel Hill, NC, John H. Calhoon, San Antonio, TX, and James I. Fann, Stanford, CA

Early Riser Session #9: Starting a Stereotactic Body Radiation Therapy Program: Thoracic Surgery Involvement in the Next Frontier Neil A. Christie, Pittsburgh, PA, and Arjun Pennathur, Pittsburgh, PA

Early Riser Session #10: Starting a Lung Cancer Screening Program Nasser K. Altorki, New York, NY

Early Riser Session #11: Pearls to Optimize Your Business Model in CT Surgery

8:15 AM – 11:45 AM

General Session II Moderators: Jeffrey B. Rich, Norfolk, VA, and David A. Fullerton, Aurora, CO 8:15 AM J. Maxwell Chamberlain Memorial Paper for General Thoracic Surgery: National Cooperative Group Trials of “High-Risk” Patients with Lung Cancer: Are They Truly High-Risk? V. Puri, T. D. Crabtree, J. M. Bell, A. S. Krupnick, D. Kreisel, G. A. Patterson, B. F. Meyers Washington University School of Medicine in St. Louis, MO Discussant: Mark K. Ferguson, Chicago, IL

Vinay Badhwar, Pittsburgh, PA

Early Riser Session #12: Controversies in Aortic Valve Repair in Congenital Patients Emile A. Bacha, New York, NY 7:00 AM – 8:00 AM

ADMIT ONE

Early Riser Health Policy Forum: Transitioning from the Sustainable Growth Rate Formula—Solutions for Medicare Physician Payment Reform Course Description: The Sustainable Growth Rate (SGR) formula was created to control Medicare spending for physician services by setting an annual target for allowable spending growth. Whenever the target is exceeded, the additional spending must be recouped in future years. This results in payment cuts for all physician services. It is well recognized that one of the fundamental problems with the current Medicare physician payment system is that it only rewards the provision of more services and more complicated procedures. This structural flaw has significantly contributed to previously scheduled payment cuts, most of which have been averted by Congress. Panelists in this session will identify proposals that provide for a permanent fix to the flawed SGR payment formula, focusing on models that reward patient outcomes based on risk-adjusted quality outcomes data and the efficient use of limited resources. This forum will discuss ways to ensure that medical specialties have an incentive to control the growth rate of their services and payments by identifying the most effective and appropriate treatment for patients. The session will also provide insight in the utility of the STS National Database for this purpose and demonstrate how sharing outcomes data allows physicians to change their practice patterns to achieve more efficient care delivery and increased patient value.

ADMIT ONE

8:35 AM J. Maxwell Chamberlain Memorial Paper for Congenital Heart Surgery: Effect of Conduit Type and Size on Right VentriclePulmonary Artery Conduit Durability in Infants Less Than 2 Years of Age: A Congenital Heart Surgeons’ Society Study J. Poynter1, P. Eghtesady2, B. McCrindle1, H. L. Walters3, P. M. Kirshbom4, E. H. Blackstone5, S. A. Husain6, D. M. Overman7, E. H. Austin8, T. B. Karamlou9, A. J. Lodge10, J. D. St. Louis11, P. J. Gruber12, G. Ziemer13, R. R. Davies14, J. W. Brown15, W. G. Williams1, J.P. Jacobs17, C. I. Tchervenkov16, M. L. Jacobs5, C. A. Caldarone1 1 The Hospital for Sick Children, University of Toronto, ON, Canada; 2 Washington University School of Medicine, St. Louis, MO; 3 Children’s Hospital of Michigan, Detroit; 4Emory University School of Medicine, Atlanta, GA; 5Cleveland Clinic, OH; 6The University of Texas Health Science Center at San Antonio; 7The Children’s Heart Clinic, Children’s Hospitals and Clinics of Minnesota, Minneapolis; 8 Kosair Children’s Hospital, University of Louisville, KY; 9University of California, San Francisco; 10Duke University Medical Center, Durham, NC; 11Amplatz Children’s Hospital, University of Minnesota, Minneapolis; 12Primary Children’s Hospital, Salt Lake City, UT; 13 Comer Children’s Hospital, The University of Chicago, IL; 14Nemours Cardiac Center/A.I. duPont Hospital for Children, Wilmington, DE; 15Riley Hospital for Children, Indiana University, Indianapolis; 16 The Montreal Children’s Hospital, McGill University, QC, Canada; 17 Cardiac Surgical Associates, St. Petersburg, FL Discussant: Ivan M. Rebeyka, Edmonton, AB, Canada

Indicates that a ticket is required to attend. 49th ANNUAL MEETING

Advance Program 21

T uesd ay, J anuary 29, 2013

8:55 AM J. Maxwell Chamberlain Memorial Paper for Adult Cardiac Surgery: Composite Analysis of 189,793 Medicare Patients with Multi-vessel Coronary Disease Demonstrates a Long-Term Advantage for CABG Compared to Stent Placement F. H. Edwards1, D. M. Shahian9, M. V. Grau-Sepulveda3, F. L. Grover8, J. E. Mayer10, S. M. O’Brien3, E. DeLong3, E. D. Peterson3, C. McKay6, R. E. Shaw5, K. N. Garratt11, G. Dangas12, J. Messenger13, L. Klein4, J. Popma7, W. S. Weintraub2 1 University of Florida, Jacksonville; 2Christiana Care Center for Outcome Research, Newark, DE; 3Duke Clinical Research Institute, Durham, NC; 4Advocate Illinois Masonic Medical Center, Chicago; 5 California Pacific Medical Center, San Francisco; 6Harbor-UCLA Medical Center, Torrance, CA; 7Beth Israel Deaconess Medical Center, Boston, MA; 8University of Colorado School of Medicine, Aurora; 9Massachusetts General Hospital, Boston; 10Children’s Hospital Boston, MA; 11Lenox Hill Heart and Vascular Institute of New York, NY; 12Columbia University Medical Center, New York, NY; 13 University of Colorado School of Medicine, Aurora Discussant: Michael J. Mack, Plano, TX 9:15 AM – 9:45 AM T he Society of Thoracic

Surgery Forward

Surgeons: Moving Cardiothoracic

9:15 AM Important STS National Database Issues David M. Shahian, Boston, MA 9:20 AM STS Research Center Fred H. Edwards, Amelia Island, FL 9:25 AM ProvenCare Collaborative for Lung Cancer Matthew A. Facktor, Danville, PA 9:30 AM Choosing Wisely: Physicians Taking the Lead in How We Use Health Care Resources Douglas E. Wood, Seattle, WA 9:35 AM STS 50th Annual Meeting Kick-off Douglas E. Wood, Seattle, WA 9:45 AM

Break—Visit Exhibits and Scientific Posters

10:30 AM Award Presentations President’s Award TSDA Benson R. Wilcox Award TSRA Socrates Award Earl Bakken Scientific Achievement Award 10:45 AM C. Walton Lillehei Lecture Carolyn M. Clancy, Rockville, MD 11:45 AM – 12:45 PM

ADMIT ONE

Ethics Debate: Patients Declared Dead for Organ Donation Are Not Really Dead: Should the Dead Donor Rule Be Abandoned? Course Description: The dead donor rule (DDR) is neither a law nor an explicit policy; rather, it is an ethical requirement at the time of organ recovery for transplantation, with legal implications. For decades, it has been widely considered to be an integral and crucial component of the organ donation process. The DDR has been stated in several different ways, but in its simplest form, it says that patients must be declared dead before their vital organs are removed. This determination can be made either by neurological criteria (brain death) or by cessation of circulation criteria (donation after cardiac death, or DCD). The DDR has been challenged on grounds that pronouncing death based on DCD or brain death is an unsustainable fiction—such patients are not really dead, and we should honestly recognize this fact and allow recovery of organs from patients who are technically alive but on the brink of certain death. This issue will be addressed in a debate by two outstanding ethicists who have been leading scholars in this field.

22


www.sts.org

Learning Objectives: Upon completion of this program, participants should be able to:  Discuss the criteria for declaration of death at the time of organ donation;  Describe the reasons for and against abandoning the dead donor rule; and  Demonstrate the logic behind the ethical and legal decisions when declaring death in potential organ donors. Facilitator: Robert M. Sade, Charleston, SC Pro: Franklin G. Miller, Bethesda, MD Con: Alexander M. Capron, Los Angeles, CA 11:45 AM – 12:45 PM

Residents Luncheon 12:45 PM – 2:45 PM

Adult Cardiac Session: Mitral Valve Moderators: Vinay Badhwar, Pittsburgh, PA, and Aubrey C. Galloway, New York, NY 12:45 PM Trends and Outcomes of Tricuspid Valve Surgery in North America: An Analysis of over 50,000 Patients from the STS Adult Cardiac Surgery Database A. Kilic1, P. Saha-Chaudhuri2, J. S. Rankin3, J. V. Conte1 1 The Johns Hopkins Hospital, Baltimore, MD; 2Duke University School of Medicine, Durham, NC; 3Centennial Medical Center and Vanderbilt University, Nashville, TN 1:00 PM The Benchmark for Isolated Mitral Valve Surgery: Analysis of 77,836 Patients from the STS National Database S. Chatterjee1, S. Sheng2, J. M. Brennan2, S. M. O’Brien2, J. C. Alexander1, J. S.Rankin3, P. J. Pearson1, R. M. Suri4, J. S. Gammie5 1 North Shore University Health System, Evanston, IL; 2Duke University, Durham, NC; 3Centennial Medical Center, Nashville, TN; 4Mayo Clinic, Rochester, MN; 5University of Maryland Medical Center, Baltimore 1:15 PM Preoperative Pulmonary Hypertension and Atrial Fibrillation Predict Postoperative Left Ventricular Dysfunction after Mitral Valve Repair for Degenerative Disease R. Varghese, S. Itagaki, A. C. Anyanwu, F. Milla, J. Castillo, D. H. Adams The Mount Sinai Medical Center, New York, NY 1:30 PM Minimally Invasive Mitral Valve Surgery Can Be Performed with Optimal Outcomes in the Presence of Left Ventricular Dysfunction P. Atluri, J. Fox, W. Y. Szeto, W. C. Hargrove University of Pennsylvania, Philadelphia 1:45 PM Mid-term Results of the Cut & Transfer Technique, Papillary Muscle Relocation, and Left Ventricular Plication in Patients with Ischemic Mitral Regurgitation G. Esposito, S. Bichi, P. Pellegrino, D. Patrini, P. M. Tartara, M. Redaelli, C. Poloni, P. Gerometta Cliniche Humanitas Gavazzeni, Bergamo, Italy 2:00 PM Mitral Valve Repair, Not Replacement, Provides Improved Long-Term Outcomes in Patients with a Low Ejection Fraction S. R. Neravetla, R. L. Gunter, P. Kilgo, J. D. Puskas, O. M. Lattouf, E. P. Chen, M. E. Halkos, J. D. Vega, R. A. Guyton, V. H. Thourani Emory University, Atlanta, GA 2:15 PM Debate: Non-Sternotomy Isolated MVR Is the New Gold Standard Pro: Hugo Vanermen, Aalst, Belgium Con: David H. Adams, New York, NY* 12:45 PM – 2:45 PM

Adult Cardiac Session: TAVR Moderators: Vinod H. Thourani, Atlanta, GA, and John V. Conte, Baltimore, MD 12:45 PM Medium-Term Clinical and Hemodynamic Outcomes of Transapical Aortic Valve Implantation: Results from the I-TA Registry A. D’Onofrio1, M. Agrifoglio2, L. Cota3, G. Luzi4, P. M. Tartara6, G. Domenico Cresce5, S. Salizzoni7, G. Gerosa1 1 University of Padova, Italy; 2University of Milan, Italy; 3Clinica Montevergine, Mercogliano, Italy; 4San Camillo Hospital, Rome, Italy; 5 San Bortolo Hospital, Vicenza, Italy; 6Humanitas Gavazzeni, Milan, Italy; 7University of Turin, Italy


1:00 PM Is Percutaneous Femoral Approach for Transcatheter Aortic Valve Implantation Always Better? A Comparison with Femoral Surgical Cut-Down G. Bruschi, F. De Marco, L. Botta, P. Colombo, T. Colombo, S. Klugmann, L. Martinelli Niguarda Ca’ Granda Hospital, Milan, Italy 1:15 PM Aortic Valve Replacement after Previous Heart Surgery in High-Risk Patients: Transapical Aortic Valve Implantation Versus Conventional Aortic Valve Replacement M. Scherner, N. Madershahian, P. Rahmanian, K. Kuhr, S. Rosenkranz, E. W. Kuhn, J. Strauch, J. Wippermann, T. C. Wahlers University Hospital of Cologne, Germany 1:30 PM Pulmonary Function Tests (PFTs) May Not Accurately Reflect Chronic Lung Disease (COPD) or Pulmonary Morbidity in Patients Undergoing Aortic Valve Replacement (AVR) for Critical Aortic Stenosis (AS) K. L. Roper1, M. J. Magee3, E. M. Holper 3, M. A. Herbert3, T. M. Dewey 3, T.Snelus1, M. J. Mack 2 1 Cardiopulmonary Research Science and Technology Institute, Dallas, TX; 2The Heart Hospital Baylor Plano, TX; 3Medical City Dallas Hospital, TX

1:30 PM Debate: Total Body Perfusion for Arch Reconstruction Improves Outcomes Pro: V. S. Reddy, Nashville, TN Con: Ralph S. Mosca, New York, NY 2:00 PM Newborn Aortic Arch Reconstruction with Multi-site Arterial Cannulation and Continuous Cardiopulmonary Bypass Improves Postoperative Renal Function J. M. Hammel, I. Abdullah, K. F. Duncan University of Nebraska Medical Center, Omaha 2:15 PM Short-Term Bilateral Pulmonary Artery Banding Prior to Stage 1 Norwood for All Hypoplastic Left Heart Syndrome: Potential for Improved Outcomes N. Ota, Y. Ide, K. Sakamoto Mt. Fuji Shizuoka Children’s Hospital, Japan 2:30 PM Hybrid Approach in Hypoplastic Left Heart Syndrome: The Fate of the Pulmonary Arteries B. Rosser, O. Kretschmar, W. Knirsch, H. Dave, R. Pretre University Children’s Hospital Zürich, Switzerland 12:45 PM – 2:45 PM

1:45 PM Improved Mitral Valve Performance after Transapical Aortic Valve Implantation M. Haensig, D. M. Holzhey, M. A. Borger, A. Linke, J. Seeburger, S. Lehmann, G. Schuler, F. W. Mohr Heart Center Leipzig, Germany 2:00 PM Female Gender Differently Affects Periprocedural Outcomes after TAVI or Surgical Aortic Valve Replacement: Results From a Propensity-Matched Female Population of the Italian OBSERVANT Multicenter Study F. Onorati1, P. D’Errigo2, C. Grossi3, M. Barbanti4, R. D.Covello5, S. Rosato2, A. Maraschini2, S. Gennaro6, C. Tamburino4, F. Seccareccia2, F. Santini1 1 University of Verona Medical School, Italy; 2National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy; 3Santa Croce Hospital, Cuneo, Italy; 4Ferrarotto Hospital, University of Catania, Italy; 5IRCCS San Raffaele Hospital, Milan, Italy; 6Careggi Hospital, Florence, Italy 2:15 PM Debate: All Aortic Valve Replacements Will Be Done with Transcatheter Technology By 2020 Pro: Michael J. Mack, Plano, TX* Con: Craig R. Smith, New York, NY* 12:45 PM – 2:45 PM

Congenital Session: Pediatric Congenital II Moderators: Ralph S. Mosca, New York, NY, and Sitaram Emani, Boston, MA 12:45 PM Cellular Effects of Preoperative Hypoxia on White Matter Injury after Cardiopulmonary Bypass in a Combined Experimental Paradigm Using Rodent Hypoxic and Brain Slice Models K. Agematsu, N. Ishibashi, J. Scafidi, L. Korotcova, V. Gallo, R. A. Jonas Children’s National Medical Center, Washington, DC 1:00 PM Ten-Year Experience Using Mild Hypothermic Continuous Selective Cerebral Perfusion (MHCSP) for Aortic Arch Reconstruction J. P. Starr, R. N. Gates, A. Quill Children’s Hospital of Orange County, Orange, CA 1:15 PM Norwood Reconstruction Using Continuous Coronary Perfusion: A Safe and Translatable Technique J. W. Turek, R. Hanfland, T. L. Davenport, B. E. Reinking, P. M. Poston, J. E. Davis University of Iowa Hospitals and Clinics, Iowa City

ADMIT ONE

General Thoracic Session: Esophageal Moderators: K. Robert Shen, Rochester, MN, and Thomas K. Varghese, Seattle, WA 12:45 PM Endobronchial Ultrasound Added to Endoscopic Ultrasound Improves Staging in Esophageal Cancer M. Liberman, N. Hanna, A. Duranceau, V. Thiffault, P. Ferraro University of Montreal, QC, Canada 1:00 PM Predictors of Anastomotic Leak after Esophagectomy: An Analysis of the STS General Thoracic Surgery Database E. S. Kassis1, A. S. Kosinski2, P. Ross1, J. M. Donahue3, V. C. Daniel1 1 The Ohio State University Medical Center, Columbus; 2Duke University, Durham, NC; 3The University of Maryland Medical Center, Baltimore 1:15 PM Surgery for Benign Esophageal Disease: Does Surgeon Specialty Matter? M. S. Kent2, T. Wang1, S. P. Gangadharan2, R. I. Whyte2 1 Harvard University, Cambridge, MA; 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 1:30 PM Assessment of Morbidity and Mortality after Esophagectomy Using a Modified Frailty Index A. Hodari, Z. T. Hammoud, J. Borgi, A. Tsiouris, I. Rubinfeld Henry Ford Hospital, Detroit, MI 1:45 PM Does the Seventh Edition AJCC Staging System for Esophageal Adenocarcinoma Predict Survival after Neoadjuvant Therapy? J. Y. Kim1, R. Nelson1, S. L. Chen1, W. Hofstetter 2, J. Kim1, S. G. Swisher 2, D. J. Raz1 1 City of Hope Cancer Center, Duarte, CA; 2MD Anderson Cancer Center, Houston, TX 2:00 PM Roux-en-Y Near Esophagojejunostomy for Failed Anti-Reflux Surgery: An Analysis of Outcomes in Over 100 Patients O. Awais1, J. D. Luketich1, N. Reddy1, R. M. Levy1, M. J. Schuchert1, W. E. Gooding2, L. Crist1, R. J. Landreneau1, A. Pennathur1 1 University of Pittsburgh Medical Center, PA; 2University of Pittsburgh Cancer Institute, PA 2:15 PM Debate: Induction Therapy Should Not Be Used for T2N0 Esophageal Cancer Pro: Steven R. DeMeester, Los Angeles, CA Con: Wayne Hofstetter, Houston, TX


Advance Program 23


12:45 PM – 2:45 PM

General Thoracic Session: Lung Cancer II Moderators: Frank C. Detterbeck, New Haven, CT, and Traves D. Crabtree, St. Louis, MO 12:45 PM External Validation of the STS General Thoracic Surgery Database M. J. Magee1, C. D. Wright5, D. McDonald4, F. G. Fernandez2, B. D. Kozower 3 1 Medical City Dallas Hospital, TX; 2Emory University School of Medicine, Atlanta, GA; 3University of Virginia, Charlottesville; 4The Society of Thoracic Surgeons, Chicago, IL; 5Massachusetts General Hospital, Boston, MA 1:00 PM A Comparison of Length of Stay, Readmission Rate, and Facility Reimbursement Following Lobectomy of the Lung R. K. Freeman, A. J. Ascioti, R. S. Mahidhara St. Vincent Hospital, Indianapolis, IN 1:15 PM Natural History of Ground Glass Nodules Detected on the Chest Computed Tomography Scan after Major Lung Resection H. Kim, J. Jeon, Y. W. Seong, I. Park, C. Kang, Y. Kim Seoul National University Hospital, Republic of Korea 1:30 PM A Dominant, Invasive Adenocarcinoma Associated with Multifocal In-situ Lesions Does Not Represent M1 Disease and Should Be Treated Surgically B. Gu, S. P. Stephanie, C. D. Hoang, R. I. Whyte, V. Nair, R. E. Merritt, J. B. Shrager Stanford University School of Medicine, CA 1:45 PM Survival Comparison of Non-Small Cell Lung Cancer with Local Treatment Modalities Y. M. Carter, K. Lucia, M. B. Marshall Georgetown University Hospital, Washington, DC 2:00 PM Recurrence of Pulmonary Carcinoid Tumors after Resection: Implications for Postoperative Surveillance F. Lou1, I. S. Sarkaria1, M. C. Pietanza1, W. Travis1, M. Roh3, G. Sica2, D. G. Healy4, V. W. Rusch1, J. Huang1 1 Memorial Sloan-Kettering Cancer Center, New York, NY; 2Emory University School of Medicine, Atlanta, GA; 3Dong-A University College of Medicine, Busan, Republic of Korea; 4St. Vincent’s University Hospital, Dublin, Ireland 2:15 PM Visceral Pleural Invasion Is Not Predictive of Survival in NSCLC Patients with Small Tumors in a North American Patient Population E. A. David, C. Wai, A. M. Correa, W. L. Hofstetter, D. C. Rice, J. A. Roth, S. G. Swisher, G. L. Walsh, A. A. Vaporciyan, P. F. Thall, R. J. Mehran University of Texas MD Anderson Cancer Center, Houston 2:30 PM The Impact of Histopathologic Response on Pathologic TNM Lung Cancer Staging System (AJCC Seventh) Following Neoadjuvant Chemotherapy B. Sepesi1, A. M. Correa1, A. Pataer1, N. Kalhor1, B. N. Bekele2, J. J. Erasmus1, W. Hofstetter1, E. S. Kim1, R. Komaki1, R. J. Mehran1, C. A. Moran1, V. Papadimitrakopoulou1, D. C. Rice1, J. A. Roth1, A. A. Vaporciyan1, G. L. Walsh1, W. N. William1, I. Wistuba1, S. G. Swisher1 1 The University of Texas MD Anderson Cancer Center, Houston; 2 Gilead Sciences, Foster City, CA 12:45 PM – 2:45 PM

Patient Safety Symposium: The Nexus of Data, Outcomes, and Public Awareness Course Description: Cardiothoracic surgeons were the first medical specialty group to publicly report clinical outcomes using registry data, with the belief that the public has a right to know and understand the quality of surgical outcomes. Ensuring that patients, payers, legislators, and health care policy makers have access to fair and meaningful data promotes health care accountability, transparency, and informed decision making. This program will compare different data sources, discuss the limitations of public reporting, and examine its impact on patient safety.

24


www.sts.org

Learning Objectives: Upon completion of this program, participants should be able to:  Identify differences between administrative and clinical data;  Discuss pros and cons of publicly reporting cardiac surgical outcomes;  Describe the rationale for reporting composite outcomes; and  Summarize the importance of accurate data and transparency in shared decision making. Moderator: James I. Fann, Stanford, CA

Patient Safety & Public Reporting: Are They Connected? 12:45 PM Introductory Remarks James I. Fann, Stanford, CA 12:50 PM Public Reporting Has Improved Patient Safety in Cardiac Surgery: NY State Stephen J. Lahey, Farmington, CT 1:00 PM What We Learned from Bristol: Can Outcomes Data Influence Patient Safety? TBD 1:10 PM Cardiology Referrals Should Only Be Based on Surgeon Mortality Rates David L. Brown, Stony Brook, NY 1:20 PM Limits of Surgeon Profiling: What Are the “Best” Surgeon Outcomes? David M. Shahian, Boston, MA 1:30 PM Interactive Panel & Audience Discussion T. Sloane Guy, Philadelphia, PA, and Felix W. Tsai, Norfolk, VA*

Utilizing Data Tools to Facilitate a Culture of Safety 1:50 PM Instituting a Culture of Safety at Your Hospital Denise Murphy, Bryn Mawr, PA 2:00 PM Administrative Versus Clinical Databases: A Thoracic Surgeon’s Journey M. Blair Marshall, Washington, DC 2:10 PM A Method for Utilizing the STS National Database Candace Trace, Wynnewood, PA 2:20 PM Interactive Panel & Audience Discussion T. Sloane Guy, Philadelphia, PA, and Felix W. Tsai, Norfolk, VA* 12:45 PM – 2:45 PM

SCA @ STS

Course Description: Transfusions of blood products occur in anywhere from 10% to 90% of patients undergoing coronary artery surgery, depending upon the cardiac surgical program. This degree of disparate utilization of blood products suggests that there are opportunities for standardizing behavior and improving resource utilization and quality of care. This symposium, presented jointly by the Society of Cardiovascular Anesthesiologists and STS, will provide participants with an evidence-based approach to the utilization of blood products—specifically, packed red blood cells. Learning Objectives: Upon completion of this program, participants should be able to:  Summarize the evidence behind the current guidelines for transfusion triggers in open heart surgery and critically ill patients;  Discuss the risks of transfusion, as well as complications that are associated with transfusions in open heart surgery;  Recognize when the guidelines for specific transfusion triggers are not applicable;  Discuss the barriers to changing behavior regarding adherence to guidelines; and  Identify the high-risk patient for transfusion and apply perioperative techniques to minimize blood loss and the need for transfusions. Moderators: Glenn J. R. Whitman, Baltimore, MD, and Stanton K. Shernan, Boston, MA 12:45 PM

he Ideal Hemoglobin Trigger for Transfusion: What Is the Evidence? T Jeffrey L. Carson, New Brunswick, NJ

1:05 PM Transfusion Guidelines: Why Are They Not Followed? Soloman Aronson, Durham, NC


1:25 PM Transfusion Management of the High-Risk Patient Charles R. Bridges, Charlotte, NC 1:45 PM Discussion 2:15 PM Transfusion of One and Two Units of Red Blood Cells Is Associated with Increased Morbidity and Mortality Following Isolated Coronary Artery Bypass Surgery: A Propensity Analysis of 16,835 On-Pump Procedures G. Paone1, R. J. Brewer1, P. F. Theurer 2, G. F. Bell2, C. M. Cogan1, R. L. Prager 3 1 Henry Ford Hospital, Detroit, MI; 2Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, East Lansing; 3 University of Michigan, Ann Arbor 2:30 PM Blood Transfusion in Cardiac Surgery Does Increase the Risk of 5-Year Mortality: Results from a Contemporary Series of 1,714 Propensity-Matched Patients R. E. Shaw1, C. K. Johnson1, G. Ferrari2, A. W. Mak1, M. E. Brizzio1, K. B. Sayles1, N. Rioux1, J. S. Sperling1, A. Zapolanski1, J. B. Grau1 1 Valley-Columbia Heart Center, Columbia University College of Physicians and Surgeons, Ridgewood, NJ; 2University of Pennsylvania School of Medicine, Glenolden 2:45 PM – 3:30 PM


Adult Cardiac Session: General Moderators: Howard Song, Portland, OR, and Niv Ad, Falls Church, VA 3:30 PM Readmissions after Cardiac Surgery: Experience of the NIH / CIHR Cardiothoracic Surgical Trials Network J. H. Alexander1, A. Iribarne2, P. T. O’Gara3, H. L. Chang4, A. M. Gillinov5, E. Moquete4, J. D. Puskas6, E. Bagiella4, M. Mayer7, T. B. Ferguson8, S. Burks9, L. P. Perrault10, K. Johnston9, J. J. DeRose11, A. Neill6, W. Taddei-Peters12, A. Moskowitz4, M. A. Acker7 1 Duke University Medical Center, Durham, NC; 2Columbia University Medical Center, New York, NY; 3Brigham and Women’s Hospital, Boston, MA; 4Mount Sinai School of Medicine, New York, NY; 5 Cleveland Clinic, OH; 6Emory University, Atlanta, GA; 7University of Pennsylvania Medical Center, Philadelphia; 8East Carolina Heart Institute at ECU, Greenville, NC; 9University of Virginia Medical Center Health Sciences Center, Charlottesville; 10Montreal Heart Institute, QC, Canada; 11Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY; 12National Heart, Lung, and Blood Institute, Bethesda, MD 3:45 PM Preoperative Hematocrit Is a Powerful Predictor of Adverse Outcomes in CABG Surgery: A Report from the STS Adult Cardiac Surgery Database M. L. Williams1, M. S. Slaughter1, X. He2, J. S. Gammie3 1 University of Louisville, KY; 2Duke Clinical Research Institute, Durham, NC; 3University of Maryland, Baltimore 4:00 PM The Safety and Efficacy of Minimally Invasive Mitral Valve Surgery and Cox-Maze Procedure without Aortic Cross Clamp and Cardioplegic Arrest P. S. Massimiano, B. Yanagawa, S. Hunt, Li. Henry, N. Ad Heart and Vascular Institute, Inova, Falls Church, VA 4:15 PM Mitral Valve Repair Versus Replacement for Moderate-to-Severe Mitral Regurgitation in Patients Undergoing Concomitant Aortic Valve Replacement G. Kim, J. Kim, S. Choo, C. Chung, J. Lee, S. Jung Asan Medical Center, Seoul, Republic of Korea 4:30 PM Emergent Repair of Acute Type A Dissection at 28°C: The Impact of Selective Antegrade Cerebral Perfusion and Mild Hypothermic Circulatory Arrest G. M. Comas, B. Leshnower, R. Myung, M. E. Halkos, V. H. Thourani, J.D. Puskas, R. A. Guyton, P. Kilgo, E. P. Chen Emory University, Atlanta, GA ADMIT ONE

4:45 PM No Difference in 1-Year Vein Graft Failure or 5-Year Clinical Outcomes Between Open and Closed Tunnel Endoscopic Vein Harvesting Devices: Results from the PREVENT-IV Trial S. van Diepen1, J. M. Brennan2, K. B. Allen3, G. E. Hafley 2, E.Reyes2, T. B Ferguson4, E. D. Peterson2, J. B. Williams2, C. M. Gibson5, M. J. Mack6, N. T. Kouchoukos7, J. H. Alexander 2, R. D. Lopes2 1 University of Alberta, Edmonton, Canada; 2Duke Clinical Research Institute, Durham, NC; 3Mid America Heart Institute, St. Luke’s Hospital, Kansas City, MO; 4East Carolina University, Greenville, NC; 5 PERFUSE Angiographic Laboratory, Boston, MA; 6Cardiopulmonary Research Science and Technology Institute, Dallas, TX; 7Missouri Baptist Medical Center, St Louis 5:00 PM Debate: Tissue Valves Should Not Be Used in Patients Younger Than 65 Pro: John D. Puskas, Atlanta, GA Con: Thomas E. MacGillivray, Boston, MA 3:30 PM – 5:30 PM

Adult Cardiac Session: Aortic Valve Moderators: Vaughn A. Starnes, Los Angeles, CA, and Thomas M. Beaver, Gainesville, FL 3:30 PM Baseline Costs for Isolated Elective Surgical Aortic Valve Replacement Based on the STS Predicted Risk of Mortality Score J. B. Rich1, E. Fonner 2, G. Ailawadi3, A. M. Speir4 1 Sentara Heart Hospital, Norfolk, VA; 2Virginia Cardiac Surgery Quality Initiative, Falls Church; 3University of Virginia, Charlottesville; 4Inova Heart and Vascular Institute, Fairfax, VA 3:45 PM

ate Outcomes Comparison for Non-Elderly Patients Between L Bioprosthetic and Mechanical Valves in the Aortic Position: A Propensity-Matched Analysis Spanning 18 Years R. S. McClure, M. Cevasco, S. McGurk, A. Maloney, G. Salvio, G. Tokmaji, L. H. Cohn Brigham and Women’s Hospital, Boston, MA

4:00 PM Aortic Valve Replacement: Using A Statewide Database Identifies a Procedural Volume Hinge Point H. J. Patel1, M. A. Herbert2, D. H. Drake3, E. C. Hanson4, P. F. Theurer5, G. F. Bell5, R. L. Prager1 1 University of Michigan Medical Center, Ann Arbor; 2Southwest Data Consultants, Dallas, TX; 3Munson Medical Center, Traverse City, MI; 4 Beaumont Hospital, Troy, MI; 5Michigan Society of Thoracic and Cardiovascular Surgeons, Ann Arbor 4:15 PM Sutureless Pericardial Valve for Isolated Aortic Valve Replacement in Right Anterior Minithoracotomy: Initial Experience of a Single Centre D. Gilmanov, A. Miceli, M. Glauber G. Monasterio Tuscany Foundation - G. Pasquinucci Heart Hospital, Massa, Italy 4:30 PM Long-Term Durability of Bicuspid Aortic Valve Repair L. G. Svensson, A. H. Al Kindi, G. B. Pettersson, A. M. Gillinov, T. Mihaljevic, J. F. Sabik, E. H. Blackstone, B. W. Lytle Cleveland Clinic, OH 4:45 PM The Perceval S Sutureless Aortic Valve Bioprosthesis Has the Potential of Shortening Surgical Time: Does It Also Result in Improved Patient Outcome? G. Santarpino, S. Pfeiffer, G. Concistré, I. Grossmann, M. H. Hinzmann, T. J. Fischlein Klinukum Nürnberg, Nuremberg, Germany 5:00 PM Debate: Should We Repair Bicuspid Aortic Valve? Pro: Gebrine El Khoury, Brussels, Belgium Con: Neal D. Kon, Winston-Salem, NC


Advance Program 25


3:30 PM – 5:30 PM

3:30 PM – 5:30 PM

Moderators: Benjamin D. Kozower, Charlottesville, VA, and Ara A. Vaporciyan, Houston, TX

Course Description: This course will provide participants with a timely review of recent key clinical trials as well as studies in progress. The trials covered in this session encompass the full spectrum of the surgical treatment of cardiac disease. Each session will conclude with expert commentary to lend a clinical perspective that will impact a surgeon’s daily practice.

Cardiothoracic Surgical Education


3:30 PM Surgical Resident Awareness of Financial Reimbursement and Documentation Requirements: Results of a Multi-institutional Survey K. W. Yount1, B. N. Reames2, C. D. Kensinger 3, M. A. Boeck4, P. W. Thompson5, J.D. Forrester 6, G. R. Upchurch1, P. G. Gauger 2, I. L. Kron1, C. L. Lau1 1 University of Virginia, Charlottesville; 2University of Michigan, Ann Arbor; 3Vanderbilt University, Nashville, TN; 4Columbia University, New York, NY; 5Emory University, Atlanta, GA; 6Stanford University, Palo Alto, CA 3:45 PM Thoracic Surgical Resident Education: A Costly Endeavor J. H. Calhoon1, C. Baisden1, B. Holler1, G. L. Hicks2, E. L. Bove 6, C. D. Wright3, W. H. Merrill5, D. A. Fullerton4 1 The University of Texas Health Science Center at San Antonio; 2 University of Rochester, NY; 3Massachussetts General Hospital, Boston; 4University of Colorado, Denver; 5University of Mississippi, Jackson; 6University of Michigan, Ann Arbor

Learning Objectives: Upon completion of this program, participants should be able to:  Explain the criteria by which various studies on interventional versus surgical treatment for coronary artery disease have been conducted and validated;  Discuss the changing spectrum of TAVR patient selection and outcomes; and  Summarize the evolution of ventricular assist devices and their indications for use. Moderators: Keith A. Horvath, Bethesda, MD, and Joseph F. Sabik III, Cleveland, OH

Session I: Ischemic — PCI Versus CABG Trials 3:30 PM SYNTAX Trial Update Friedrich W. Mohr, Leipzig, Germany

4:00 PM Trends in Applications for Cardiothoracic Fellowship in Comparison with Other Surgical Subspecialties M. B. Marshall1, S. M. Pousatis2 1 Georgetown University Hospital, Washington, DC; 2Georgetown University School of Medicine, Washington, DC

3:40 PM Freedom Trial Update Valentin Fuster, New York, NY*

4:15 PM Motivations and Demographics of I-6 and Traditional 5 + 2 CT Surgery Residents T. K. Varghese, N. A. Mokadam, E. D. Verrier, D. Wallyce, D. E. Wood University of Washington, Seattle

Session II: Percutaneous Valve Trials

4:30 PM The Society of Thoracic Surgeons ”Looking to the Future” Scholarship Program: Outcomes of Our Investment in 184 Recipients S. C. Yang1, R. S. Higgins2, A. A. Vaporciyan3, W. H. Merrill4 1 Johns Hopkins Medical Institutions, Baltimore, MD; 2Ohio State University Medical Center, Columbus; 3University of Texas MD Anderson Cancer Center, Houston; 4Vanderbilt University Hospital, Nashville, TN 4:45 PM Multi-center Coronary Artery Anastomosis Assessment: The Joint Council on Thoracic Surgery Education Tool Is Reliable Among Raters R. Lee1, D. Enter1, X. Lou1, R. H. Feins2, G. L. Hicks3, M. G. Gasparri4, H. Takayama5, J. N. Young 6, J. H. Calhoon7, F. A. Crawford8, N. A. Mokadam9, J. I. Fann10 1 Northwestern University, Chicago, IL; 2University of North Carolina at Chapel Hill; 3University of Rochester, NY; 4Medical College of Wisconsin Affiliated Hospitals, Milwaukee; 5New York Presbyterian Hospital-Columbia, NY; 6University of California-Davis; 7University of Texas Health Science Center at San Antonio; 8Medical University of South Carolina, Charleston; 9University of Washington, Seattle; 10 Stanford University, CA 5:00 PM Debate: Simulation Training Is More Effective Than Operating on Patients Pro: James I. Fann, Stanford, CA Con: Michael A. Acker, Philadelphia, PA

3:50 PM Commentary TBD

4:00 PM PARTNER Trial: Cohort A & B Craig R. Smith, New York, NY* 4:07 PM CoreValve Trials David H. Adams, New York, NY* 4:14 PM

PARTNER II Trial: Cohort A D. Craig Miller, Stanford, CA*

4:21 PM Commentary Lars G. Svensson, Cleveland, OH*

Session III: Heart Failure and LVAD Trials 4:30 PM ADVANCE Trial Update Mark S. Slaughter, Louisville, KY 4:37 PM ENDURANCE Trial Update Francis D. Pagani, Ann Arbor, MI 4:44 PM Circulite Trial Nader Moazani, Cleveland, OH 4:50 PM Commentary O. Howard Frazier, Houston, TX*

Session IV: National Cardiothoracic Surgery Research Network Trials 5:00 PM Stem Cells for Heart Failure/LVAD Implantation Robert E. Michler, New York, NY 5:07 PM Repair, Replace, or Leave It Be: What To Do with Ischemic Mitral Valve Regurgitation TBD 5:14 PM Treating Atrial Fibrillation at the Time of Mitral Valve Repair TBD 5:21 PM Commentary Timothy J. Gardner, Wilmington, DE

26


www.sts.org


3:30 PM – 5:30 PM

Congenital Session: Pediatric Congenital III Moderators: Carl L. Backer, Chicago, IL, and S. Adil Husain, San Antonio, TX 3:30 PM The Usefulness of Aortopexy in Central Airway Obstruction after Correction Surgery for Congenital Heart Disease W. Jang, W. Kim Seoul National University Children’s Hospital, Republic of Korea

4:30 PM Utilization of Cardiothoracic Surgeons for Operative Penetrating Thoracic Trauma and Its Impact on Clinical Outcomes N. M. Mollberg1, D. E. Wood1, D. R. Tabachnick 2, S. R. Wise2, M. G. Massad3 1 University of Washington, Seattle; 2University of Illinois at Mount Sinai Hospital, Chicago; 3University of Illinois, Chicago 4:45 PM Thoracoscopic Nuss Procedure for Adults with Pectus Excavatum: Excellent Long-Term Results and Patient Satisfaction W. C. Hanna, M. A. Ko, M. Blitz, Y. Shargall, C. G. Compeau University of Toronto, ON, Canada

3:45 PM Anterior Tracheal Suspension for Tracheobronchomalacia in Infants and Children M. E. Mitchell1, R. Chun2, D. J. Beste2, R. Berens2, T. Martin2, N.S. Ghanayem2, T. Sato2, M. Uhing2, D. Parakininkas2, P. M. Simpson2, J. S. Tweddell2, J. E. Kerschner2 1 Children’s Hospital of Wisconsin, Milwaukee; 2Medical College of Wisconsin, Milwaukee

5:00 PM Lymph Node Dissection and Pulmonary Metastasectomy for Metastatic Renal Cell Carcinoma: An 11-Year Single Center Experience N. Kudelin, S. Bolukbas, J. Schirren Dr. Horst Schmidt Klinik, Wiesbaden, Germany

4:00 PM External Stenting for Airway Compression Associated with Congenital Heart Surgery in Small Children M. Ando1, H. Hasegawa2, Y. Nagase3 1 Sakakibara Heart Institute, Tokyo, Japan; 2Tokyo Women’s Medical University Medical Center East, Japan; 3Ginza Heart Clinic, Tokyo, Japan

5:15 PM Prevalence and Outcomes of Anatomic Lung Resection for Hemoptysis: An Analysis of the Nationwide Inpatient Sample Database S. Paul, A. Nasar, J. Port, P. C. Lee, B. M. Stiles, W. Andrews, A. Sedrakyan, N. K. Altorki New York-Presbyterian/Weill Cornell, New York, NY

4:15 PM Management of Tracheobronchial Malacia in the Congenital Heart Patient Michael J. Rutter, Cincinnati, OH

3:30 PM – 5:30 PM

4:45 PM Outcomes of Heart Transplantation in Small Children Bridged with Ventricular Assist Devices A. Kilic, K. Nelson, J. Scheel, W. Ravekes, D. E. Cameron, L. A. Vricella The Johns Hopkins Hospital, Baltimore, MD 5:00 PM Surgical Repair of Pulmonary Venous Stenosis—A Word of Caution K. R. Kanter, P. M. Kirshbom, B. E. Kogon Emory University School of Medicine, Atlanta, GA 5:15 PM Natural and Modified History of Anomalous Pulmonary Veins from Left Lung Y. Kotani, D. Chetan, J. Zhu, V. Anand, C. A. Caldarone, G. S. Van Arsdell, J. G. Coles, O. Honjo The Hospital for Sick Children, Toronto, ON, Canada 3:30 PM – 5:30 PM

General Thoracic Session: Mediastinal/Pulmonary II Moderators: Daniel J. Boffa, New Haven, CT, and Rishinda M. Reddy, Ann Arbor, MI 3:30 PM Stenting for Malignant Central Airway Obstruction in 100 Cases: Short- and Long-Term Outcomes and Lessons Learned S. Rehmani1, S. S. Razi2, R. S. Lebovics1, A. Evans1, F. Bhora1 1 St. Lukes-Roosevelt Hospital Center, New York, NY; 2University of Connecticut Health Center, Hartford 3:45 PM How Long the Bronchus Should We Resect? Bronchial Resection Margin Length and Adjuvant Radiotherapy D. Kim1, H. Kim1, Y. Choi1, K. Kim2, J. Kim1, Y. Shim1 1 Samsung Medical Center, Seoul, Republic of Korea; 2Seoul National University Bundang Hospital, Republic of Korea 4:00 PM 25-Year Experience with Subclavian Artery Resection and Reconstruction for Thoracic Inlet Cancers B. Lahon, E. Fadel, O. Mercier, S. Mussot, D. Fabre, S. Hamdi, T. Le Chevalier, P. G. Dartevelle Hôpital Marie Lannelongue, Le Plessis Robinson, France 4:15 PM Are We Focusing on the Right Thing During One-Lung Ventilation? A Multi-Centre Survey of Academic Anesthesiologists B. Kidane1, S. Choi2, D. Fortin3, T. O’Hare4, G. Nicolaou1, N. Badner1, R. I. Inculet3, P. D. Slinger 2, R. A. Malthaner 3 1 Western University, London, ON, Canada; 2University of Toronto, ON, Canada; 3London Health Sciences Centre, ON, Canada; 4McMaster University, Hamilton, ON, Canada ADMIT ONE

What CT Surgeons Need to Know About Vascular Surgery in 2013 Course Description: This course will focus on vascular surgery topics relevant to practicing cardiothoracic surgeons. Topics to be presented include carotid artery occlusive disease, open distal leg revascularization, abdominal aortic aneurysms, and current training and educational opportunities. The overall goal of the course is to update the cardiothoracic surgeon with selected state-of-the art information on common vascular surgery problems and present new options for fellowship training in cardiothoracic and vascular surgery. Learning Objectives: Upon completion of this program, participants should be able to:  Adapt their practices and training in order to maintain a vascular practice in the future;  Formulate a plan for management of patients with carotid artery occlusive disease;  Identify open surgical options for patients requiring operation for lower extremity limb salvage; and  Distinguish which patients with abdominal aortic aneurysms will benefit from open repair. Moderators: A. Michael Borkon, Kansas City, MO, and Juan A. Crestanello, Columbus, OH 3:30 PM Treatment of Carotid Artery Occlusive Disease Michael J. Reardon, Houston, TX 3:55 PM Does Anyone Do Open Distal Revascularization Anymore? Keith B. Allen, Kansas City, MO 4:20 PM Repair of Abdominal Aortic Aneurysms: A New Era A. Michael Borkon, Kansas City, MO 4:45 PM Back to the Future: 21st Century Vascular Training in Cardiothoracic Surgery George J. Magovern Jr., Pittsburgh, PA 5:10 PM Discussion 6:30 PM – 9:00 PM

ADMIT ONE

STS Social Event


Advance Program 27

Wednesd ay, Janua ry 30, 2013

Course #3: Hybrid Revascularization

6:30 AM – 9:30 AM

Registration: STS 49th Annual Meeting

Course Directors: Joseph F. Sabik III, Cleveland, OH, and John D. Puskas, Atlanta, GA

7:00 AM – 10:00 AM

STS University

ADMIT ONE

Course #1: Mitral Valve Repair Course Directors: Rakesh M. Suri, Rochester, MN, and James S. Gammie, Baltimore, MD Course Description: Surgical mitral valve repair for severe degenerative mitral regurgitation can improve symptoms and restore normal life expectancy. Current ACC/AHA guidelines recommend referral of asymptomatic patients without overt left ventricular dysfunction for mitral valve repair to experienced centers with a >90% repair rate and low perioperative morbidity. The techniques of degenerative mitral valve repair are well established and reproducible. This course will provide hands-on experience with the following via open, thoracoscopic, and robotic approaches: 1) mitral valve analysis, 2) mitral leaflet prolapse correction using resectional versus neochordal techniques, and 3) complete versus partial annuloplasty placement. Participants will learn and practice mitral valve repair in small groups, guided by expert faculty who are international leaders in contemporary open, minimally invasive, and robotic valve repair. The objective is to guide participants in performing mitral valve repair for a broad range of pathologic subsets, encompassing both simple and more complex multi-scallop disease. Learning Objectives: Upon completion of this program, participants should be able to:  Recall essential degenerative mitral anatomy;  Discuss the principles of valve analysis;  Review technical aspects of annuloplasty sizing and implantation; and  Review technical aspects of resection versus neochordal approaches.

Course #2: Valve-Sparing Root Replacement and Aortic Arch Repair Course Directors: Duke E. Cameron, Baltimore, MD, and Edward P. Chen, Atlanta, GA Course Description: This course will provide a comprehensive review of the operative techniques and critical steps necessary for a successful valvesparing aortic root replacement (VSRR). Faculty members will use video-based instruction to cover surgical nuances for both the reimplantation and remodeling procedures. A hands-on experience with porcine hearts will follow the lecture. Several proctors who are familiar with the operative techniques will be available for consultation and assistance. Learning Objectives: Upon completion of this program, participants should be able to:  Describe the anatomy of the aortic root;  Summarize the technical steps necessary for successful performance of a VSRR;  Apply different methods in choosing a graft size; and  Discuss leaflet repair and annuloplasty methods.

28


www.sts.org

Course Description: In this course, participants will learn the surgical and percutaneous coronary revascularization techniques of hybrid coronary revascularization. Hybrid coronary revascularization treats patients with both minimally invasive surgical and percutaneous coronary revascularization. Using simulators and presentations, participants will learn the surgical techniques of endoscopic robotic and open minimally invasive thoracotomy, internal mammary artery harvesting, internal mammary artery to coronary artery anastomoses, and basic percutaneous coronary revascularization techniques. Selection of appropriate patients for hybrid revascularization will also be reviewed, as well as the timing and order of the two revascularization strategies. Learning Objectives: Upon completion of this program, participants should be able to:  Summarize the surgical techniques of endoscopic robotic and open minimally invasive thoracotomy coronary artery bypass surgery;  Describe the basic techniques of percutaneous coronary revascularization; and  Discuss patient selection and timing of the two revascularization strategies of hybrid coronary revascularization.

Course #4: TAVR/TEVAR Course Directors: Eric E. Roselli, Cleveland, OH, and Wilson Y. Szeto, Philadelphia, PA Course Description: New skills are required for transcatheter aortic valve replacement (TAVR) and thoracic endovascular aortic repair (TEVAR). This course will introduce attendees to novel endovascular techniques for the treatment of aortic stenosis and thoracic aortic disease. The hands-on lab experience will provide participants with the opportunity to either practice or observe an expert perform a variety of procedures utilizing the latest technology. Each attendee will have ample opportunity for interaction with expert faculty on a variety of procedures, including transfemoral and transapical aortic valve replacement, introduction to wires and catheters, and all aspects of TEVAR. Learning Objectives: Upon completion of this program, participants should be able to:  Practice with experts and compare techniques on transfemoral and transapical aortic valve replacement;  Classify the techniques required to expertly perform TEVAR and to practice the implant procedure with consideration of technical pitfalls; and  Compare and appraise techniques with multiple different wires and catheters utilized in the performance of TAVR and TEVAR.


Course #5: Short- and Long-Term Mechanical Support

Course #8: Novel Techniques in Esophageal and Tracheal Surgery

Course Directors: Nicholas G. Smedira, Cleveland, OH, and Walter P. Dembitsky, San Diego, CA

Course Directors: Cameron D. Wright, Boston, MA, and Christopher R. Morse, Boston, MA

Course Description: The course is designed to familiarize participants with currently available forms of short- and long-term mechanical circulatory support. Participants will gain hands-on experience focusing on techniques for optimal device insertion, minimizing both short- and long-term complications, and optimization of device settings. At each station, the instructor will provide a brief overview of the surgical techniques or the device itself. The participants will then have the opportunity to work directly with the instructor to discuss issues related to insertion and medical management of the device.

Course Description: Tracheal and esophageal resection and reconstruction require unique technical skills to achieve success and minimize complications, such as leaks and stricture. Participants will be introduced to several techniques for airway and esophageal reconstruction with an emphasis in the different technical aspects (“pearls”) of the anastomosis. The seminar will include brief introductions of the different techniques followed by hands-on experience that participants can incorporate into their practices. Techniques will include tracheal and sleeve anastomosis, hand-sewn anastomosis, and stapled anastomosis (linear and end-to-end).

Learning Objectives: Upon completion of this program, participants should be able to:  Select optimal short-term devices for the presenting clinical condition;  Discuss vascular access for short-term devices to minimize limb complications;  Summarize the technical pearls for the insertion and exchange of left ventricular assist devices; and  Discuss troubleshooting and device optimization.

Course #6: VATS and Robotic Lobectomy Course Directors: Scott J. Swanson, Boston, MA, and Bernard J. Park, Hackensack, NJ Course Description: This program will review the indications, patient selection, technical steps, and recent advances in video-assisted thoracic surgery (VATS) and robotic lobectomy. Two short didactic lectures will precede the session, which is mainly dedicated to hands-on training for a VATS left upper lobectomy utilizing porcine heart lung blocks. Additional stations include instrument and energy device options, a robotic simulator, and robotic lobectomy. Learning Objectives: Upon completion of this program, participants should be able to:  Describe the indications and steps to perform VATS/robotic lobectomy;  Discuss potential pitfalls and strategies for intraoperative troubleshooting to successfully achieve minimally invasive lobectomy;  Identify instruments and other technologies available for the performance of minimally invasive lobectomy; and  Discuss the potential utilization of robotic technology for minimally invasive lobectomy.

Course #7: Ultrasound- and Navigation-Guided Bronchoscopy Course Directors: Frank C. Detterbeck, New Haven, CT, and Armin Ernst, Boston, MA

Learning Objectives: Upon completion of this program, participants should be able to:  Perform tracheal/airway resection and reconstruction;  Perform esophageal hand-sewn anastomosis; and  Perform esophageal stapled anastomosis (linear and end-to-end).

Course #9: Chest Wall Resection and Reconstruction/Thoracic Outlet Syndrome Course Directors: Manjit S. Bains, New York, NY, and Dean M. Donahue, Boston, MA Course Description: This course is designed to familiarize participants with various indications for resection of the chest wall and reconstruction of the chest wall with the available techniques. It will also teach participants how to evaluate trauma to the chest wall and determine when and how to stabilize the chest wall with varying techniques. It will review management of thoracic outlet syndrome (TOS). Following a short didactic session, hands-on demonstration will allow participants to see the utility of different reconstruction techniques and to use materials that they may not have worked with previously. By the end of this course, participants should feel comfortable in the management of resection and reconstruction of the chest wall. The session on TOS will involve visual aids and a small group discussion regarding the technical details of first rib resection. Learning Objectives: Upon completion of this program, participants should be able to: Discuss indications for chest wall resection and reconstruction, as well as fixation of the chest wall with fractures;  Discuss repair evaluation and treatment of TOS;  Summarize the techniques and materials needed for the repair of chest wall defects; and  Select and perform the repair of chest wall defects with appropriate techniques and with economic considerations. 

Course Description: Ultrasound-guided bronchoscopy has attained a firm place in the endoscopic staging armamentarium of mediastinal lymph nodes. Electromagnetic navigation is an interesting new technology aimed at facilitating the endoscopic biopsy of peripheral lung lesion. In this course, leaders in the field will provide a short didactic overview, followed by a focused, hands-on opportunity to practice these techniques on models and simulators. Small group sessions will facilitate the opportunity for close instructor/ learner interaction. Learning Objectives: Upon completion of this program, participants should be able to:  Discuss how endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS) are used in mediastinal staging;  Summarize the complementary roles of EBUS and EUS; and  Describe the potential and limitations of electromagnetic guidance.

ADMIT ONE

Indicates that a ticket is required to attend. 49th ANNUAL MEETING

Advance Program 29


Course #10: ECMO

Course #12: Traditional and Modified Konno Procedures

Course Directors: Aaron M. Cheng, Seattle, WA, and Dan J. Raz, Duarte, CA

Course Directors: John W. Brown, Indianapolis, IN, and Christopher A. Caldarone, Toronto, ON, Canada

Course Description: This is a hands-on course on the indications and management of adult extracorporeal membrane oxygenator (ECMO) support, with a focus on veno-venous (V-V) ECMO support for primary respiratory failure. The course will feature a brief didactic session which will include indications for V-V and veno-arterial (V-A) ECMO, an introduction to the components of the circuit, key management principles, and an overview of weaning from ECMO support. Course instructors will then lead several interactive, hands-on stations, which will include discussions on the physiology of ECMO in respiratory failure, an interactive display of the ECMO circuit and variations on the circuit, a demonstration of the variety of cannulas and technology available, and troubleshooting of simulated ECMO-related problems. This course is geared toward both cardiothoracic surgeons and critical care providers. Learning Objectives: Upon completion of this program, participants should be able to:  Discuss appropriate indications for ECMO support, including for acute respiratory failure (VV-ECLS) and cardiopulmonary arrest (ECPR);  Summarize different cannulation options for ECMO support and troubleshoot difficulties associated with cannulation and ECMO initiation;  Discuss rational management of anticoagulation and bleeding during ECMO; and  Discuss modern ECMO circuit design and technology.

Course #11: ICU/Echo Course Directors: Thomas E. MacGillivray, Boston, MA, and Glenn J. R. Whitman, Baltimore, MD Course Description: This course will review utilization of focused ultrasound examination of the heart, pleural space, and central veins. While there will be a brief didactic session, most of the emphasis will be placed on hands-on sessions with ultrasound simulators and live models. Topics will include: basic cardiac anatomy and physiology as visualized by three common transthoracic views; inferior vena cava (IVC) evaluation to determine intravascular volume; pleural space pathology, such as pneumothorax and pleural effusions; and ultrasound techniques for central vein visualization and cannulation. Learning Objectives: Upon completion of this program, participants should be able to:  Generate an echocardiographic parasternal, apical, and subcostal view of the heart;  Evaluate the IVC to help determine volume status;  Identify the pleura and sliding lungs; and  Utilize ultrasound to safely accomplish subclavian and internal jugular venous cannulation.

30


www.sts.org

Course Description: This course will review the anatomic features and surgical techniques used in performing traditional Konno and Ross/Konno procedures and other techniques of aortic annular and left ventricular outflow tract (LVOT) enlargement. The technique of valve-sparing Konno procedures for enlargement of the sub-annular LVOT will also be described. Learning Objectives: Upon completion of this program, participants should be able to:  Identify pertinent anatomy and surgical landmarks in the LVOT;  Discuss the techniques involved in enlargement of the LVOT with replacement of the aortic valve with and without the pulmonary autograft; and  Summarize the techniques involved in enlargement of the LVOT with preservation of the aortic valve.

SCIENTI F IC P OSTERS

A D U LT C A R D I AC P OS T ERS A Reduced Anticoagulation Protocol in Primary Aortic Valve Replacement and/or Coronary Artery Bypass Grafting: The Prospective, Randomized APPACHE Study P. Oses, G. Nesseris, J. Calderon, J. Guibaud, F. Roubertie, L. Barandon, X. G. Roques Haut-Leveque Hospital, University of Bordeaux 2, Pessac, France The Outcome of Concomitant Cox-Maze III Procedure Using Argon-Based Cryosurgical Platform: A Single Center Experience with 250 Consecutive Cases B. Yanagawa, P. S. Massimiano, S. D. Holmes, L. Henry, S. Hunt, N. Ad Heart and Vascular Institute, INOVA, Falls Church, VA Morbidity, Not Mortality, is Decreased after Off-Pump Coronary Artery Bypass Surgery: Analysis of 3,898 Propensity-Matched Patients G. Paone1, R. J. Brewer1, P. F. Theurer 2, G. F. Bell2, C. M. Cogan1, R. L. Prager3 1 Henry Ford Hospital, Detroit, MI; 2Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, East Lansing, MI; 3University of Michigan, Ann Arbor Cirrhosis as a Moderator of Outcomes in CABG and OPCAB Operations: A 12-Year PopulationBased Study R. R. Gopaldas1, D. Chu2, L. D. Cornwell3, T. K. Dao4, S. A. LeMaire2, J. S. Coselli2, F. G. Bakaeen2 1 The University of Missouri School of Medicine, Columbia; 2Texas Heart Institute at St. Luke’s Episcopal Hospital, Houston; 3Baylor College of Medicine, Houston, TX; 4 University of Houston, TX Hybrid Biventricular Assist Devices Improve 1-Year Survival in Acute Cardiogenic Shock J. F. Lazar, M. P. Schiralli, M. Schneider, B. Pisula, W. Hallinan, M. F. Swartz, H. T. Massey, G. L. Hicks University of Rochester, NY Impact of Preoperative Statin Therapy on Postoperative Outcome in Cardiac Surgery Patients: Meta-Analysis of 90,000 Patients E. W. Kuhn, O. J. Liakopoulos, S. Stange, A. C. Deppe, I. Slottosch, M. Scherner, Y. Choi, T. C. Wahlers University of Cologne, Köln, Germany Surviving 20 Years after Heart Transplantation: A Success Story H. Rodriguez Cetina Biefer, V. Falk, M. J. Wilhelm Clinic for Cardiovascular Surgery, Zurich, Switzerland Survival Prediction Models for Coronary Intervention Strategic Decision Support S. Raza, J. F. Sabik, S. Ellis, P. L. Houghtaling, E. H. Blackstone, B. W. Lytle Cleveland Clinic, OH Aortic Valve Reconstruction with Autologous Pericardium for Bicuspid Aortic Valves: Usefulness of Tricuspidization S. Ozaki, I. Kawase, S. Uchida, H. Yamashita, Y. Nozawa, T. Matsuyama, M. Takatoo, S. Hagiwara Toho University Medical Center Ohashi Hospital, Meguro-ku, Japan Short-Term Clinical Outcomes of Initial Medical Treatment for Acute Type A Intramural Hematoma and Aortic Dissection with Thrombosed Thoracic False Lumen S. Watanabe, M. Hanyu, Y. Arai, A. Nagasawa Kokura Memorial Hospital, Kitakyushu, Japan Outcomes Following Implantable Left Ventricular Assist Device Replacement Procedures M. Schechter, M. A. Daneshmand, C. Milano Duke University Medical Center, Durham, NC Continuous Flow Left Ventricular Assist Device Implant in the Elderly is Associated with Increased, But Acceptable Risk P. Atluri, A. B. Goldstone, J. P. Donnelly, J. W. MacArthur, C. M. Zalewski, J. L. Howard, A. S. Fairman, Y. Shudo, J. E. Rame, M. A. Acker, Y. J. Woo University of Pennsylvania, Philadelphia

Repair for Acute Type A Aortic Dissection: Antegrade Perfusion Provides Superior Long-Term Outcome C. D. Etz, J. G. da Rocha e Silva, K. von Aspern, S. Leontyev, F. F. Girrbach, M. Misfeld, M. A. Borger, F. W. Mohr Heart Center Leipzig, Germany Stem Cell Therapy Combined with Myocardial Revascularization: A Pilot Study Using the Harvest Technique E. A. Mostafa, M. M. Mostafa, M. Elfiky, A. Hassouna, M. Sobhi Ain Shams University Hospital, Cairo, Egypt Outcome of the Impella Device for Acute Mechanical Circulatory Support A. Lemaire, M. B. Anderson, T. W. Prendergast, N. R. Stockmaster, A. E. Goodman, A. M. Lozano, P. M. Scholz, G. P. Batsides Robert Wood Johnson Medical Center, Princeton, NJ Hemolysis, Pump Thrombus, and Neurologic Events in Continuous Flow Left Ventricular Assist Device (LVAD) Recipients: A Contemporary Analysis of Prothrombotic Events B. A. Whitson, P. Eckman, F. Kamdar, A. M. Lacey, S. J. Shumway, K. K. Liao, R. John University of Minnesota, Minneapolis Calcineurin Inhibitor Free Immunosuppression Using Everolimus (Certican) after Heart Transplantation: 2-Year Follow Up H. A. Welp1, S. Martens, J. Sindermann, H. H. Scheld, J. Stypmann University Hospital Münster, Germany Blood Transfusion in Isolated CABG Associated with a Three-Fold Increase in Risk of Morality C. Shults, P. Kilgo, M. E. Halkos, O. M. Lattouf, V. H. Thourani, W. A. Cooper, R. Myung, R. A. Guyton, J. D. Puskas Emory University, Atlanta, GA In Vivo Application of Tissue-Engineered Blood Vessels of Bacterial Cellulose as Small Arterial Substitutes M. Scherner1, S. Reutter1, D. Klemm2, A. Sterner-Kock1, K. Dinger1, T. Richter2, Y. Choi1, T. C. Wahlers1, J. Wippermann1 1 University Hospital of Cologne, Germany; 2University of Jena, Germany Current Outcomes for Tricuspid Valve Infective Endocarditis Surgery: Lessons from the STS Adult Cardiac Surgery Database J. G. Gaca1, S. Sheng2, J. S. Rankin3, M. L. Williams4, R. M. Suri5, V. H. Thourani6, S. M. O’Brien2, J. S. Gammie7 1 Duke University, Durham, NC; 2Duke Clinical Research Institute, Durham, NC; 3 Vanderbilt University, Nashville, TN; 4University of Louisville, KY; 5Mayo Clinic, Rochester, MN; 6Emory University, Atlanta, GA; 7University of Maryland, Baltimore An Analysis of Acute Changes in Mitral Valve Geometry Following Stand-Alone Surgical Annuloplasty for Bileaflet Prolapse in Barlow’s Disease D. Maselli, A. Salica, L. Weltert, R. Scaffa, S. Nardella, A. Bellisario, R. De Paulis European Hospital, Rome, Italy Repair or Prosthesis Insertion in Ischemic Mitral Regurgitation: Two Faces of the Same Medal A. M. Calafiore1, A. L. Iacò1, M. Di Mauro2 1 Prince Sultan Cardiac Center, Riyadh, Saudi Arabia; 2University of L’Aquila, Italy De Vega Annuloplasty: A Forgotten Procedure for the Forgotten Valve? H. Hwang1, H. Chang1, D. Jeong2, H. Ahn1 1 Seoul National University, Republic of Korea; 2Samsung Medical Center, Seoul, Republic of Korea Does Predischarge Transthoracic Echocardiography Post-Valve Surgery Add Value? D. Lamont, B. Yanagawa, G. Pritchard, L. Henry, S. Hunt, L. S. Halpin, N. Ad Cardiac Vascular & Thoracic Surgery Associates, Falls Church, VA Repeat Sternotomy: No Longer a Risk Factor in Mitral Valve Surgery M. Ghoreishi1, G. Hobbs2, M. Y. Dawood1, B. P. Griffith1, J. S. Gammie1 1 University of Maryland School of Medicine, Baltimore; 2West Virginia University, Morgantown

49th ANNUAL MEETING

Advance Program 31


Co-Transplantation of Mesenchymal Stem Cells Improves the Myocardial Integration of iPS Cell-Derived Cardiomyocytes K. Neef1, V. Lenerz1, A. Fatima1, C. Stamm2, O. J. Liakopoulos1, T. Saric1, T. C. Wahlers1, Y. Choi1 1 University of Cologne, Germany; 2 Charite University Berlin, Germany Increasing Repair Feasibility of Complex Mitral Valve Prolapse with the Chordae System Technique M. Scorsin1, G. Vaccari1, O. Dyrda1, N. Al-Attar2, S. Trimboli1, C. Comoglio1, A. Lessana3, J. Pomar4 1 Maria Pia Hospital, Turin, Italy; 2Hôpital Bichat, Paris, France; 3Institut Mutualiste Montsouris, Paris, France; 4Hospital Clinico de Barcelona, Spain TAVI and Need for Postprocedural Pacemaker Insertion: Technique Matters V. Herwig, A. Harnath, S. Schenk, D. Fritzsche Sana Heart Center Cottbus, Germany Aortic Valve Replacement with Sutureless Bioprosthesis: 1-Year Clinical and Hemodynamic Outcomes A. Messina, M. Cirillo, E. Villa, M. Campana, F. Brunelli, M. Dalla Tomba, Z. Mhagna, G. Troise Poliambulanza Foundation Hospital, Brescia, Italy Impact of Preoperative Chronic Lung Disease on Long-Term Survival for Patients Undergoing Aortic Valve Replacement R. L. Gunter, S. R. Neravetla, P. Kilgo, R. A. Guyton, E. P. Chen, W. A. Cooper, M. E. Halkos, J. D. Puskas, O. M. Lattouf, V. Babaliaros, R. Myung, V. H. Thourani Emory University, Atlanta, GA Twenty-Year Analysis of Autologous Support of the Pulmonary Autograft in the Ross Procedure Using a Variant Inclusion Cylinder Method, in Adults Younger Than 60 Years P. D. Skillington1, J. Takkenberg2, L. Grigg1, M. Larobina1 1 Royal Melbourne Hospital, Parkville, VIC, Australia; 2Erasmus University Medical Center, Rotterdam, Netherlands

Nonresectional Single-Suture Leaflet Remodeling for Degenerative Mitral Regurgitation Facilitates Minimally Invasive Mitral Valve Repair J. W. MacArthur, Y. Shudo, A. S. Fairman, A. B. Goldstone, P. Atluri, Y. J. Woo University of Pennsylvania, Philadelphia Primary Aortic Valve Repair is Inferior to Root Reimplantation in Bicuspid Aortic Insufficiency P. Vallabhajosyula, W. Y. Szeto, C. Komlo, T. J. Wallen, N. Desai, J. E. Bavaria Hospital of the University of Pennsylvania, Philadelphia Risk Factors Predicting the Postoperative Outcome in 134 Patients with Active Endocarditis S. Neragi-miandoab, D. A. D’alessandro, R. A. Bello, D. J. Goldstein, J. J. DeRose, R. E. Michler Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY Quality of Life after Surgical Versus Percutaneous Coronary Revascularization: A Meta-Analysis E. Angeloni, U. Benedetto, A. Roscitano, F. Capuano, C. Comito, G. Melina, R. Sinatra Università di Roma, Sant’ Andrea Hospital, Rome, Italy A Contemporary Cost Analysis of Postoperative Morbidity Following Coronary Artery Bypass Grafting with and without Concomitant Aortic Valve Replacement to Improve Patient Quality and Cost Effective Care D. J. LaPar1, I. K. Crosby1, J. B. Rich3, E. Fonner4, I. L. Kron1, G. Ailawadi1, A. M. Speir2 1 University of Virginia, Charlottesville; 2INOVA Heart and Vascular Institute, Falls Church, VA; 3Mid-Atlantic Cardiothoracic Surgeons , Norfolk, VA; 4Virginia Cardiac Surgery Quality Initiative, Charlottesville, VA Deep Hypothermic Circulatory Arrest Versus Non-Deep Hypothermic Beating Heart Strategy in Thoracoabdominal Aortic Surgery J. Kim, W. Lee, S. Jung, S. Choo, C. Chung, J. Lee Asan Medical Center, Seoul, Republic of Korea

C ONG EN I TA L P OS T ERS The Value of 3D Implant Templates for Transcatheter Aortic Valve Implantation Planning M. Gessat1, S. H. Sündermann1, J. Kempfert2, T. Walther2, V. Falk1 1 University Hospital Zürich, Switzerland; 2Kerkhoff Clinic, Bad Nauheim, Germany Long-Term Impact of Stentless Aortic Bioprosthesis Implantation on Late Cardiac Function: A Comparative Study of Stentless and Stented Aortic Bioprosthesis for Aortic Stenosis T. Murashita, Y. Okada, N. Fukunaga, Y. Konishi, T. Koyama Kobe City Medical Center General Hospital, Japan Aortic Valve Reconstruction Using Autologous Pericardium for Octogenarian and Nonagenarian S. Ozaki, I. Kawase, S. Uchida, H. Yamashita, Y. Nozawa, T. Matsuyama, M. Takatoo, S. Hagiwara Toho University Medical Center Ohashi Hospital, Meguro-ku, Japan The Transient Outward and Sustained Outward Potassium Current Changes Account for Atrial Fibrillation in Isolated Human Atrial Myocytes C. Zhang, Y. Okamoto, T. Ohba, G. D. Yamaura, M. Motukawa, F. Tanaka, K. Shiroto, H. Sato, S. Shibata, K. Ishibashi, H. Yamamoto, K. Ono, F. Yamamoto Akita University Graduate School of Medicine, Japan Implant and Short-Term Outcome with a Second Generation Self-Expandable Transapical Aortic Valve: Single Centre Post CE-Mark Experience with the JenaValveTM System F. Rueter, D. T. Inderbitzin, M. Grapow, P. Matt, U. P. Schurr, F. S. Eckstein, O. Reuthebuch University Hospital Basel, Switzerland Impact of Three-Dimensional Echocardiography on Classification of the Severity of Aortic Stenosis J. S. Jainandunsing2, J. Lee1, O. Shakil1, P. Hess1, R. Matyal1, K. R. Khabbaz1, J. H. Gorman3, R. C. Gorman3, F. Mahmood1 1 Beth Israel Deaconess Medical Center - Harvard Medical School, Boston, MA; 2 University Medical Center Groningen, University of Groningen, Netherlands; 3 Hospital of the University of Pennsylvania, Philadelphia

32


www.sts.org

Blood Conservation Strategies for Infants Undergoing Open Heart Surgery: Impact of Less Hemodilution with Integrated Low Prime Circuits S. Gunaydin1, Y. Yalcinbas2, K. Mccusker3, T. Sarioglu2 1 University of Kirikkale, Ankara, Turkey; 2Acibadem University, Istanbul, Turkey; 3 Portsmouth Regional Hospital, Portsmouth, NH Bilateral Pulmonary Artery Banding as Rescue Intervention Prior to Definitive Surgery in High-Risk Neonates with Ductal-Dependent Systemic Outflow Obstruction R. A. Russell1, N. S. Ghanayem1, M. E. Mitchell2, R. K. Woods2, J. S. Tweddell2 1 Medical College of Wisconsin, Milwaukee; 2Children’s Hospital of Wisconsin, Milwaukee Heart Transplantation for the Failing Fontan C. L. Backer, H. M. Russell, E. Pahl, S. J. Kindel, K. E. Gambetta, J. G. Gossett, B. J. Deal Ann & Robert H. Lurie Children’s Hospital of Chicago, IL Surgical Pulmonary Valve Replacement: A Benchmark for Outcomes Comparisons M. S. Khan, T. W. Dietzman, A. X. Samayoa, J. S. Heinle, C. D. Fraser, A. Liou, E. D. Mckenzie Texas Children’s Hospital, Baylor College of Medicine, Houston Results of Rapid-Response Extracorporeal Membrane Oxygenation Support in Children with Refractory Cardiac Arrest Following Cardiac Surgery B. Alsoufi1, A. A. Awan1, C. Manlhiot2, Z. Y. Al-halees1, B. McCrindle2, M. D. Al-ahmadi1, A.Kalloghlian1 1 Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 2Labatt Family Heart Center, Hospital for Sick Children, Toronto, ON, Canada Poor Left Ventricular Compliance Long after Successful Ross-Konno Operation T. Hoashi, K. Kagisaki, I. Shiraishi, T. Yagihara, H. Ichikawa National Cerebral and Cardiovascular Center, Suita, Japan


Creating a Value Index: A Method to Compare Regional Programs Performing Congenital Heart Surgery S. A. Husain, M. S. Rahman, D. A. Forgione, L. C. Kane, S. Neish, C. Baisden, J. H. Calhoon The University of Texas Health Science Center at San Antonio, TX Clinical Outcomes of Common Atrioventricular Valve Repair in Patients with Functional Single Ventricle Y. Misumi, K. Kagisaki, T. Hoashi, T. Yagihara, H. Ichikawa National Cerebral and Cardiovascular Center, Suita, Osaka, Japan Hypercoagulability Markers Predict Thrombosis in Single Ventricle Neonates Undergoing Cardiac Surgery S. Emani, D. Zurakowski, C. W. Baird, F. A. Pigula, C. C. Trenor, S. Emani Boston Children’s Hospital, MA Blood Conservation Surgery in Pediatric Cardiac Patients: A Paradigm Shift to Blood Utilization M. Karimi, I. Florentino-Pineda, T. Weatherred, A. Qadeer, C. Rosenberg, A. E. Hudacko Georgia Health Science University, Augusta Hypertensive Changes in the Aorta of Neonates and Infants with Coarctation M. F. Swartz, F. J. Gensini, J. M. Cholette, R. W. Kavey, G. M. Alfieris University of Rochester-Strong Memorial Hospital, NY Regression of Left Ventricular Hypertrophy in Children after the Ross Operation: An Intermediate-Term Follow Up J. M. Lehoux, M. F. Swartz, N. Atallah-Yunes, G. M. Alfieris University of Rochester, NY Long-Term Outcomes of Arterial Switch Operation in Patients with Transposition of Great Arteries and Left Ventricular Outflow Tract Obstruction D. Kalfa, V. Lambert, M. Ly, E. Le Bret, E. Garcia, E. Belli Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France Failed Autograft Following the Ross Procedure in Children: Management and Outcomes R. Mark, M. G. Dale, J. J. Shah, W. Albers, D. P. Chen, R. S. Fortuna University of Illinois College of Medicine at Peoria, IL Extra-anatomic Bypass for the Treatment of Midaortic Syndrome in Children R. Hetzer, D. O. Absi, F. Berger, E. B. Delmo Walter Deutsches Herzzentrum Berlin, Germany Risk Factors and Outcomes in Children with Arch Obstruction Following the Norwood Operation A. Walters, M. F. Swartz, G. M. Alfieris University of Rochester-Strong Memorial Hospital, NY Association of Postoperative Complications with Intraoperative Blood Product Transfusions in Pediatric Cardiopulmonary Bypass Surgery Patients C. N. Scipione, A. Iyengar, P. Sheth, R. G. Ohye, L. Q. Riegger, E. L. Bove, E. J. Devaney, J. C. Hirsch University of Michigan, Ann Arbor Inadequate Technical Performance Scores Are Associated with Late Mortality and Need for Late Re-intervention in a 13-Month Cohort of Patients Followed for 4 Years M. Nathan, F. A. Pigula, H. Liu, K. Gauvreau, S. D. Colan, F. E. Fynn-thompson, S. Emani, C. W. Baird, J. E. Mayer, P. J. del Nido Children’s Hospital Boston, MA Impact of Right Ventricular Outflow Tract Reconstruction Strategies on the Risk of Pulmonary Valve Implantation after the Repair of Tetralogy of Fallot: Pulmonary Annulus Preservation Versus Transannular Patching T. Yun, G. Kim, J. Kim, S. Han, H. Kim Asan Medical Center, Seoul, Republic of Korea

Troponin-I is a Predictor of Mortality in Patients Who Received Extracorporeal Membrane Oxygenation Following Congenital Cardiac Surgery A. Rüffer1, F. Münch1, S. Potapov2, A. Purbojo1, O. Toka1, S. Dittrich1, R. A. Cesnjevar1 1 University Hospital Erlangen, Germany; 2Friedrich Alexander University ErlangenNuremberg, Erlangen, Germany One Size Does Not Fit All: The Influence of Age at Surgery in Outcomes Following Norwood Operation T. B. Karamlou1, K. Sexson1, A. R. Parrish2, K. F. Welke2, L. C. Permut2, D. M. Mcmullan2, G. A. Cohen1 1 University of San Francisco, CA; 2Seattle Children’s Hospital, WA Aspirin Resistance in Patients with Single Ventricle Physiology and Shunts is Not Dose Dependent A. Mir, K. J. Guleserian, J. S. Wolovits, J. Journeycake, L. C. Heistein, M. S. Lemler 1 The University of Texas Southwestern Medical Center, Dallas First Report of Risk Models from Japan Congenital Cardiovascular Surgery Database (JCCVSD) A. Murakami1, H.Miyata1, S. Takamoto2, S. Sano4, T.Takaoka1, T. Konuma3, G. Matsumura3, K. Hirose5, M. Kimura1, A. Tomotaki1, A. Umeki1 1 The University of Tokyo, Japan; 2Mitsui Memorial Hospital, Tokyo, Japan; 3Tokyo Women’s Medical College, Japan; 4Okayama University, Japan; 5Tenri Yorozu Soudannsyo Hospital, Nara, Japan Correction of Type IV (Mixed) Total Anomalous Pulmonary Venous Connection: A Review of the Pediatric Cardiac Care Consortium J. D. St. Louis1, B. A. Harvey1, J. Menk1, J. E. O’Brien2, R. Bryant1, L. Kochilas1 1 University of Minnesota, Minneapolis; 2Children’s Mercy Hospitals and Clinics, Kansas City, MO

G ENER A L T HOR AC I C P OS T ERS Long-Term Survival of Non-Small Cell Lung Cancer That is Greater Than 70 mm in Diameter M. Poullis, M. Shackcloth, N. Mediratta, R. Warwick Liverpool Heart and Chest Hospital, United Kingdom Utility of Vacuum-Assisted Closure Therapy in General Thoracic Surgery A. Gonfiotti, M. O. Jaus, S. Baiguera, P. Macchiarini University Hospital Careggi, Firenze, Italy The Influence of Hemostatic Agents on Bone Healing Following Median Sternotomy: A Randomized Clinical Trial R. F. Vestergaaard1, P. H. Nielsen1, K. A. Terp1, K. Søballe2, G. Andersen1, J. M. Hasenkam1 1 Aarhus University Hospital, Skejby, Denmark; 2Aarhus University Hospital, Tage Hansens Gade, Denmark Resection of T4 Non-Small Cell Lung Cancer Invading the Spine D. Galetta, A. Pardolesi, R. Gasparri, A. Borri, F. Petrella, M. Casiraghi, A. Tessitore, L. Spaggiari European Institute of Oncology, Milan, Italy The Role of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating Stage I from Stage II Lung Cancer K. Yasufuku1, T. Nakajima1, T. K. Waddell1, S. Keshavjee1, I. Yoshino2 1 Toronto General Hospital, ON, Canada; 2Graduate School of Medicine, Chiba University, Japan Silent Aspiration Following Esophagectomy: Assessment and Management Through Pathway-Driven Patient Care Can Reduce Costs N. P. Jaik1, S. A. Deppen1, T. R. Dirda2, L. F. McBride1, E. L. Grogan1, E. S. Lambright1, J. C. Nesbitt1, J. B. Putnam1 1 Vanderbilt University, Nashville, TN; 2Meharry School of Medicine, Nashville, TN Staged Bilateral Lung Volume Reduction with No Tissue Resection in Awake Patients E. Pompeo, P. Rogliani, O. Schillaci, C. Saltini, B. Cristino, G. Novelli Policlinico Tor Vergata University, Rome, Italy 49th ANNUAL MEETING

Advance Program 33


Effects of Prophylactic Use of Sirolimus on BOS Development in Lung Transplant Recipients V. Y. Sacher1, K. Srivastava1, D. Fertel2, A. L. Panos1, D. M. Nguyen1, T. M. Baxter1, S. Shafazand3, S. M. Pham1 1 University of Miami, Jackson Memorial Hospital, FL; 2Florida International University, Miami; 3University of Miami, FL The Effect of Lung Size Mismatch on Survival after Single and Bilateral Lung Transplantation M. Eberlein1, R. M. Reed3, G. J. Arnaoutakis2, S. Bolukbas4, K. R. Parekh1, C. A. Merlo2, A. S. Shah2 1 University of Iowa, Iowa City; 2The Johns Hopkins University, Baltimore, MD; 3 University of Maryland, Baltimore; 4Horst Schmidt Kliniken, Wiesbaden, Germany Surgical Treatment of Nontuberculous Mycobacterial Lung Disease Y. Shiraishi, N. Katsuragi, H. Kita, A. Hyogotani, M. Hiramatsu, K. Shimoda Fukujuji Hospital, Tokyo, Japan Hospital Resource Utilization and Outcomes of Pleurectomy/Decortication Compared to Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma R. B. Cameron, O. Olevsky, M. Selch, M. C. Fishbein, F. Abtin, W. D. Wallace, C. Lai, R. Suh, A. Rorie David Geffen School of Medicine at the University of California, Los Angeles Utilization of the Donor Lung after Asphyxiation or Drowning: Effect on Survival and Rejection in Lung Transplant Recipients B. A. Whitson, M. I. Hertz, R. F. Kelly, S. J. Shumway, J. D’Cunha University of Minnesota, Minneapolis Adenocarcinoma of the Esophagus with Signet Ring Cell Features Portends a Poor Prognosis J. M. Enlow, C. Denlinger, C. E. Reed Medical University of South Carolina, Charleston Long-Term Survival of Patients with IIIb-N3 Non-Small Cell Lung Cancer Treated with Surgical Resection D. J. Raz, R. Nelson, J. Y. Kim City of Hope Medical Center, Duarte, CA The Impact of EGFR Mutation Status on Outcomes in Patients with Resected Stage I Non-Small Cell Lung Cancers M. Lanuti1, M. R. Lee2, L. V. Sequist1, D. J. Mathisen1 1 Massachusetts General Hospital, Boston; 2Harvard Medical School, Boston, MA Impact of the Universal Bed on Decreasing Hospital Length of Stay Following Esophagectomy B. Nam, V. L. Sales, T. L. Weigel University of Wisconsin, Madison A Health Provider Team Education Program and Postoperative Pathway for Patients Undergoing Esophagectomy Improves Outcomes D. T. Cooke, F. Kromah, J. Harvey-Taylor, V. Kuderer, R. F. Calhoun University of California, Davis Medical Center, Sacramento Usefulness of Combined 18FFDG PET/CT for Predicting the WHO Malignancy Grade of Thymic Epithelial Tumors: A Multicenter Analysis on 47 Patients F. Lococo1, A. Cesario2, S. Margaritora1, G. Cardillo3, J. Okami4, G. Treglia5, S. Cavuto6, P. M. Granone1 1 Catholic University, Rome, Italy; 2IRCCS San Raffaele Pisana, Rome, Italy; 3Osaka Medical Hospital for Cancer and Cardiovascular Diseases, Japan; 4Institute of Nuclear Medicine, Catholic University, Rome, Italy; 5Azienda Ospedaliera San Camillo Forlanini, Rome, Italy; 6IRCCS Azienda Ospedaliera Arcispedale Santa Maria Nuova, Reggio Emilia, Italy The Next Generation Pectus Excavatum Repair Technique: New Devices Make a Difference H. Park, S. Sung, J. Park, H. Jeon, B. Yoo, K. Kim, Y. Wang Seoul St. Mary’s Hospital, The Catholic University of Korea, Republic of Korea Thoracoscopic Pulmonary Resection Under Spontaneous-Breathing Laryngeal Mask Anaesthesia (LMA) M. C. Ambrogi, S. Korasidis, F. Davini, R. Gemignani, O. Fanucchi, A. Mussi University of Pisa, Italy

34


www.sts.org

Fate of Newly Detected Lesions on Chest Computed Tomography During Postoperative Surveillance for Non-Small Cell Lung Cancer J. Lee, Y. Lee, K. Park, C. Park, Y. Jeon, C. Choi Gachon University Gil Hospital, Incheon, Republic of Korea Reconstruction of the Superior Vena Cava by Biological Conduit: Assessment of Long-Term Patency by Magnetic Resonance Imaging A. D’Andrilli1, C. N. De Cecco1, G. Maurizi1, G. Muscogiuri1, C. Poggi1, R. Baldini1, F. Venuta2, E. A. Rendina1 1 University LaSapienza- Sant’Andrea Hospital, Rome, Italy; 2University SapienzaPoliclinico Umberto I, Rome, Italy Surgery after Induction Therapy for Pathologically Downstaged T0N0 and T1-2N0 NSCLC: An Unexpected Excellent Long-Term Survival C. Gebitekin1, A. Toker2, H. Melek1, S. Erus2, A. S. Bayram1, B. Ozkan2, T. Evrensel1, S. Saruhan1, E. Ulker1 1 Uludag University, School of Medicine, Bursa, Turkey; 2Istanbul University, Istanbul School of Medicine, Turkey Low Morbidity and High Accuracy of Video-Assisted Lung Biopsy for Interstitial Lung Disease: Prevention of Acute Exacerbation by Selective Segmental Ventilation Y. Miyata, Y. Tsutani, T. Mimae, T. Yoshiya, Y. Ibuki, K. Misumi, N. Ishikawa, N. Hattori, M. Okada Hiroshima University, Japan Thoracoscopy Without Lung Isolation Utilizing Single Lumen Endotracheal Tube Intubation and Carbon Dioxide Insufflation M. Sancheti, B. P. Dewan, A. Pickens, F. G. Fernandez, D. L. Miller, S. D. Force 1 Emory University, Atlanta, GA The Level of Sympathetic Chain Removal Has No Effect on Incidence or Severity of Compensatory Hyperhidrosis Following Thoracoscopic Sympathectomy M. D. Iannettoni, D. M. Davis, W. R. Lynch, K. R. Parekh University of Iowa, Iowa City Early Removal of Urinary Catheters with Thoracic Epidurals: A Prospective Trial Y. Hu, C. L. Lau, D. R. Jones, B. D. Kozower University of Virginia, Charlottesville Lung Transplantation in Patients Older Than 70 Years: Midterm Outcomes C. Bermudez, D. B. Zaldonis, N. Shigemura, M. M. Crespo, J. Pilewski, J. McDyer, M. R. Morrell, C. J. Gries, S. Haider, J. K. Bhama University of Pittsburgh Medical Center, PA Comparative Analysis of Pleural Recurrence and Long-Term Survival Between Thoracotomy and Thoracoscopic Lobectomy for Non-Small Cell Lung Cancer with Visceral Pleural Invasion S. H. Kim1, H. Kim1, Y. Choi1, K. Kim2, J. Kim1, Y. Shim1 1 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 2Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea Superior Sulcus Tumor: Factors Affecting Survival in a Single-Center Experience with 104 Cases D. Galetta, A. Borri, R. Gasparri, F. Petrella, M. Casiraghi, A. Tessitore, A. Pardolesi, L. Spaggiari European Institute of Oncology, Milan, Italy Bullectomy for Symptomatic or Complicated Giant Bulla of the Lung P. Krishnamohan, K. R. Shen, D. A. Wigle, M. S. Allen, F. C. Nichols, S. D. Cassivi, C. Deschamps Mayo Clinic, Rochester, MN Coronary Artery Calcification Score Predicts Post-Lobectomy Morbidity J. A. Frankel, S. M. Keller, A. Jacobi, J. M. Levsky, B. Zalta, A. Godelman, L. B. Haramati Montefiore Medical Center, Bronx, NY

When registering, be sure to choose the value-added option and take advantage of special pre-meeting prices for . . .

STS 49th Annual Meeting Online and STS/AATS Tech-Con 2013 Online

With such a full schedule, it’s difficult to attend every presentation of interest. Through these web-based video presentations, earn CME credit for sessions you were unable to attend or give yourself the opportunity to review sessions of special interest in the comfort of your home or office. You’ll be able to experience presenter slide animation, cursor movement, and full audio from the vast majority of sessions. In addition to viewing presentations on your computer, you can also access them from your iPad and most Android and iOS mobile devices. When registering for the STS 49th Annual Meeting and STS/AATS Tech-Con 2013, don’t forget to sign up for both online products at special discounted meeting registrant rates. After January 18, 2013, pricing will be significantly higher.

A c c r e d i tat i o n S tat e m e n t The Society of Thoracic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

STS 49th Annual Meeting Online The Society of Thoracic Surgeons designates this enduring material for a maximum of 82.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

S T S / A AT S T e c h - C o n 2 0 13 o n l i n e The Society of Thoracic Surgeons designates this enduring material for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

49th ANNUAL MEETING

Advance Program 35

REGISTR ATION INSTRUCTIONS

Please carefully read the instructions below before completing the online registration form. REGISTRATION IS AVAILABLE ONLINE ONLY AT WWW.STS.ORG/ANNUALMEETING Deadline: Advance registration will end Friday, January 18, 2013. Please note: Registration fees will increase after this date. For questions about registration, contact Debbie Watrous, STS Meetings Coordinator, at [email protected].

REGISTRATION CATEGORIES Registration is open to all physicians and other individuals in the health care field and includes a name badge, Program, admission to the Exhibit Hall, and all sessions other than those indicated as ticketed events. Pricing for ticketed sessions is itemized on page 38. Please note that STS members are NOT automatically registered for the Annual Meeting. STS SURGEON MEMBER: This category is for STS Active and International members. STS ASSOCIATE PHYSICIAN MEMBER: This category is for member physicians who work with cardiothoracic surgeons. STS ASSOCIATE ALLIED HEALTH MEMBER: This category is for PhD research scientists, physician assistants, perfusionists, nurses, nurse practitioners, practice administrators, data managers, and other allied health care professionals who are STS members. STS PRE-CANDIDATE AND CANDIDATE MEMBER: Pre-Candidate: This category is for medical students and general surgery residents who are STS members. Candidate: This category is for cardiothoracic surgery residents/fellows who are STS members. NON-MEMBER PHYSICIAN: This category is for non-member cardiothoracic surgeons and other physicians who work with cardiothoracic surgeons. Those with pending membership applications must register as non-members for this meeting. NON-MEMBER ALLIED HEALTH: This category includes all non-member PhD research scientists, physician assistants, perfusionists, nurses, nurse practitioners, practice administrators, data managers, and other allied health care professionals who work with cardiothoracic surgeons. NON-MEMBER RESIDENTS, FELLOWS, AND MEDICAL STUDENTS: In order to register for the STS 49th Annual Meeting, non-member medical students, general surgery residents, and cardiothoracic surgery residents/fellows must complete a registration certification form, which can be found on www.sts.org/annualmeeting. Completed forms must be uploaded to the applicant’s STS profile page. Residents and fellows must have their chief of service sign the certification form, and medical students must send a copy of their current student identification card.

BECOME AN STS ASSOCIATE, CANDIDATE, OR PRE-CANDIDATE MEMBER! Non-members interested in attending the STS 49th Annual Meeting can gain numerous benefits by applying for STS Associate, Candidate, or Pre-Candidate Membership. STS Associate Membership is open to physicians not eligible for Active or International Membership, scientists conducting research in the field of thoracic surgery, physician assistants, perfusionists, nurses, nurse practitioners, practice administrators, data managers, and other health care professionals who support and work directly with cardiothoracic surgeons.

36


www.sts.org

STS Candidate Membership is open to cardiothoracic surgery residents/fellows. STS Pre-Candidate Membership is open to general surgery residents and medical students. Note that one of the benefits of STS Candidate and Pre-Candidate Membership is that Annual Meeting registration is FREE. (Additional costs apply for standalone symposia and ticketed events.) Applications for Associate, Candidate, or Pre-Candidate Membership must be submitted by January 15, 2013, to allow time for processing. Those approved for membership can attend the STS 49th Annual Meeting as a member and begin enjoying member benefits right away. For membership information and an application, visit www.sts.org/membership or contact Sarah Foreman, STS Member Services Coordinator, at [email protected].

SEPARATE MEETINGS AND SESSIONS STS/AATS Tech-Con 2013 Registration for this meeting is separate from the STS 49th Annual Meeting, and as such, has a separate registration fee. Registering for the STS 49th Annual Meeting does NOT automatically register you for Tech-Con. STS/SCA: Intraoperative Echo and Decision Making in Cardiovascular Surgery Registration for this meeting is separate from the STS 49th Annual Meeting, and as such, has a separate registration fee. Registering for the STS 49th Annual Meeting does NOT automatically register you for the STS/SCA course. STS/ACCP: Primer on Advanced and Therapeutic Bronchoscopy: Theory and Hands-On Session Registration for this meeting is separate from the STS 49th Annual Meeting, and as such, has a separate registration fee. Registering for the STS 49th Annual Meeting does NOT automatically register you for the STS/ACCP course. STS Practice Management Summit Registration for this meeting is separate from the STS 49th Annual Meeting, although the STS Practice Management Summit’s fee is reduced if you also register for the STS 49th Annual Meeting. Registering for the STS 49th Annual Meeting does NOT automatically register you for the Summit. Ticketed Sessions and STS University ONE The sessions and courses in this program marked with ADMIT require tickets to attend. Please see the chart on page 38 for pricing details.

CANCELLATION POLICY All cancellation requests must be made in writing and postmarked or e-mailed to The Society of Thoracic Surgeons, 633 N. Saint Clair Street, Floor 23, Chicago, IL, 60611 or [email protected] by Friday, January 18, 2013. Requests for refunds will not be honored if submitted after that date. A processing fee of $50 will be charged for all cancellations.

ONSITE REGISTRATION INFORMATION Onsite registration will be located in the West Lobby of the Los Angeles Convention Center during the following times: Friday, January 25, 2013 Saturday, January 26, 2013 Sunday, January 27, 2013 Monday, January 28, 2013 Tuesday, January 29, 2013 Wednesday, January 30, 2013

3:00 PM – 6:00 PM 7:00 AM – 6:00 PM 7:00 AM – 6:30 PM 6:30 AM – 5:00 PM 6:30 AM – 4:30 PM 6:30 AM – 9:30 AM

T r avel and Housing In formation

6

1. JW Marriott Hotel Los Angeles at L.A. LIVE (Adjacent to Convention Center)

5

7

2. The Ritz Carlton Los Angeles (Adjacent to Convention Center)

3. L uxe City Center Hotel (1 block to Convention Center)

4

2

4. Sheraton Los Angeles Downtown (4 blocks to Convention Center)

5. Westin Bonaventure Hotel & Suites (6 blocks to Convention Center)

1 3

Convention Center

6. The LA Hotel Downtown (7 blocks to Convention Center)

7. Omni Los Angeles (8 blocks to Convention Center)

AIR TRAVEL

HOUSING INSTRUCTIONS

The Los Angeles International Airport (LAX) is located approximately 20 miles from the Los Angeles Convention Center and the official STS hotels.

STS has secured special rates at a number of Los Angeles hotels. You can make housing reservations online at www.sts.org/annualmeeting. Housing requests must be received by Experient (the STS Housing Bureau) no later than Friday, December 28, 2012.

GROUND TRANSPORTATION FROM LAX Car Rental STS has negotiated special car rental rates from Hertz Rent a Car. Reservations may be placed at www.hertz.com or from within the United States and Canada at (800) 654-2240; from international locations, call (405) 749-4434. To receive the special STS rate, reference convention number (CV#) 04R50002. Taxi Service Taxis depart from designated taxi zones centrally located at the airport. Los Angeles Yellow Cab is the largest taxi company in the city. To book a cab, you can download their “Taxi Magic” app on your smartphone or tablet or visit www.layellowcab.com. Shuttle Service / Private Car SuperShuttle provides airport shuttle service or private car service to all official STS hotels. To make a reservation, visit www.supershuttle.com/locations/LAXairportshuttlelosangeles.aspx or call (310) 782-6600 or toll-free (800) 258-3862. Book your transportation in advance to secure the best rates. Public Transportation Several public transportation options are available at LAX:

Exhibiting companies requiring 10 or more rooms must contact Experient at (866) 229-2386 or (301) 694-5243 or e-mail [email protected].

TRANSPORTATION TO THE CONVENTION CENTER Complimentary shuttle service will be provided beginning Friday, January 25, 2013, between the Los Angeles Convention Center and the following official STS hotels: Sheraton Los Angeles Downtown Hotel, Westin Bonaventure Hotel & Suites, The L.A. Hotel Downtown, and Omni Los Angeles (other official STS hotels are located within walking distance of the convention center). A schedule will be posted in the lobby of each hotel.

LAX FlyAway The LAX FlyAway offers round-trip service 7 days a week between LAX and Union Station in downtown Los Angeles. Depending on traffic, the travel time is approximately 30–50 minutes. Reservations are not required: Simply look for the green “FlyAway, Buses, and Long Distance Vans” signs in the lower arrivals level of each terminal. Visit www.lawa.org/welcome_LAX.aspx?id=292 for more information. LA Metro You can take Metro bus or rail lines from the airport to several downtown locations. Visit www.metro.net for more information. 49th ANNUAL MEETING

Advance Program 37

p ricing

Surgeon Members

Associate Physician Members

Associate Allied Health Members

Candidate and Pre-Candidate Members

Non-Member Residents, Fellows, and Medical Students

Non-Member Physicians

Non-Member Allied Health

Through January 18 / After January 18

$200 / $300

$200 / $300

$100 / $200

$0

$100 / $200

$750 / $900

$200 / $350

+ STS Practice Management Summit

$50

$50

$50

$0

$50

$50

$50

STS Practice Management Summit ONLY

$100

$100

$100

$0

$100

$100

$100

STS 49th Annual Meeting

Standalone Symposia *Annual Meeting registration not required to attend STS/SCA: Intraoperative Echo and Decision Making in Cardiovascular Surgery

$200

$200

$100

$100

$150

$250

$150

STS/ACCP: Primer on Advanced and Therapeutic Bronchoscopy: Theory and Hands-On Session

$200

$200

$100

$100

$150

$250

$150

Ticketed Sessions *Must be signed up for Annual Meeting OR Tech-Con to attend General Thoracic Parallel (with Tech-Con registration)

$0

$0

$0

$0

$0

$0

$0

Congenital Parallel (with Tech-Con registration)

$0

$0

$0

$0

$0

$0

$0

General Thoracic Parallel (without Tech-Con registration)

$75

$75

$75

$75

$75

$75

$75

Congenital Parallel (without Tech-Con registration)

$75

$75

$75

$75

$75

$75

$75

Ticketed Sessions *Must be signed up for Annual Meeting to attend STS/AATS Cardiothoracic Critical Care Symposium

$250

$250

$250

$250

$350

$350

$350

International Reception and Symposium

$40

$40

$40

$40

$40

$40

$40

Early Riser Sessions (each)

$40

$40

$40

$40

$40

$40

$40

Health Policy Forum

$40

$40

$40

$40

$40

$40

$40

Ethics Debate

$40

$40

$40

$40

$40

$40

$40

Tuesday Night Social Event (tentative)

$135

$135

$135

$135

$135

$135

$135

STS University courses (each)

$125

$125

$125

$40

$125

$125

$125

$375 / $475

$375 / $475

$375 / $475

$0

$0

$600 / $700

$600 / $700

STS/AATS Tech-Con 2013 Through January 18 / After January 18

STS 49th Annual Meeting Online *Must be signed up for the Annual Meeting to get the Pre-Meeting or Onsite price Pre-Meeting (Through January 18)

$75

$75

$75

$0

$150

$150

$150

Onsite (January 19 - January 30)

$150

$150

$150

$0

$300

$300

$300

Post-Meeting (After January 30)

$300

$300

$300

$0

$600

$600

$600

STS/AATS Tech-Con 2013 Online *Must be signed up for Tech-Con to get the Pre-Meeting or Onsite price Pre-Meeting (Through January 18)

$75

$75

$75

$0

$150

$150

$150

Onsite (January 19 - January 30)

$150

$150

$150

$0

$300

$300

$300

Post-Meeting (After January 30)

$300

$300

$300

$0

$600

$600

$600

38


www.sts.org

Sp ouse a nd Guest Activities

Visit www.sts.org/annualmeeting to register today!

Drago Centro Cooking School

SPOUSE/GUEST REGISTRATION

Date: Tour Time: Cost:

Registration will be held at the Los Angeles Convention Center. STS will provide complimentary shuttle service between the convention center and certain official STS hotels. Friday, January 25, 2013 Saturday, January 26, 2013 Sunday, January 27, 2013 Monday, January 28, 2013 Tuesday, January 29, 2013

ADMIT ONE

Monday, January 28, 2013 12:15 PM – 2:30 PM *Buses will leave the convention center promptly at noon. $175 per person

3:00 PM – 6:00 PM 7:00 AM – 6:00 PM 7:00 AM – 6:30 PM 6:30 AM – 5:00 PM 6:30 AM – 4:30 PM

SPOUSE/GUEST HOSPITALITY AREA Dates: Sunday, January 27 – Tuesday, January 29, 2013 Time: 9:00 AM – 11:00 AM Location: Room 501C Tour information will be available in the convention center’s hospitality area. A complimentary light continental breakfast will be served each morning.

SPOUSE/GUEST TOURS STS Spouse/Guest Postgraduate Program: Meet the Generations Date: Time:

Cost:

ADMIT ONE

Sunday, January 27, 2013 2:00 PM – 4:30 PM *This event will be held at the convention center in room 501 A/B. $60 per person

Drago Centro is a fine dining Italian restaurant in downtown Los Angeles. Guests will enjoy a hands-on cooking experience in a private room with one of Drago Centro’s master chefs. The class will conclude with a tour of the main kitchen and a fresh batch of the restaurant’s homemade cookies.

Warner Brothers Studio Tour Date: Tour Time: Cost:

ADMIT ONE

Tuesday, January 29, 2013 10:30 AM – 1:00 PM *Buses will leave the convention center promptly at 9:30 AM. $135 per person

Our workplaces and families are made up of an exciting, though not always harmonious, mixture of four different generational cohorts: Traditionalists, Boomers, Xers, and the youngsters from Generation NeXt. Successfully managing relationships requires the ability to understand, communicate with, and motivate people from each generational group. This workshop will address generational issues and provide suggestions for improving interpersonal effectiveness.

Go behind the scenes of your favorite TV shows and movies at the world’s busiest motion picture and television studio. The tour will give you a glimpse into Hollywood at work, as carts take you through back lot streets, sound stages, sets, and craft shops. Keep your eyes open for a celebrity, as production will be happening all around. A snack will be provided during the drive back to the convention center. Please note: A photo ID is required for studio access.

Dr. Mark Taylor is a nationally recognized educator and speaker at the forefront of transformations in education and workforce management. Building on almost 30 years of experience in higher education, management, and service professions, Dr. Taylor has worked with more than 500 schools, companies, and organizations, and has consulted with clients such as 20th Century Fox Motion Pictures, Wal-Mart, FEMA, and the US Army.

The Getty Center Tour

Zumba Class Date: Time:

Cost:

ADMIT ONE

Monday, January 28, 2013 9:30 AM – 10:30 AM *This class will be held at the JW Marriott L.A. Live. $20 per person

ADMIT ONE

Date: Tuesday, January 29, 2013 Tour Time: 1:00 PM – 3:30 PM *Buses will leave the convention center promptly at noon. Cost: $80 per person Los Angeles isn’t only about movie stars. The city is also home to worldrenowned museums, such as the Getty Center. On this tour, you’ll experience the museum’s collection of Western Art from the Middle Ages to the present, displayed against dramatic architecture, tranquil gardens, and breathtaking views. A docent will provide an hour-long tour, and you’ll have additional time to explore on your own. A boxed lunch will be provided.

Are you ready to dance yourself into shape? That’s exactly what Zumba is all about. You’ll burn calories while having fun during this easy-to-follow, Latin-inspired workout. Fitness enthusiasts of all levels can participate, so get ready to sweat!

49th ANNUAL MEETING

Advance Program 39

S P ONSORS A ND EX HIB ITORS

The Society gratefully acknowledges Medtronic, Inc. as a patron sponsor of the STS 49th Annual Meeting. Please thank the following exhibitor partners* when you visit the Exhibit Hall during the STS 49th Annual Meeting. Exhibit Hall hours are: Sunday, 4:30 PM – 6:30 PM ; Monday and Tuesday, 9:00 AM – 4:30 PM.

A & E Medical Corporation ABIOMED, Inc. AcryMed, Inc. ACUTE Innovations Aesculap, Inc. Alere Home Monitoring Products/Quality Assured Services American Association for Thoracic Surgery (AATS) Anchor Products Co. Annals of Thoracic Surgery, The Applied Fiberoptics Association of Physician Assistants in Cardiovascular Surgery (APACVS) AtriCure, Inc. Atrium Medical/MAQUET Baxter BFW Biomet Microfixation CardiacAssist, Inc. Cardica, Inc. CardioPulse (formerly CAOS) CareFusion Cincinnati Sub-Zero Clear Catheter Systems Consumer Reports Cook Medical CorMatrix Cardiovascular, Inc. Covidien CryoLife, Inc. CSA Medical CTSNet Dallen Medical Designs for Vision, Inc. Domain Surgical Dornier MedTech America, Inc. Eastman Chemical Company EBM Corporation Edwards Lifesciences Elsevier Essential Pharmaceuticals

Estech Ethicon Endo - Surgery European Association for Cardio-Thoracic Surgery (EACTS) European Society of Thoracic Surgeons (ESTS) Fehling Surgical Instruments Figure 8 Surgical Genesee BioMedical Gore & Associates, Inc. Heart Hugger/General Cardiac Technology HeartWare, Inc. HRA Healthcare Research and Analytics International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Intuitive Surgical, Inc. Kapp Surgical Instruments, Inc. Karl Storz Endoscopy America KLS Martin, L.P. Koros USA Lexion Medical LifeNet Health LSI Solutions MAQUET MED Alliance Solutions, LLC Medafor, Inc. Medela, Inc. Medical Concepts Europe Medistim MEDMIX SYSTEMS AG Medtronic, Inc. MedXPert North America Mended Hearts, Inc. Mountain States Health Alliance Nadia International, Inc. nContact, Inc. Neomend New Wave Surgical Corp. Olympus America, Inc. On-X Life Technologies, Inc. Oxford University Press Pace Medical, Inc.

PECA Labs Pemco Medical pfm medical, inc. Pioneer Surgical Technology Quest Medical, Inc. Regional Data Managers: STS National Database Richard Wolf Medical Instruments Rose Micro Solutions Rultract, Inc. Rumex International, Co. Sanofi BioSurgery Scanlan International, Inc. Society for Heart Valve Disease, The Society of Thoracic Surgeons, The Sontec Instruments, Inc. Sorin Group Spectranetics Spiration, Inc. St. Jude Medical, Inc. Stryker Endoscopy STS Public Reporting Online Sunoptic Technologies superDimension Surgical Acuity, Inc. SurgiTel Systems/General Scientific Corp. SynCardia Systems, Inc. Synthes CMF Teleflex Terumo Cardiovascular Systems Corporation Thompson Surgical Instruments, Inc. Thoracic Surgery Foundation for Research and Education (TSFRE) Thoramet Surgical Products, Inc. Thoratec Corporation Transonic Varian Medical Systems Vitalcor, Inc. Vitalitec Geister Wexler Surgical

*This list includes sponsors and exhibitors committed as of October 18, 2012.

Meet exhibitors during the Opening Reception from 4:30 PM to 6:30 PM on Sunday, January 27, 2013. 40


www.sts.org

A NNU A L MEETING TASK F ORCES AND ABSTRA CT REVIEWERS

WORKFORCE ON ANNUAL MEETING John V. Conte, Chair Erle H. Austin III Frank C. Detterbeck Gregory P. Fontana Vinod H. Thourani

Baltimore, MD Louisville, KY New Haven, CT Los Angeles, CA Atlanta, GA

WORKFORCE ON ANNUAL MEETING (PROGRAM TASK FORCE) John V. Conte, Chair Vinay Badhwar Todd M. Dewey Michael P. Fischbein James Jaggers Christine L. Lau Thomas E. MacGillivray John D. Mitchell K. Robert Shen Alan M. Speir Wilson Y. Szeto Thomas K. Varghese Jr.

Baltimore, MD Pittsburgh, PA Dallas, TX Stanford, CA Aurora, CO Charlottesville, VA Boston, MA Aurora, CO Rochester, MN Falls Church, VA Philadelphia, PA Seattle, WA

WORKFORCE ON ANNUAL MEETING (STS UNIVERSITY TASK FORCE) Vinod H. Thourani, Chair Robert J. Cerfolio James R. Edgerton Harold G. Roberts Jr. Nicholas G. Smedira Todd S. Weiser David D. Yuh

Atlanta, GA Birmingham, AL Dallas, TX Fort Lauderdale, FL Cleveland, OH New York, NY New Haven, CT

WORKFORCE ON ANNUAL MEETING (SURGICAL SYMPOSIA TASK FORCE) Erle H. Austin III, Co-Chair Louisville, KY Frank C. Detterbeck, Co-Chair New Haven, CT Mark S. Bleiweis Gainesville, FL Montreal, QC, Canada Moishe A. Liberman New York, NY Ralph S. Mosca Richard I. Whyte Boston, MA

WORKFORCE ON ANNUAL MEETING (TECH-CON TASK FORCE)* Gregory P. Fontana, Chair Arvind K. Agnihotri Michael Argenziano Shanda H. Blackmon Marc de Perrot Robert W. Emery Jr. Robert C. Hagberg Ali Khoynezhad Jonathon M. Philpott *Joint STS/AATS activity

Los Angeles, CA Boston, MA New York, NY Houston, TX Toronto, ON, Canada St. Paul, MN Boston, MA Los Angeles, CA Norfolk, VA

As Chair of the Workforce on Annual Meeting, I would like to thank the members of the Annual Meeting Task Forces and all abstract reviewers who volunteered their time, energy, and expertise in developing the STS 49th Annual Meeting program. John V. Conte, Chair, Workforce on Annual Meeting Abstract Reviewers Ghulam Abbas Anwar S. A. Abd-elfattah Gorav Ailawadi Giorgio M. Aru Pavan Atluri Erle H. Austin III Emile A. Bacha Vinay Badhwar Faisal G. Bakaeen Richard J. Battafarano Thomas M. Beaver Christian Bermudez Friedhelm Beyersdorf Ricardo Beyruti Jay K. Bhama Daniel J. Boffa Steven W. Boyce Ross M. Bremner David A. Bull John G. Byrne John H. Calhoon Margarita T. Camacho Duke E. Cameron Andrea J. Carpenter Stephen D. Cassivi David J. Chambers Andrew C. Chang Edward P. Chen Danny Chu Joseph B. Clark Lawrence H. Cohn Yolonda L. Colson John V. Conte Joel D. Cooper Juan A. Crestanello Richard C. Daly Marcelo C. DaSilva Michael J. Davidson Malcolm M. Decamp Pedro J. del Nido Ralph E. Delius Todd M. Dewey J. Michael DiMaio Verdi J. DiSesa Dean M. Donahue John A. Elefteriades Richard P. Embrey Robert W. Emery John Entwistle III Christian D. Etz James I. Fann Kathleen N. Fenton Hiran C. Fernando Victor A. Ferraris Michael S. Firstenberg

Michael P. Fischbein Raja M. Flores Seth D. Force Kenneth L. Franco Joseph S. Friedberg Stephanie M. Fuller David A. Fullerton Henning A. Gaissert Mark E. Galantowicz Aubrey C. Galloway Sanjiv K. Gandhi James J. Gangemi Kristopher M. George Thomas G. Gleason Daniel J. Goldstein Raja R. Gopaldas L. Michael Graver Bartley P. Griffith Eric L. Grogan Peter J. Gruber Robert A. Gustafson Michael E. Halkos John W. Hammon Jeffrey S. Heinle Charles B. Huddleston Mark D. Iannettoni Jeffrey P. Jacobs Robert D. B. Jaquiss Valluvan Jeevanandam Lyle D. Joyce Lauren C. Kane Riyad C. Karmy-Jones Kemp H. Kernstine Sr. Kenneth A. Kesler Benjamin D. Kozower John J. Lamberti Rodney J. Landreneau Michael Lanuti Christine L. Lau Jennifer S. Lawton Shu S. Lin Kevin W. Lobdell Donald E. Low Thomas E. MacGillivray Joren C. Madsen Daniel Marelli M. Blair Marshall Christopher E. Mascio David P. Mason Constantine Mavroudis John E. Mayer Jr. Donna E. Maziak Patrick M. McCarthy Walter H. Merrill Tomislav Mihaljevic

John D. Miller John D. Mitchell Victor O. Morell Cullen D. Morris Christopher R. Morse Sudish C. Murthy Katie S. Nason Jose L. Navia Dao M. Nguyen Richard G. Ohye Arjun Pennathur Mark D. Plunkett V. Seenu Reddy Michael F. Reed Brian L. Reemtsen Gaetano Rocco Eric E. Roselli Todd K. Rosengart Valerie W. Rusch Joseph F. Sabik III Jorge D. Salazar Christopher T. Salerno Juan A. Sanchez Edward B. Savage Matthew J. Schuchert K. Robert Shen Brett C. Sheridan Joseph B. Shrager Nicholas G. Smedira Howard Song Alan M. Speir Thomas L. Spray Robert W. Stewart Lars G. Svensson Julie A. Swain Wilson Y. Szeto Roy T. Temes Michael F. Teodori Ajit K. Tharakan Patricia A. Thistlethwaite Vinod H. Thourani Robert F. Tranbaugh Curt Tribble Mark W. Turrentine Akif Undar Thomas K. Varghese Jakob Vinten-Johansen John C. Wain Jr. Jennifer D. Walker Benny Weksler Michael J. Weyant Glenn J. R. Whitman Richard I. Whyte J. Nilas Young Marco A. Zenati

49th ANNUAL MEETING

Advance Program 41

The Society of Thoracic Surgeons Education Disclosure Policy The Society of Thoracic Surgeons 633 N. Saint Clair Street, Floor 23 Chicago, IL 60611-3658 www.sts.org

49th A n n u a l Meeting & Exhibition Adva nce Program Los Angeles, California Exhibit dates: january 27 – 29, 2013 meeting dates: january 26 – 30, 2013 42


www.sts.org